mitomycin has been researched along with Adenocarcinoma in 633 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gemcitabine-based chemotherapy is a commonly used first-line treatment for patients with pancreatic and biliary tract cancer." | 9.14 | Second-line treatment with a combination of continuous 5-fluorouracil, doxorubicin, and mitomycin-C (conti-FAM) in gemcitabine-pretreated pancreatic and biliary tract cancer. ( Jeong, JS; Kim, BG; Kim, HJ; Kim, SH; Kim, YH; Kwon, HC; Lee, S; Oh, SY; Rho, MH; Rho, MS, 2009) |
| "Based on the observation of topoisomerase-1, upregulation by mitomycin C (MMC), and the phase I antitumor activity of sequential MMC/irinotecan in esophageal cancer, we conducted a phase II evaluation of two schedules of this combination in previously untreated stage III/IV esophageal/gastroesophageal junction adenocarcinomas." | 9.14 | Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma. ( Abbas, A; Bekaii-Saab, T; Burak, W; Lustberg, MB; Lustberg, ME; McCracken-Bussa, B; Otterson, G; Villalona-Calero, MA; Young, D, 2010) |
| "This study evaluates the maximum tolerated dose (MTD) and activity of mitomycin, docetaxel, and irinotecan (MDI) regimen on metastatic pancreatic adenocarcinoma, previously treated with gemcitabine-containing chemotherapy." | 9.11 | Salvage chemotherapy with mitomycin, docetaxel, and irinotecan (MDI regimen) in metastatic pancreatic adenocarcinoma: a phase I and II trial. ( Bonetto, E; Di Carlo, V; Nicoletti, R; Panucci, MG; Passoni, P; Reni, M; Ronzoni, M; Staudacher, C; Villa, E; Zerbi, A, 2004) |
| "Both mitomycin C combination regimens seem to provide an acceptable therapeutic index in patients with fluoropyrimidine/leucovorin-pretreated metastatic colorectal cancer." | 9.10 | Randomized phase II study of irinotecan plus mitomycin C vs. oxaliplatin plus mitomycin C in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer. ( Brugger, S; Depisch, D; Fiebiger, W; Kornek, GV; Kovats, E; Lang, F; Raderer, M; Scheithauer, W; Ullrich-Pur, H; Valencak, J, 2002) |
| " The aim of the present study was to evaluate the effectiveness and safety of a combined-treatment modality consisting of systemic chemotherapy with 24-h continuous infusional gemcitabine and mitomycin C, plus external beam radiotherapy in patients with localized unresectable adenocarcinoma of the pancreas." | 9.09 | Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine. ( Kornek, GV; Kraus, G; Pötter, R; Rogy, M; Scheithauer, W; Schratter, A; Selzer, E; Ulrich-Pur, H, 2001) |
| "Thirty-seven consecutive patients with advanced and/or metastatic gastric adenocarcinoma received a combination of 5-fluorouracil 600 mg/m2 on days 1, 8, 29, 36; epidoxorubicin 75 mg/m2 i." | 9.07 | Combination chemotherapy of 5-fluorouracil, epidoxorubicin and mitomycin C in the palliative treatment of locally advanced and/or metastatic adenocarcinoma of the stomach. ( Bajardi, G; Cannata, G; Cipolla, C; Curto, G; Gebbia, V; Latteri, M; Mastrandrea, G; Pischedda, G; Testa, A; Valenza, R, 1994) |
| "From January 1980 to December 1986, 20 patients with adenocarcinoma of the sigmoid colon were treated with a 6 hours preoperative intra-arterial infusion of mitomycin-C followed by potentially curative surgery (Group A)." | 9.07 | Preoperative intra-arterial mitomycin-C in the management of sigmoid adenocarcinoma: long-term results of a pilot study. ( Campora, E; Cariati, A; De Caro, G; Fardelli, R; Gianquinto, D; Secco, GB; Sertoli, MR; Zoli, S, 1994) |
| "In a randomized trial we compared single-agent epirubicin with the FEM (5-fluorouracil/epirubicin/mitomycin) combination in patients with locally advanced and/or metastatic adenocarcinoma of the pancreas." | 9.07 | Comparison of single-agent epirubicin and 5-fluorouracil/epirubicin/mitomycin in patients with advanced adenocarcinoma of the pancreas. ( Coombes, RC; Glees, J; Topham, C, 1993) |
| "A prospective randomized study to compare the effectiveness of pleurodesis by two new sclerosing agents: OK-432 and mitomycin C were conducted in 53 patients with malignant pleural effusion caused by lung cancer." | 9.07 | Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial. ( Chang, DB; Kuo, SH; Lee, LN; Luh, KT; Yang, PC; Yu, CJ, 1992) |
| "Twenty-two patients with inoperable adenocarcinoma of the pancreas were treated with 5-fluorouracil (5-FU), mitomycin C (Mito-C), and 1(-2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (MeCCNU)." | 9.06 | Activity of 5-fluorouracil, mitomycin C, and methyl CCNU in inoperable adenocarcinoma of pancreas. ( Chapman, J; Chinn, B; Groshko, G; Maniscalco, B; Piper, D; Reznik, S; Vaughn, C; Ward, D, 1989) |
| "Fifty patients with inoperable adenocarcinoma of the lung were randomized in a prospective study to receive either standard doses or high doses of 5-fluorouracil, adriamycin, and mitomycin-C (FAM versus Hi-FAM)." | 9.06 | 5-fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy in advanced adenocarcinoma of the lung: comparison of two dosage schedules. ( Ip, M; Kung, TM; Lam, WK; Sham, MK; So, SY, 1987) |
| "Twenty-nine patients with advanced adenocarcinoma of the pancreas were treated with a combination of mitomycin-C, 5-fluorouracil, and adriamycin (MIFA III)." | 9.05 | MIFA III (mitomycin-C, 5-fluorouracil, and adriamycin) chemotherapy for advanced adenocarcinoma of the pancreas. ( Cheng, EW; Magill, GB; Sordillo, PP; Sternberg, CN, 1984) |
| "A patient receiving the antitumor agent mitomycin C (MMC) in combination with 5-fluorouracil and adriamycin because of adenocarcinoma of Vater's papilla manifested hemolytic-uremic syndrome (HUS) after five cycles of 5-fluorouracil-adriamycin-MMC combination chemotherapy." | 8.77 | Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy. ( Binsack, T; Mergenthaler, HG; Wilmanns, W, 1988) |
| " Mitomycin C (MMC) is frequently used but not devoid of toxicity, of which the most common and feared is neutropenia." | 7.81 | Mitomycin C Pharmacokinetics as Predictor of Severe Neutropenia in Hyperthermic Intraperitoneal Therapy. ( Brigand, C; Brumaru, D; Kemmel, V; Lessinger, JM; Mercoli, HA; Meyer, N; Romain, B, 2015) |
| "The combination regimen of mitomycin-C/5-FU/leucovorin showed marginal activity and tolerable toxicity profiles in heavily pretreated metastatic colorectal cancer patients." | 7.76 | Mitomycin-C, 5-fluorouracil, and leucovorin as a salvage therapy in patients with metastatic colorectal adenocarcinoma. ( Choi, IK; Choi, YJ; Kang, EJ; Kim, JS; Kim, ST; Kim, YH; Oh, SC; Park, KH; Seo, JH; Shin, SW, 2010) |
| "To assess the role of mitomycin C (MMC) in the management of pharyngoesophageal stricture after total laryngopharyngectomy and free flap reconstruction." | 7.72 | Mitomycin C for the treatment of pharyngoesophageal stricture after total laryngopharyngectomy and microvascular free tissue reconstruction. ( Annino, DJ; Goguen, LA, 2003) |
| "To evaluate the efficacy and toxicity of the combination of mitomycin C, etoposide, cisplatin, and epirubicin (MEPA) as neoadjuvant therapy for patients with cervical adenocarcinoma." | 7.72 | A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix. ( Nishiura, K; Obata, H; Okugawa, T; Tabata, T; Tanaka, K; Toyoda, N; Yanoh, K, 2004) |
| "The clinical efficacy and safety of irinotecan (CPT-11) therapy were studied retrospectively in patients with fluoropyrimidine-resistant advanced colorectal cancer." | 7.72 | [Clinical study of irinotecan therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer]. ( Hirao, K; Hirasaki, S; Hyodo, I; Kajiwara, T; Kubo, Y; Kurita, A; Masumoto, T; Moriwaki, T; Nasu, J; Nishina, T; Tsuzuki, T; Tubouchi, E, 2004) |
| "The aim of this study is to clarify whether the expression of metallothionein (MT) is related with the malignant potential in primary colorectal cancer and/or synchronous liver metastasis." | 7.71 | Expression of metallothionein in colorectal cancers and synchronous liver metastases. ( Dhar, DK; Hishikawa, Y; Kimoto, T; Kohno, H; Koji, T; Kubota, H; Nagasue, N; Tachibana, M; Ueda, S, 2001) |
| "Between May 1990 and February 1995, 16 patients with adenocarcinoma or adenosquamous carcinoma of the uterine cervix were prescribed neoadjuvant chemotherapy consisting of cisplatin (50 mg/m2) on day 1, mitomycin C (10 mg/m2) on day 1, and etoposide (100 mg/m2) on days 1, 3, and 5 (MEP)." | 7.70 | Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix. ( Fukuda, K; Hara, K; Iwasaka, T; Nakao, Y; Sugimori, H; Uchiyama, M; Yokoyama, M, 1998) |
| "We investigated the mechanism of mitomycin C (MMC)-induced apoptosis in SNU-16 human gastric adenocarcinoma cells." | 7.70 | Mitomycin C induces apoptosis in a caspases-dependent and Fas/CD95-independent manner in human gastric adenocarcinoma cells. ( Choe, TB; Hong, SI; Hwang, CS; Jang, JJ; Lee, SH; Park, IC; Park, MJ; Rhee, CH; Whang, DY, 2000) |
| "The interaction of photodynamic therapy (PDT) and a chemotherapeutic drug, mitomycin C (MMC), was investigated using WiDr human colon adenocarcinoma tumours implanted on Balb/c athymic nude mice." | 7.69 | Anti-tumour activity of photodynamic therapy in combination with mitomycin C in nude mice with human colon adenocarcinoma. ( Iani, V; Ma, LW; Moan, J; Steen, HB, 1995) |
| "The ability of lonidamine (LND), an energolytic derivative of indazole carboxylic acid, to modulate the cytotoxic activity of mitomycin C (MMC) and 1,3,bis(2-chloroethyl)-1-nitrosourea (BCNU) was investigated in two human adenocarcinoma cell lines (LoVo and HT29) expressing different sensitivity profiles to the drugs." | 7.69 | In vitro effect of lonidamine on the cytotoxicity of mitomycin C and BCNU in human colon adenocarcinoma cells. ( Bearzatto, A; Costa, A; Orlandi, L; Silvestrini, R; Villa, R; Zaffaroni, N, 1994) |
| "We reviewed our results with chemotherapy for adenocarcinoma of the esophagus or gastroesophageal junction tumors in patients treated with 5-fluorouracil, Adriamycin, and mitomycin C (FAM) regimen as developed by MacDonald and colleagues for adenocarcinoma of the stomach." | 7.69 | 5-Fluorouracil, adriamycin, and mitomycin C in adenocarcinoma of the esophagus or gastroesophageal junction tumors. ( Allred, C; Khansur, T; Tavassoli, M, 1994) |
| "The purpose of this study was to assess the efficacy of verapamil (20 microM) and hyperthermia (42 degrees C) as modifiers of mitomycin C (MMC), used at different concentrations, in inhibiting the growth of human gastric adenocarcinoma (AGS) cells." | 7.69 | Effect of mitomycin C, verapamil, and hyperthermia on human gastric adenocarcinoma. ( Buras, RR; Evans, SR; Nauta, RJ; Shabahang, M; Shchepotin, IB, 1994) |
| "Intraperitoneal chemo-hyperthermia with mitomycin C was used to treat 28 patients with far advanced digestive adenocarcinoma and histologically confirmed peritoneal carcinomatosis." | 7.69 | Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis. ( Banssillon, V; Bienvenu, J; Brachet, A; Burgard, G; Carry, PY; Gilly, FN; Guibert, B; Panteix, G; Salle, B; Sayag, AC, 1994) |
| "Two cases of recurrent breast cancer, for which combined therapy using toremifene and oral chemotherapeutic agents were effective, are reported." | 7.69 | [Complete tumor regression obtained by chemoendocrine therapy including toremifene in two cases of pulmonary metastasis of breast cancer with a history of tamoxifen treatment]. ( Asanuma, F; Miyagawa, T; Toyoda, H; Uesato, K; Yamada, Y, 1997) |
| "5-Fluorouracil (5-FU) has been an accepted effective against colorectal cancer, but combination regimens resulted in a lesser effect than 5-FU alone." | 7.69 | 5-Fluorouracil + cisplatin + mitomycin C is a relatively most effective combination against xenograft lines of human colorectal cancer. ( Imamura, M; Kawabata, K; Nio, Y, 1997) |
| "We developed a mitomycin C (MMC)-resistant human lung adenocarcinoma cell subline, SPC-A1/DM4, from cloned SPC-A1/D13 parent cells by 1 h exposures to escalating concentrations of the drug over 17 months." | 7.68 | Isolation of a mitomycin-resistant human lung adenocarcinoma cell subline to investigate the modulation by sodium butyrate of cell growth and drug resistance. ( Dong, QG; Gong, LL; Wang, EZ; Wang, HJ, 1993) |
| "The effects of photodynamic therapy (PDT) alone and in combination with Mitomycin C (MMC) on WiDr cells, a human colon adenocarcinoma cell line, were investigated." | 7.68 | Potentiation of photodynamic therapy by mitomycin C in cultured human colon adenocarcinoma cells. ( Berg, K; Ma, LW; Moan, J; Peng, Q; Steen, HB, 1993) |
| " The cytotoxicity and cytokinetic effects of Mitomycin C (MC) and/or photochemotherapy (PCT) in cultured human colon adenocarcinoma (WiDr) cells were investigated using colony formation to determine cell survival and DNA flow cytometry to analyze cell kinetics." | 7.68 | Cytotoxicity and cytokinetic effects of mitomycin C and/or photochemotherapy in a human colon adenocarcinoma cell line. ( Berg, K; Ma, LW; Moan, J; Peng, Q; Rimington, C; Saether, H; Steen, HB, 1992) |
| "Flow cytometry (FCM) was used to investigate the effect of mitomycin C (MC) on the cellular uptake of Photofrin II (PII) in a cultured human colon adenocarcinoma cell line (WiDr)." | 7.68 | Effect of mitomycin C on the uptake of photofrin II in a human colon adenocarcinoma cell line. ( Berg, K; Ma, LW; Moan, J; Peng, Q; Steen, HB, 1992) |
| "We have evaluated the effect of 5-fluorouracil 600 mg/m2, doxorubicin ('Adriamycin') 40 mg/m2, and Mitomycin-C 4 mg/m2 (FAM) in two groups of patients with adenocarcinoma of the oesophagus, as either a preoperative or primary treatment." | 7.68 | A phase II study of 5-fluorouracil, adriamycin and mitomycin-C in adenocarcinoma of the oesophagus. ( Allen, SM; Cullen, MH; Matthews, HR; Steel, A; Walker, SJ, 1991) |
| "An advanced breast cancer patient refractory to CAF (Cyclophosphamide, Adriamycin, 5-fluorouracil), 5-FU-Methotrexate sequential therapy and Tamoxifen was treated with the combination 5' DFUR, MMC, Etoposide and MPA." | 7.68 | [5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer]. ( Ohtagaki, S; Toge, T; Toi, M; Yagi, M; Yoshinaka, K, 1991) |
| "Twenty-six patients with advanced bronchogenic adenocarcinoma or large cell carcinoma were treated by combination chemotherapy consisting of Ftorafur, adriamycin and mitomycin C (FAM II)." | 7.67 | Ftorafur, adriamycin and mitomycin C (FAM II) for extensive bronchogenic adenocarcinoma and large cell carcinoma. ( Cruciani, AR; De Marinis, A; Nunziati, F; Portalone, L; Salvati, F, 1984) |
| "A regimen combining hepatic irradiation and intravenous dacarbazine and mitomycin C for treating colorectal adenocarcinoma with liver metastases offers no advance in the management of patients with this disease." | 7.67 | Inefficacy of dacarbazine, mitomycin C, and hepatic irradiation in patients with metastatic adenocarcinoma of the gastrointestinal tract. ( Evans, M; Hellmann, K; Jones, R; Newton, K; Peters, N; Phillips, RH; Smith, BJ, 1984) |
| "Thirty patients with advanced colorectal adenocarcinoma were treated by chemotherapy with an alternating regimen consisting of 5-fluorouracil (5-FU)-mitomycin C and 5-FU-dacarbazine at 3-week intervals." | 7.67 | Alternating 5-FU-mitomycin C/5-FU-dacarbazine in advanced colorectal adenocarcinoma: a phase II study. ( Droz, JP; Herait, P; Kac, JL; Rougier, P; Theodore, C, 1989) |
| "A 49 year old woman treated for metastatic adenocarcinoma of the breast suddenly developed the symptoms of acute pulmonary edema 90 minutes after infusion of mitomycin C/vinblastine." | 7.67 | [Acute dyspnea following intravenous administration of vinblastine/mitomycin C]. ( Gattiker, HH; Lagler, U, 1989) |
| "Nineteen patients with adenocarcinoma of unknown primary were treated with the m-FAM regimen, consisting of methotrexate 50 mg/m2 days 0, 28; 5-fluorouracil 600 mg/m2 days 1, 8, 29, 36; Adriamycin 30 mg/m2 days 1, 29; and mitomycin-C 10 mg/m2 day 1." | 7.67 | Phase II trial of methotrexate-FAM (m-FAM) in adenocarcinoma of unknown primary. ( Falchuk, SC; Le Chevalier, T; Rouesse, J; Sevin, D; Spielman, M; Treat, J; Tremblay, C; Woolley, PV, 1989) |
| "A human salivary gland adenocarcinoma cell line was cultivated in the presence of dibutyryl cyclic AMP (dB-cAMP), cis-diammine dichloroplatinum (cisplatin) or mitomycin C (MMC) only, or of the combination of dB-cAMP and each of the antineoplastic drugs." | 7.67 | Enhancement of cis-diamminedichloroplatinum and mitomycin C-induced sister chromatid exchanges by dibutyryl cyclic AMP in a human salivary gland adenocarcinoma cell line in culture. ( Azuma, M; Hayashi, Y; Oishi, Y; Sato, M; Yanagawa, T; Yoshida, H; Yura, Y, 1988) |
| "KW 2083, which is a new mitomycin C derivative currently under clinical investigation, was tested for its antitumor effect on the growth of human carcinoma of the lung by using an in vitro clonogenic assay system." | 7.67 | Evaluation of a new drug 7-N-(p-hydroxyphenyl)-mitomycin C [KW 2083] against carcinoma of the lung by the human tumor clonogenic assay. ( Hoshi, A; Kanzawa, F; Matsushima, Y; Miyazawa, N; Saijo, N; Shimizu, E, 1985) |
| "Fifty-four patients with adenocarcinoma and large cell carcinoma of the lung, 16 with localized surgically resected disease and 38 with metastatic disease, were treated with 5-fluorouracil, doxorubicin, and mitomycin-C (FAM), in an attempt to prolong previously reported survival times in the patients." | 7.67 | 5-Fluorouracil, doxorubicin, and mitomycin-C in the treatment of adenocarcinoma and large cell carcinoma of the lung. ( Shaw, MK; Shaw, MT, 1987) |
| "After treatment with mitomycin C, a patient developed pulmonary hypertension with interstitial infiltrates, microangiopathic hemolytic anemia, systemic hypertension, and renal failure with the nephrotic syndrome." | 7.67 | Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome. ( McCarthy, JT; Staats, BA, 1986) |
| "Fourteen patients with advanced adenocarcinoma of the lung were treated with a combination chemotherapy of mitomycin C, adriamycin and cisplatin (MAP)." | 7.67 | [Combination chemotherapy with mitomycin C, adriamycin and cisplatin (MAP) in advanced adenocarcinoma of the lung: clinical effect and renal toxicity]. ( Fujii, M; Kiura, K; Okabe, K; Toki, H, 1987) |
| "A 64-year-old woman who was diagnosed as inoperable intrahepatic bile duct cancer with massive liver metastasis was treated with 5-fluorouracil (5-FU), adriamycin (ADM) and mitomycin-C (MMC)." | 7.67 | [A case of intrahepatic bile duct cancer responding to 5-fluorouracil, adriamycin and mitomycin C chemotherapy]. ( Hasegawa, H; Kozakai, M; Misu, Y; Saitoh, Y; Shikata, J; Takada, T; Tsuchiya, S; Uchiyama, K; Yasuda, H, 1988) |
| "The combination of 5-fluorouracil (5-FU), doxorubicin, and mitomycin (FAM) is often recommended for empiric management of patients with adenocarcinoma of unknown primary." | 7.67 | 5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary. ( Ahlgren, JD; Goldberg, RM; Schein, PS; Smith, FP; Ueno, W, 1986) |
| "Fifty-three patients with inoperable adenocarcinoma of the lung were treated with 5-fluorouracil, Adriamycin, and mitomycin-C (FAM) in two dose schedules: schedule 1--5-FU 600 mg/m2 days 1, 8, 29, and 36 and Adriamycin 30 mg/m2 days 1 and 29 and mitomycin-C 10 mg/m2 day 1 repeated every 8 weeks." | 7.67 | 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) in the treatment of inoperable adenocarcinoma of the lung. ( Burkes, R; DeBoer, G; Evans, WK; Paul, K; Shepherd, FA, 1986) |
| "A thrombotic microangiopathy resembling the hemolytic uremic syndrome was diagnosed in 12 patients with adenocarcinoma, in whom the tumor was in complete or near-complete remission after treatment with mitomycin C-containing drug regimens." | 7.67 | Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. ( Cantrell, JE; Phillips, TM; Schein, PS, 1985) |
| "Sixty-two patients with metastatic hormonal refractory adenocarcinoma of the prostate received a combination of doxorubicin, mitomycin-C, and 5-fluorouracil (DMF)." | 7.66 | Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancer. ( Grant, C; Johnson, DE; Logothetis, CJ; Ogden, S; Samuels, ML; Trindade, A; von Eschenbach, AC, 1983) |
| "One hundred patients suffering from advanced breast cancers and resisting to one (15) or several (85) drugs previously administered have been treated by an association of mitomycin C, thiotepa and vindesine, given every 3 weeks." | 7.66 | [Chemotherapy associating mitomycin C, thiotepa and vindesine in advanced breast cancers. Study of 100 cases (author's transl)]. ( Brunet, R; Bui, BN; Chauvergne, J; Durand, M; Hoerni, B; Mauriac, L, 1981) |
| "Thirty-four patients with gastric cancer, 16 after failure of first-line chemotherapy and 18 after failure of at least two prior chemotherapies, were included." | 6.73 | Mitomycin C plus infusional 5-fluorouracil in platinum-refractory gastric adenocarcinoma: an extended multicenter phase II study. ( Al-Batran, SE; Bokemeyer, C; Hartmann, JT; Horger, M; Jäger, E; Kanz, L; Königsrainer, A; Meisinger, I; Nehls, O; Pintoffl, JP; Quietzsch, D, 2007) |
| "Dipyridamole 75 mg was administered orally three times daily during the FU administration." | 6.73 | Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700. ( Barstis, JJ; Bendetti, JK; Isacoff, WH; Jazieh, AR; Macdonald, JS; Philip, PA, 2007) |
| "Etoposide is a topoisomerase II inhibitor with evidence for phase-specific and schedule-dependent activity." | 6.68 | A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tract. ( Boardman, P; Braybrooke, JP; Ganesan, TS; Harris, AL; O'Byrne, KJ; Propper, DJ; Salisbury, AJ; Saunders, MP; Talbot, DC; Taylor, M, 1997) |
| "Mitomycin C (MMC) has been widely used in this context, and despite good tolerability, there are doubts regarding its true benefit." | 5.38 | A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer. ( Costa, FP; Ferrarotto, R; Hoff, PM; Kopetz, S; Machado, K; Mak, MP; Overman, MJ; Shah, N; Takahashi, TK, 2012) |
| "Unresectable intrahepatic cholangiocarcinoma has a poor prognosis, with a median survival of 5 to 8 months without treatment." | 5.37 | Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. ( Albert, M; Christians, K; Fraker, D; Kiefer, MV; McNally, M; Olthoff, K; Pappas, S; Rilling, W; Robertson, M; Soulen, MC; Sun, W, 2011) |
| "Valproic acid has been demonstrated to mediate cytotoxic effects against tumor cells by acting as a histone-deacetylase inhibitor." | 5.33 | Synergistic effects of valproic acid and mitomycin C in adenocarcinoma cell lines and fresh tumor cells of patients with colon cancer. ( Atmaca, A; Chow, KU; Friedmann, I; Jäger, E; Weidmann, E, 2006) |
| "Mitomycin C (10 mg/m2) was administered as a bolus injection on day 2." | 5.28 | Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. ( Coia, LR; Engstrom, PF; Hanks, GE; Paul, AR; Stafford, PM, 1991) |
| "Persistent or recurrent peritoneal carcinomatosis (PC) documented at second-look surgery has proved relatively refractory to second-line therapy." | 5.27 | Intraperitoneal mitomycin C in the treatment of peritoneal carcinomatosis following second-look surgery. ( Alberts, DS; Graham, V; Monk, BJ; Surwit, EA, 1988) |
| " Twenty-one patients with PC (12 gastric cancer, 5 colorectal cancer, 2 ovarian cancer, 1 pseudomyxoma peritonei, 1 malignant mesothelioma) were treated with CRS + HIPEC with hydroxycamptothecin 20 mg and mitomycin C 30 mg in 12,000 mL of normal saline at 43 +/- ." | 5.14 | Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases. ( al-shammaa Hassan, AH; Li, Y; Liu, SY; Lu, YL; Yang, GL; Yang, XJ; Yonemura, Y; Zhang, JW, 2009) |
| "Gemcitabine-based chemotherapy is a commonly used first-line treatment for patients with pancreatic and biliary tract cancer." | 5.14 | Second-line treatment with a combination of continuous 5-fluorouracil, doxorubicin, and mitomycin-C (conti-FAM) in gemcitabine-pretreated pancreatic and biliary tract cancer. ( Jeong, JS; Kim, BG; Kim, HJ; Kim, SH; Kim, YH; Kwon, HC; Lee, S; Oh, SY; Rho, MH; Rho, MS, 2009) |
| "Based on the observation of topoisomerase-1, upregulation by mitomycin C (MMC), and the phase I antitumor activity of sequential MMC/irinotecan in esophageal cancer, we conducted a phase II evaluation of two schedules of this combination in previously untreated stage III/IV esophageal/gastroesophageal junction adenocarcinomas." | 5.14 | Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma. ( Abbas, A; Bekaii-Saab, T; Burak, W; Lustberg, MB; Lustberg, ME; McCracken-Bussa, B; Otterson, G; Villalona-Calero, MA; Young, D, 2010) |
| "This study evaluates the maximum tolerated dose (MTD) and activity of mitomycin, docetaxel, and irinotecan (MDI) regimen on metastatic pancreatic adenocarcinoma, previously treated with gemcitabine-containing chemotherapy." | 5.11 | Salvage chemotherapy with mitomycin, docetaxel, and irinotecan (MDI regimen) in metastatic pancreatic adenocarcinoma: a phase I and II trial. ( Bonetto, E; Di Carlo, V; Nicoletti, R; Panucci, MG; Passoni, P; Reni, M; Ronzoni, M; Staudacher, C; Villa, E; Zerbi, A, 2004) |
| "The aim of this study was to evaluate the activity and toxicity of a combination regimen of CPT-11 and mitomycin-c as second-line chemotherapy for pretreated patients with advanced, metastatic, or both, gastric adenocarcinoma." | 5.11 | Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106). ( Battaglia, C; Colucci, G; Di Bisceglie, M; Gebbia, N; Gebbia, V; Giuliani, F; Maiello, E; Molica, S; Vinciarelli, G, 2005) |
| "The aim of this phase II study was to investigate the tolerance and efficacy of a second-line irinotecan/mitomycin C combination in patients with advanced gastric or colorectal cancer, pretreated with 5-fluorouracil." | 5.10 | Phase II study of irinotecan and mitomycin C in 5-fluorouracil-pretreated patients with advanced colorectal and gastric cancer. ( Bamias, A; Papamichael, D; Pavlidis, N; Syrigos, K, 2003) |
| "Both mitomycin C combination regimens seem to provide an acceptable therapeutic index in patients with fluoropyrimidine/leucovorin-pretreated metastatic colorectal cancer." | 5.10 | Randomized phase II study of irinotecan plus mitomycin C vs. oxaliplatin plus mitomycin C in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer. ( Brugger, S; Depisch, D; Fiebiger, W; Kornek, GV; Kovats, E; Lang, F; Raderer, M; Scheithauer, W; Ullrich-Pur, H; Valencak, J, 2002) |
| " The aim of the present study was to evaluate the effectiveness and safety of a combined-treatment modality consisting of systemic chemotherapy with 24-h continuous infusional gemcitabine and mitomycin C, plus external beam radiotherapy in patients with localized unresectable adenocarcinoma of the pancreas." | 5.09 | Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine. ( Kornek, GV; Kraus, G; Pötter, R; Rogy, M; Scheithauer, W; Schratter, A; Selzer, E; Ulrich-Pur, H, 2001) |
| "We have reported a 33% partial response rate with acceptable toxicity using weekly 24-h infusion of high-dose 5-fluorouracil (5-FU) and leucovorin (LV) in patients with far advanced biliary tract cancers (BTC)." | 5.09 | Mitomycin C with weekly 24-h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract and periampullar carcinomas. ( Chen, JS; Jan, YY; Liau, CT; Lin, YC, 2001) |
| "From May 1988 to June 1992, 129 eligible patients suffering from measurable advanced colorectal cancer were enrolled in a randomized study comparing bolus fluorouracil plus leucovorin (FU-FA); continuous fluorouracil infusion (FU-cont); FUcont plus cyclophosphamide and mitomycin C (FUMIC)." | 5.08 | A randomized study of bolus fluorouracil plus folinic acid versus 21-day fluorouracil infusion alone or in association with cyclophosphamide and mitomycin C in advanced colorectal carcinoma. ( Bonnel, C; Caudry, M; Caudry, Y; Dujols, JP; Floquet, A; Marsault, C; Maton, O; Pujol, J; Quétin, P; Skawinski, P, 1995) |
| "Adjuvant intraperitoneal therapy of gastric cancer by mitomycin bound to activated carbon particles is associated with an increased rate of postoperative complications." | 5.08 | Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology. ( Czeijka, M; Holzberger, P; Jatzko, G; Lisborg, P; Neudorfer, H; Potrc, S; Rabl, H; Repse, S; Rosen, HR; Sandbichler, P; Zacherl, J, 1998) |
| "Thirty-seven consecutive patients with advanced and/or metastatic gastric adenocarcinoma received a combination of 5-fluorouracil 600 mg/m2 on days 1, 8, 29, 36; epidoxorubicin 75 mg/m2 i." | 5.07 | Combination chemotherapy of 5-fluorouracil, epidoxorubicin and mitomycin C in the palliative treatment of locally advanced and/or metastatic adenocarcinoma of the stomach. ( Bajardi, G; Cannata, G; Cipolla, C; Curto, G; Gebbia, V; Latteri, M; Mastrandrea, G; Pischedda, G; Testa, A; Valenza, R, 1994) |
| "From January 1980 to December 1986, 20 patients with adenocarcinoma of the sigmoid colon were treated with a 6 hours preoperative intra-arterial infusion of mitomycin-C followed by potentially curative surgery (Group A)." | 5.07 | Preoperative intra-arterial mitomycin-C in the management of sigmoid adenocarcinoma: long-term results of a pilot study. ( Campora, E; Cariati, A; De Caro, G; Fardelli, R; Gianquinto, D; Secco, GB; Sertoli, MR; Zoli, S, 1994) |
| "In a randomized trial we compared single-agent epirubicin with the FEM (5-fluorouracil/epirubicin/mitomycin) combination in patients with locally advanced and/or metastatic adenocarcinoma of the pancreas." | 5.07 | Comparison of single-agent epirubicin and 5-fluorouracil/epirubicin/mitomycin in patients with advanced adenocarcinoma of the pancreas. ( Coombes, RC; Glees, J; Topham, C, 1993) |
| "A prospective randomized study to compare the effectiveness of pleurodesis by two new sclerosing agents: OK-432 and mitomycin C were conducted in 53 patients with malignant pleural effusion caused by lung cancer." | 5.07 | Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial. ( Chang, DB; Kuo, SH; Lee, LN; Luh, KT; Yang, PC; Yu, CJ, 1992) |
| "One hundred eighty-seven patients with histologically proven advanced pancreatic adenocarcinoma were randomly assigned to therapy with 5-fluorouracil (5-FU) alone, to the Mallinson regimen (combined and sequential 5-FU, cyclophosphamide, methotrexate, vincristine, and mitomycin C), or to combined 5-FU, doxorubicin, and cisplatin (FAP)." | 5.06 | A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin. ( Barlow, JF; Cullinan, S; Foley, JF; Kardinal, CG; Krook, JE; Moertel, CG; Norris, BD; Schutt, AJ; Tschetter, LK; Wieand, HS, 1990) |
| "Twenty-two patients with inoperable adenocarcinoma of the pancreas were treated with 5-fluorouracil (5-FU), mitomycin C (Mito-C), and 1(-2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (MeCCNU)." | 5.06 | Activity of 5-fluorouracil, mitomycin C, and methyl CCNU in inoperable adenocarcinoma of pancreas. ( Chapman, J; Chinn, B; Groshko, G; Maniscalco, B; Piper, D; Reznik, S; Vaughn, C; Ward, D, 1989) |
| "One hundred thirty-three patients with advanced pancreatic adenocarcinoma and measurable disease were treated with 5-fluorouracil (5-FU) plus doxorubicin plus mitomycin C (FAM), streptozotocin plus mitomycin C plus 5-FU (SMF) in the regimen originally reported, and streptozotocin plus mitomycin C plus 5-FU with 5-FU and streptozotocin administered in five-day courses." | 5.06 | Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group. ( , 1986) |
| "Fifty patients with inoperable adenocarcinoma of the lung were randomized in a prospective study to receive either standard doses or high doses of 5-fluorouracil, adriamycin, and mitomycin-C (FAM versus Hi-FAM)." | 5.06 | 5-fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy in advanced adenocarcinoma of the lung: comparison of two dosage schedules. ( Ip, M; Kung, TM; Lam, WK; Sham, MK; So, SY, 1987) |
| " Twenty-four patients with malignant pericardial effusion were treated by intrapericardial instillation of anti-cancer drugs, such as Carbazilquinone, Mitomycin-C or ACNU, with pericardial drainage." | 5.05 | [Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion]. ( Fukuoka, M; Matsui, K; Negoro, S; Ryu, S; Sakaguchi, K; Sakai, N; Takada, M; Tamai, S, 1984) |
| "Twenty-nine patients with advanced adenocarcinoma of the pancreas were treated with a combination of mitomycin-C, 5-fluorouracil, and adriamycin (MIFA III)." | 5.05 | MIFA III (mitomycin-C, 5-fluorouracil, and adriamycin) chemotherapy for advanced adenocarcinoma of the pancreas. ( Cheng, EW; Magill, GB; Sordillo, PP; Sternberg, CN, 1984) |
| "Two hundred forty-one patients with unresectable gastric adenocarcinoma were entered, between December 1978 and March 1981, into a prospectively randomized comparison of three chemotherapy regimens to identify therapeutic activity and determine patient tolerability: (1) 5-fluorouracil plus Adriamycin (FA); (2) FA plus methyl-CCNU (FAMe); and (3) FA plus mitomycin C (FAMi)." | 5.05 | Randomized study of combination chemotherapy in unresectable gastric cancer. The Gastrointestinal Tumor Study Group. ( , 1984) |
| "The FAM combination with the simultaneous administration of 5-fluorouracil, doxorubicin, and mitomycin C is considered standard chemotherapy for gastric adenocarcinoma." | 5.05 | Drug combinations in the treatment of gastric adenocarcinoma: a randomized Southwest Oncology Group study. ( Athens, J; Chen, TT; Costanzi, JJ; Haas, C; Heilbrun, LK; McDonald, B; Oishi, N; Panettiere, FJ; Talley, RW, 1984) |
| "In a prospectively randomized trial, patients with advanced locally recurrent or metastatic gastric adenocarcinoma were randomized to receive 5-fluorouracil (5-FU) and methyl-CCNU; 5-FU, Adriamycin (Adria Laboratories, Columbus, Ohio), and methyl-CCNU; 5-FU, Adriamycin, and mitomycin C; or Adriamycin and mitomycin C alone." | 5.05 | An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277). ( Douglass, HO; Goudsmit, A; Klaassen, DJ; Lavin, PT; Paul, AR, 1984) |
| "In a randomized, multicenter study, 168 evaluable patients with colorectal adenocarcinoma at B2, C1 or C2 stages of the Dukes, Astler and Coller classification, were treated after radical surgery with BCG and 5-fluorouracil alone (regimen A) or in combination with hydroxyurea, methyl-CCNU and mitomycin C (regimen B)." | 5.05 | Preliminary research on the evaluation of some prognostic factors in a randomized study of adjuvant immunochemotherapy in colorectal adenocarcinoma. ( De Vecchis, L; Lagomarsino Caprino, MC; Mazzei, T; Periti, P; Popoli, P, 1984) |
| " Chemotherapy with fluorouracil (5FU) plus leucovorin remains a standard in the treatment of patients with metastatic colorectal cancer." | 4.80 | [Irinotecan in combination for colon cancer]. ( André, T; de Gramond, A; Ducreux, M; Gil-Delgado, M; Khayat, D; Ychou, M, 1998) |
| "A patient receiving the antitumor agent mitomycin C (MMC) in combination with 5-fluorouracil and adriamycin because of adenocarcinoma of Vater's papilla manifested hemolytic-uremic syndrome (HUS) after five cycles of 5-fluorouracil-adriamycin-MMC combination chemotherapy." | 4.77 | Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy. ( Binsack, T; Mergenthaler, HG; Wilmanns, W, 1988) |
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| "We aimed to evaluate the efficacy and safety of 5-fluorouracil-based neoadjuvant chemoradiotherapy (NACRT) in patients with resectable/borderline resectable pancreatic ductal adenocarcinoma (PDAC)." | 3.91 | Efficacy and safety of preoperative 5-fluorouracil, cisplatin, and mitomycin C in combination with radiotherapy in patients with resectable and borderline resectable pancreatic cancer: a long-term follow-up study. ( Abe, Y; Aiura, K; Endo, Y; Fukada, J; Hori, S; Itano, O; Kitagawa, Y; Kitago, M; Masugi, Y; Nakano, Y; Oshima, G; Shinoda, M; Yagi, H, 2019) |
| " Mitomycin C (MMC) is frequently used but not devoid of toxicity, of which the most common and feared is neutropenia." | 3.81 | Mitomycin C Pharmacokinetics as Predictor of Severe Neutropenia in Hyperthermic Intraperitoneal Therapy. ( Brigand, C; Brumaru, D; Kemmel, V; Lessinger, JM; Mercoli, HA; Meyer, N; Romain, B, 2015) |
| "FOLFOXIRI demonstrated higher efficacy compared to 5-fluorouracil, leucovorin, irinotecan (FOLFIRI) as first-line treatment of metastatic colorectal cancer." | 3.78 | Outcome of second-line treatment after first-line chemotherapy with the GONO FOLFOXIRI regimen. ( Allegrini, G; Baldi, GG; Brunetti, IM; Cortesi, E; Cremolini, C; Cupini, S; Falcone, A; Fornaro, L; Granetto, C; Loupakis, F; Masi, G; Ricci, S; Salvatore, L; Tuzi, A; Vasile, E, 2012) |
| "In patients with known BRCA 1 or 2 mutation-associated pancreatic adenocarcinoma, the addition of a DNA cross-linking agent such as cisplatin, oxaliplatin, or mitomycin to a standard gemcitabine chemotherapy backbone should be considered." | 3.77 | A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma. ( Drukker, L; Epstein, A; Gabizon, A; Isacson, R; Keinan, A; Kelsen, D; Lowery, M; O'Reilly, EM; Rachkiman, M; Reissman, P; Rosengarten, O; Segal, A; Shah, MA; Smyth, E, 2011) |
| "Mitomycin has also demonstrated efficacy when given in combination with doxorubicin and in the three-drug regimen FAM (5-fluorouracil/doxorubicin/mitomycin)." | 3.77 | Mitomycin therapy in gastric cancer. ( Macdonald, JS; Schnall, S, 1993) |
| "The combination regimen of mitomycin-C/5-FU/leucovorin showed marginal activity and tolerable toxicity profiles in heavily pretreated metastatic colorectal cancer patients." | 3.76 | Mitomycin-C, 5-fluorouracil, and leucovorin as a salvage therapy in patients with metastatic colorectal adenocarcinoma. ( Choi, IK; Choi, YJ; Kang, EJ; Kim, JS; Kim, ST; Kim, YH; Oh, SC; Park, KH; Seo, JH; Shin, SW, 2010) |
| "Twelve patients with progressive dysphagia and video-fluoroscopic evidence of upper digestive tract stricture after head and neck cancer treatment were dilated by Maloney or Savory dilators followed by the application of mitomycin C (0." | 3.74 | Role of mitomycin in upper digestive tract stricture. ( Brodsky, MB; Day, TA; Gillespie, MB; Martin-Harris, B; Sharma, AK, 2007) |
| " A reduction in urinary IL-8 levels after treatment with bacille Calmette-Guérin or mitomycin C may reflect a decrease in bladder cancer cells and/or in other cells that produce IL-8." | 3.72 | Urinary interleukin-8 levels are elevated in subjects with transitional cell carcinoma. ( Hausladen, DA; Sheryka, E; Weiss, RM; Wheeler, MA, 2003) |
| "To assess the role of mitomycin C (MMC) in the management of pharyngoesophageal stricture after total laryngopharyngectomy and free flap reconstruction." | 3.72 | Mitomycin C for the treatment of pharyngoesophageal stricture after total laryngopharyngectomy and microvascular free tissue reconstruction. ( Annino, DJ; Goguen, LA, 2003) |
| "To evaluate the efficacy and toxicity of the combination of mitomycin C, etoposide, cisplatin, and epirubicin (MEPA) as neoadjuvant therapy for patients with cervical adenocarcinoma." | 3.72 | A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix. ( Nishiura, K; Obata, H; Okugawa, T; Tabata, T; Tanaka, K; Toyoda, N; Yanoh, K, 2004) |
| "The clinical efficacy and safety of irinotecan (CPT-11) therapy were studied retrospectively in patients with fluoropyrimidine-resistant advanced colorectal cancer." | 3.72 | [Clinical study of irinotecan therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer]. ( Hirao, K; Hirasaki, S; Hyodo, I; Kajiwara, T; Kubo, Y; Kurita, A; Masumoto, T; Moriwaki, T; Nasu, J; Nishina, T; Tsuzuki, T; Tubouchi, E, 2004) |
| "The aim of this study is to clarify whether the expression of metallothionein (MT) is related with the malignant potential in primary colorectal cancer and/or synchronous liver metastasis." | 3.71 | Expression of metallothionein in colorectal cancers and synchronous liver metastases. ( Dhar, DK; Hishikawa, Y; Kimoto, T; Kohno, H; Koji, T; Kubota, H; Nagasue, N; Tachibana, M; Ueda, S, 2001) |
| "Direct intraperitoneal chemotherapy with cisplatin or mitomycin prevents peritoneal carcinomatosis in experimental investigations." | 3.71 | Prophylaxis of peritoneal carcinomatosis in experimental investigations. ( Boltze, C; Halangk, W; Hribaschek, A; Kuhn, R; Lippert, H; Pross, M; Ridwelski, K, 2001) |
| "Between May 1990 and February 1995, 16 patients with adenocarcinoma or adenosquamous carcinoma of the uterine cervix were prescribed neoadjuvant chemotherapy consisting of cisplatin (50 mg/m2) on day 1, mitomycin C (10 mg/m2) on day 1, and etoposide (100 mg/m2) on days 1, 3, and 5 (MEP)." | 3.70 | Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix. ( Fukuda, K; Hara, K; Iwasaka, T; Nakao, Y; Sugimori, H; Uchiyama, M; Yokoyama, M, 1998) |
| " In the present study, the antitumour activity, pharmacokinetics and metabolism of mitomycin C (MMC) has been determined in vivo in two murine adenocarcinomas of the colon, MAC 16 (high DT-diaphorase activity) and MAC 26 (low DT-diaphorase activity) after intra-tumoural injection of drug." | 3.70 | Pharmacological determinants of the antitumour activity of mitomycin C. ( Cummings, J; Ritchie, AA; Smyth, JF; Spanswick, VJ, 1998) |
| " In this study, a colchicine resistant subline (HCA-2/1cch) was selected from a human colon adenocarcinoma after a short period of drug exposure, as an in vitro model of drug resistance selection." | 3.70 | Multidrug resistance increment in a human colon carcinoma cell line by colchicine. ( Gil, L; Martínez Morillo, M; Ruiz Gómez, MJ; Souviron, A, 2000) |
| "From November 1983 to January 1993, 30 patients with pancreatic adenocarcinoma including 9 with carcinoma of the body and tail were treated by a multimodal approach consisting of extended pancreatectomy, intraoperative radiotherapy (IORT), and hepatic artery or portal vein infusion of mitomycin C (MMC) followed by systemic bolus injection." | 3.70 | Long-term survival after multimodality treatment for resectable pancreatic cancer. ( Fukushima, N; Kinoshita, T; Kosuge, T; Mukai, K; Ozaki, H; Shimada, K; Tokuuye, K; Yamamoto, J, 2000) |
| "We investigated the mechanism of mitomycin C (MMC)-induced apoptosis in SNU-16 human gastric adenocarcinoma cells." | 3.70 | Mitomycin C induces apoptosis in a caspases-dependent and Fas/CD95-independent manner in human gastric adenocarcinoma cells. ( Choe, TB; Hong, SI; Hwang, CS; Jang, JJ; Lee, SH; Park, IC; Park, MJ; Rhee, CH; Whang, DY, 2000) |
| "(1) To determine the toxicity of an intensified postoperative adjuvant regimen for periampullary adenocarcinoma (pancreatic and nonpancreatic) utilizing concurrent 5-fluorouracil (5-FU), leucovorin (LV), dipyridamole (DPM), and mitomycin-C (MMC) combined with split-course locoregional external beam radiotherapy (EBRT) to 50 Gy." | 3.70 | Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival. ( Abrams, RA; Cameron, JL; Chakravarthy, A; Donehower, RC; Grochow, LB; Hruban, RH; Hurwitz, H; Jaffee, EM; Korman, LT; Lillemoe, KD; O'Reilly, S; Yeo, CJ; Zahurek, ML, 2000) |
| "The interaction of photodynamic therapy (PDT) and a chemotherapeutic drug, mitomycin C (MMC), was investigated using WiDr human colon adenocarcinoma tumours implanted on Balb/c athymic nude mice." | 3.69 | Anti-tumour activity of photodynamic therapy in combination with mitomycin C in nude mice with human colon adenocarcinoma. ( Iani, V; Ma, LW; Moan, J; Steen, HB, 1995) |
| "The ability of lonidamine (LND), an energolytic derivative of indazole carboxylic acid, to modulate the cytotoxic activity of mitomycin C (MMC) and 1,3,bis(2-chloroethyl)-1-nitrosourea (BCNU) was investigated in two human adenocarcinoma cell lines (LoVo and HT29) expressing different sensitivity profiles to the drugs." | 3.69 | In vitro effect of lonidamine on the cytotoxicity of mitomycin C and BCNU in human colon adenocarcinoma cells. ( Bearzatto, A; Costa, A; Orlandi, L; Silvestrini, R; Villa, R; Zaffaroni, N, 1994) |
| "We reviewed our results with chemotherapy for adenocarcinoma of the esophagus or gastroesophageal junction tumors in patients treated with 5-fluorouracil, Adriamycin, and mitomycin C (FAM) regimen as developed by MacDonald and colleagues for adenocarcinoma of the stomach." | 3.69 | 5-Fluorouracil, adriamycin, and mitomycin C in adenocarcinoma of the esophagus or gastroesophageal junction tumors. ( Allred, C; Khansur, T; Tavassoli, M, 1994) |
| "The purpose of this study was to assess the efficacy of verapamil (20 microM) and hyperthermia (42 degrees C) as modifiers of mitomycin C (MMC), used at different concentrations, in inhibiting the growth of human gastric adenocarcinoma (AGS) cells." | 3.69 | Effect of mitomycin C, verapamil, and hyperthermia on human gastric adenocarcinoma. ( Buras, RR; Evans, SR; Nauta, RJ; Shabahang, M; Shchepotin, IB, 1994) |
| "Intraperitoneal chemo-hyperthermia with mitomycin C was used to treat 28 patients with far advanced digestive adenocarcinoma and histologically confirmed peritoneal carcinomatosis." | 3.69 | Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis. ( Banssillon, V; Bienvenu, J; Brachet, A; Burgard, G; Carry, PY; Gilly, FN; Guibert, B; Panteix, G; Salle, B; Sayag, AC, 1994) |
| "Pharmacokinetics and metabolism of mitomycin C (MMC) have been studied in NMRI mice bearing MAC 16 colon adenocarcinoma after direct intratumoural injection of either 500 micrograms free MMC or the same dose incorporated in albumin microspheres." | 3.69 | Encapsulation of mitomycin C in albumin microspheres markedly alters pharmacokinetics, drug quinone reduction in tumour tissue and antitumour activity. Implications for the drugs' in vivo mechanism of action. ( Allan, L; Cummings, J; Smyth, JF, 1994) |
| "The multidrug resistance gene product P-glycoprotein (P-GP) was assessed immunohistochemically (by antibody JSB-1) in biopsy specimens from 27 oesophageal squamous carcinomas and 10 adenocarcinomas before treatment with mitomycin, ifosfamide and cisplatin (MIC)." | 3.69 | Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer. ( Darnton, SJ; Ferry, DR; Jenner, K; Matthews, HR; Steyn, RS, 1995) |
| "In this study, the enzymology of mitomycin C (MMC) bioactivation in two murine colon adenocarcinomas, MAC 16 and MAC 26, was examined." | 3.69 | Enzymology of mitomycin C metabolic activation in tumour tissue. Characterization of a novel mitochondrial reductase. ( Cummings, J; Smyth, JF; Spanswick, VJ, 1996) |
| "Following upon earlier work the response of MCF-7 breast cancer cells to mitomycin C, a known genotoxicant, was examined." | 3.69 | A study of induced genotoxicity in MCF-7 cells. ( Bland, KI; Mark, HF; Naram, R; Santoro, K, 1995) |
| "Cultures of three human tumour cell lines, including two bladder carcinomas and one renal adenocarcinoma, and two mouse cell lines were treated with mitomycin C (concentration range 320 pM-50 microM) at a range of pH (5." | 3.69 | Sensitivity of cell lines to mitomycin C. ( Courtney, JM; Plumb, JA; Scott, R; Watts, PL, 1996) |
| "Two cases of recurrent breast cancer, for which combined therapy using toremifene and oral chemotherapeutic agents were effective, are reported." | 3.69 | [Complete tumor regression obtained by chemoendocrine therapy including toremifene in two cases of pulmonary metastasis of breast cancer with a history of tamoxifen treatment]. ( Asanuma, F; Miyagawa, T; Toyoda, H; Uesato, K; Yamada, Y, 1997) |
| "5-Fluorouracil (5-FU) has been an accepted effective against colorectal cancer, but combination regimens resulted in a lesser effect than 5-FU alone." | 3.69 | 5-Fluorouracil + cisplatin + mitomycin C is a relatively most effective combination against xenograft lines of human colorectal cancer. ( Imamura, M; Kawabata, K; Nio, Y, 1997) |
| "In order to determine whether preresectional chemoradiotherapy (CTRT) would influence resectability, local control, and survival of patients with localized pancreatic adenocarcinoma, a 5 1/2-year prospective study of 39 patients treated with preoperative radiation therapy, 5-Fluorouracil (5-FU), and Mitomycin C has been performed." | 3.68 | A single institutional experience with preoperative chemoradiotherapy for stage I-III pancreatic adenocarcinoma. ( Agarwal, P; Eisenberg, BL; Engstrom, P; Hoffman, JP; Litwin, S; Paul, AR; Scher, R; Solin, LJ; Watts, P; Weese, JL, 1993) |
| "The three-dimensional growth of cultured tumor cell lines (HT29, a colon adenocarcinoma cell line; M21, a melanoma cell line; KB, a nasopharyngeal carcinoma cell line) has been investigated in an agar culture system with a fibrin matrix in vitro." | 3.68 | Morphologic analysis of three-dimensional tumors developed in fibrin matrix and agar culture system. ( Hess, M; Koldovsky, P; Kumazawa, H, 1993) |
| "We developed a mitomycin C (MMC)-resistant human lung adenocarcinoma cell subline, SPC-A1/DM4, from cloned SPC-A1/D13 parent cells by 1 h exposures to escalating concentrations of the drug over 17 months." | 3.68 | Isolation of a mitomycin-resistant human lung adenocarcinoma cell subline to investigate the modulation by sodium butyrate of cell growth and drug resistance. ( Dong, QG; Gong, LL; Wang, EZ; Wang, HJ, 1993) |
| "Of 13 patients with adenocarcinoma treated with 5-fluorouracil, adriamycin, and mitomycin (FAM), nine showed minor histological changes compared with 14 control cases." | 3.68 | Histopathological findings in oesophageal carcinoma with and without preoperative chemotherapy. ( Allen, SM; Darnton, SJ; Edwards, CW; Matthews, HR, 1993) |
| "The effects of photodynamic therapy (PDT) alone and in combination with Mitomycin C (MMC) on WiDr cells, a human colon adenocarcinoma cell line, were investigated." | 3.68 | Potentiation of photodynamic therapy by mitomycin C in cultured human colon adenocarcinoma cells. ( Berg, K; Ma, LW; Moan, J; Peng, Q; Steen, HB, 1993) |
| " The cytotoxicity and cytokinetic effects of Mitomycin C (MC) and/or photochemotherapy (PCT) in cultured human colon adenocarcinoma (WiDr) cells were investigated using colony formation to determine cell survival and DNA flow cytometry to analyze cell kinetics." | 3.68 | Cytotoxicity and cytokinetic effects of mitomycin C and/or photochemotherapy in a human colon adenocarcinoma cell line. ( Berg, K; Ma, LW; Moan, J; Peng, Q; Rimington, C; Saether, H; Steen, HB, 1992) |
| "Ten resected oesophageal adenocarcinomas treated with preoperative chemotherapy--mitomycin-C, ifosfamide, and cisplatin (MIC)--were examined by transmission electron microscopy and their appearance compared with that of 13 concurrent untreated resected oesophageal adenocarcinomas." | 3.68 | Effects of chemotherapy on ultrastructure of oesophageal adenocarcinoma. ( Antonakopoulos, GN; Darnton, SJ; Matthews, HR; Newman, J, 1992) |
| "A 63-year-old male had undergone combination chemotherapy including adriamycin, cisplatin, mitomycin C, 5-fluorouracil and vindesine for six months for double cancer of esophagus and stomach." | 3.68 | [Chemotherapy-associated hemolytic uremic syndrome--a case report]. ( Kanamaru, R; Kikuchi, H, 1992) |
| "Flow cytometry (FCM) was used to investigate the effect of mitomycin C (MC) on the cellular uptake of Photofrin II (PII) in a cultured human colon adenocarcinoma cell line (WiDr)." | 3.68 | Effect of mitomycin C on the uptake of photofrin II in a human colon adenocarcinoma cell line. ( Berg, K; Ma, LW; Moan, J; Peng, Q; Steen, HB, 1992) |
| "We have evaluated the effect of 5-fluorouracil 600 mg/m2, doxorubicin ('Adriamycin') 40 mg/m2, and Mitomycin-C 4 mg/m2 (FAM) in two groups of patients with adenocarcinoma of the oesophagus, as either a preoperative or primary treatment." | 3.68 | A phase II study of 5-fluorouracil, adriamycin and mitomycin-C in adenocarcinoma of the oesophagus. ( Allen, SM; Cullen, MH; Matthews, HR; Steel, A; Walker, SJ, 1991) |
| "Eighty-seven colorectal adenocarcinomas from untreated patients were investigated by short term tumor cultures to test in vitro sensitivity to 5-fluorouracil and mitomycin C." | 3.68 | 5-Fluorouracil (FU) and mitomycin C (MMC) in the management of colorectal carcinoma. Part II. In vitro activity of the two drugs in short-term tumor cultures. ( Barone, C; Codacci-Pisanelli, G; Codacci-Pisanelli, M; Ferri, GM; Franchi, F; Garufi, C; Grieco, A; Pagani, V; Seminara, P, 1991) |
| "An advanced breast cancer patient refractory to CAF (Cyclophosphamide, Adriamycin, 5-fluorouracil), 5-FU-Methotrexate sequential therapy and Tamoxifen was treated with the combination 5' DFUR, MMC, Etoposide and MPA." | 3.68 | [5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer]. ( Ohtagaki, S; Toge, T; Toi, M; Yagi, M; Yoshinaka, K, 1991) |
| "As part of a Phase II chemotherapy trial using mitomycin-C, adriamycin, and vindesine, 57 patients with adenocarcinoma of unknown primary site were assessed for prognostic variables predictive of response and survival." | 3.68 | Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results. ( Chapman, D; Fiore, J; Kambhu, SA; Kelsen, DP; Niedzwiecki, D; Rosenbluth, R; Vinciguerra, V, 1990) |
| "We investigated the antitumor effects of intratumoral (IT) injection of mitomycin-C (MMC), 5-fluorouracil (5FU), adriamycin (ADR), cisplatin (CDDP), streptozotocin (STZ), and interleukin-2 (IL-2) on well-differentiated pancreatic ductal adenocarcinoma (WD PaCa), a solid tumor model in the Syrian golden hamster." | 3.68 | Experimental study on multidisciplinary treatment of pancreatic cancer. ( Makino, I; Moriai, T; Takeba, T, 1990) |
| "Twenty-six patients with advanced bronchogenic adenocarcinoma or large cell carcinoma were treated by combination chemotherapy consisting of Ftorafur, adriamycin and mitomycin C (FAM II)." | 3.67 | Ftorafur, adriamycin and mitomycin C (FAM II) for extensive bronchogenic adenocarcinoma and large cell carcinoma. ( Cruciani, AR; De Marinis, A; Nunziati, F; Portalone, L; Salvati, F, 1984) |
| "21 patients with metastatic breast cancer, refractory to conventional agents, were treated with a combination of BCNU, vincristine, mitomycin-C and prednisone given every 4 weeks." | 3.67 | Combination chemotherapy with BCNU, vincristine, mitomycin-C and prednisone in refractory breast carcinoma. A pilot study. ( Anderson, P; DiBella, NJ; Fink, K; Garfield, D; Murphy, J; Speer, J, 1984) |
| "A regimen combining hepatic irradiation and intravenous dacarbazine and mitomycin C for treating colorectal adenocarcinoma with liver metastases offers no advance in the management of patients with this disease." | 3.67 | Inefficacy of dacarbazine, mitomycin C, and hepatic irradiation in patients with metastatic adenocarcinoma of the gastrointestinal tract. ( Evans, M; Hellmann, K; Jones, R; Newton, K; Peters, N; Phillips, RH; Smith, BJ, 1984) |
| "Twenty-two previously untreated patients with advanced gastric adenocarcinoma were treated with a modification of the original 5-fluorouracil, Adriamycin (doxorubicin), and mitomycin C (FAM) combination chemotherapy." | 3.67 | Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, Adriamycin (doxorubicin), and mitomycin C (modified FAM). ( Cohen, Y; Epelbaum, R; Haim, N; Robinson, E, 1984) |
| "A 68-year-old man was treated with FAM (5-fluorouracil, doxorubicin [Adriamycin], mitomycin-C) for metastic gastric adenocarcinoma." | 3.67 | Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma. ( Kerwin, DM; Smith, FP; Tsou, E; Waldhorn, RE, 1984) |
| "Fourteen cases of adenocarcinoma with pleuritis carcinomatosa (lung cancer 10 cases, ovarian cancer 2 cases, colon cancer 2 cases) were treated with intra-pleural instillation of 7-N-(p-hydroxyphenyl)-mitomycin C (KW-2083), a derivative of mitomycin C." | 3.67 | [Effect of 7-N-(P-hydroxyphenyl)-mitomycin C (KW-2083) against pleuritis carcinomatosa]. ( Eguchi, K; Garcia-Herreros, P; Hoshi, A; Nomori, H; Saijo, N; Sasaki, Y; Shimizu, E; Shinkai, T; Tominaga, K, 1984) |
| "Eleven patients with advanced adenocarcinoma of the prostate were treated with a cyclic alternating chemotherapy (VIP-DMF therapy), consisting of a three-drug combination of vincristine, ifosfamide, and peplomycin; and a three-drug combination of adriamycin, mitomycin C and 5-fluorouracil." | 3.67 | [Alternating combination chemotherapy (VIP-DMF) in patients with advanced adenocarcinoma of the prostate]. ( Akagi, T; Hara, M; Nanba, K; Obama, T; Ochi, J; Ozaki, Y; Saegusa, M; Tanahashi, T; Tsushima, T; Yoshimoto, J, 1987) |
| " Treatment regimens usually employed cis-diammine-dichloroplatinum (CDDP) plus peplomycin for squamous cell carcinoma, and CDDP plus vindesine for adenocarcinoma." | 3.67 | [Combination chemotherapy including cisplatin in lung cancer by bronchial artery infusion]. ( Inoue, F; Mimura, H; Miyake, M; Mori, T; Orita, K; Takeda, I; Tanaka, N, 1988) |
| "Thirty patients with advanced colorectal adenocarcinoma were treated by chemotherapy with an alternating regimen consisting of 5-fluorouracil (5-FU)-mitomycin C and 5-FU-dacarbazine at 3-week intervals." | 3.67 | Alternating 5-FU-mitomycin C/5-FU-dacarbazine in advanced colorectal adenocarcinoma: a phase II study. ( Droz, JP; Herait, P; Kac, JL; Rougier, P; Theodore, C, 1989) |
| "A 49 year old woman treated for metastatic adenocarcinoma of the breast suddenly developed the symptoms of acute pulmonary edema 90 minutes after infusion of mitomycin C/vinblastine." | 3.67 | [Acute dyspnea following intravenous administration of vinblastine/mitomycin C]. ( Gattiker, HH; Lagler, U, 1989) |
| "Nineteen patients with adenocarcinoma of unknown primary were treated with the m-FAM regimen, consisting of methotrexate 50 mg/m2 days 0, 28; 5-fluorouracil 600 mg/m2 days 1, 8, 29, 36; Adriamycin 30 mg/m2 days 1, 29; and mitomycin-C 10 mg/m2 day 1." | 3.67 | Phase II trial of methotrexate-FAM (m-FAM) in adenocarcinoma of unknown primary. ( Falchuk, SC; Le Chevalier, T; Rouesse, J; Sevin, D; Spielman, M; Treat, J; Tremblay, C; Woolley, PV, 1989) |
| "A human salivary gland adenocarcinoma cell line was cultivated in the presence of dibutyryl cyclic AMP (dB-cAMP), cis-diammine dichloroplatinum (cisplatin) or mitomycin C (MMC) only, or of the combination of dB-cAMP and each of the antineoplastic drugs." | 3.67 | Enhancement of cis-diamminedichloroplatinum and mitomycin C-induced sister chromatid exchanges by dibutyryl cyclic AMP in a human salivary gland adenocarcinoma cell line in culture. ( Azuma, M; Hayashi, Y; Oishi, Y; Sato, M; Yanagawa, T; Yoshida, H; Yura, Y, 1988) |
| "KW 2083, which is a new mitomycin C derivative currently under clinical investigation, was tested for its antitumor effect on the growth of human carcinoma of the lung by using an in vitro clonogenic assay system." | 3.67 | Evaluation of a new drug 7-N-(p-hydroxyphenyl)-mitomycin C [KW 2083] against carcinoma of the lung by the human tumor clonogenic assay. ( Hoshi, A; Kanzawa, F; Matsushima, Y; Miyazawa, N; Saijo, N; Shimizu, E, 1985) |
| "Fifty-four patients with adenocarcinoma and large cell carcinoma of the lung, 16 with localized surgically resected disease and 38 with metastatic disease, were treated with 5-fluorouracil, doxorubicin, and mitomycin-C (FAM), in an attempt to prolong previously reported survival times in the patients." | 3.67 | 5-Fluorouracil, doxorubicin, and mitomycin-C in the treatment of adenocarcinoma and large cell carcinoma of the lung. ( Shaw, MK; Shaw, MT, 1987) |
| "After treatment with mitomycin C, a patient developed pulmonary hypertension with interstitial infiltrates, microangiopathic hemolytic anemia, systemic hypertension, and renal failure with the nephrotic syndrome." | 3.67 | Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome. ( McCarthy, JT; Staats, BA, 1986) |
| "Neoadjuvant therapy combining 5-fluorouracil, mitomycin C, and moderate-dose radiotherapy was given preoperatively to 29 patients with adenocarcinoma of the rectum, 3 patients with squamous cell cancer, and 1 patient with basaloid carcinoma of the anus." | 3.67 | Combined preoperative neoadjuvant radiotherapy and chemotherapy for anal and rectal cancer. ( Muff, NS; Shetabi, H; Smith, DE, 1986) |
| "Fourteen patients with advanced adenocarcinoma of the lung were treated with a combination chemotherapy of mitomycin C, adriamycin and cisplatin (MAP)." | 3.67 | [Combination chemotherapy with mitomycin C, adriamycin and cisplatin (MAP) in advanced adenocarcinoma of the lung: clinical effect and renal toxicity]. ( Fujii, M; Kiura, K; Okabe, K; Toki, H, 1987) |
| " A yellow crystalline product, named rebeccamycin, was isolated from the mycelium and was found to have activity against P388 leukemia, L1210 leukemia and B16 melanoma implanted in mice." | 3.67 | Production and biological activity of rebeccamycin, a novel antitumor agent. ( Bradner, WT; Bush, JA; Catino, JJ; Long, BH; Tomita, K, 1987) |
| "A 55-year-old female, in which an unresectable Borrmann II-type gastric cancer (moderately differentiated adenocarcinoma) extending from vicinity of the cardia to the lower portion of the corpus, with direct invasion into the pancreas and extensive lymph node metastases, confirmed by laparotomy, was treated postoperatively by 3 courses of chemotherapy with cisplatinum in combination with mitomycin C and 5-fluorouracil." | 3.67 | Cure of advanced gastric cancer by combined chemotherapy with cisplatinum, mitomycin C, and 5-fluorouracil. ( Azuma, S; Furuta, T; Kawata, R; Ohashi, H; Saji, S; Sakata, K; Shimokawa, K; Suzuki, M; Tanemura, H, 1988) |
| "A 64-year-old woman who was diagnosed as inoperable intrahepatic bile duct cancer with massive liver metastasis was treated with 5-fluorouracil (5-FU), adriamycin (ADM) and mitomycin-C (MMC)." | 3.67 | [A case of intrahepatic bile duct cancer responding to 5-fluorouracil, adriamycin and mitomycin C chemotherapy]. ( Hasegawa, H; Kozakai, M; Misu, Y; Saitoh, Y; Shikata, J; Takada, T; Tsuchiya, S; Uchiyama, K; Yasuda, H, 1988) |
| "The combination of 5-fluorouracil (5-FU), doxorubicin, and mitomycin (FAM) is often recommended for empiric management of patients with adenocarcinoma of unknown primary." | 3.67 | 5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary. ( Ahlgren, JD; Goldberg, RM; Schein, PS; Smith, FP; Ueno, W, 1986) |
| "Fifty-three patients with inoperable adenocarcinoma of the lung were treated with 5-fluorouracil, Adriamycin, and mitomycin-C (FAM) in two dose schedules: schedule 1--5-FU 600 mg/m2 days 1, 8, 29, and 36 and Adriamycin 30 mg/m2 days 1 and 29 and mitomycin-C 10 mg/m2 day 1 repeated every 8 weeks." | 3.67 | 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) in the treatment of inoperable adenocarcinoma of the lung. ( Burkes, R; DeBoer, G; Evans, WK; Paul, K; Shepherd, FA, 1986) |
| "A thrombotic microangiopathy resembling the hemolytic uremic syndrome was diagnosed in 12 patients with adenocarcinoma, in whom the tumor was in complete or near-complete remission after treatment with mitomycin C-containing drug regimens." | 3.67 | Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. ( Cantrell, JE; Phillips, TM; Schein, PS, 1985) |
| "Bestatin enhanced the antitumor effects of mitomycin C, 5-fluorouracil and cis-dichlorodiammineplatinum against a syngeneic solid tumor of colon adenocarcinoma 26 in BALB/c mice." | 3.67 | Enhancement of antitumor effect of cytotoxic agents by bestatin. ( Abe, F; Ashizawa, J; Horinishi, H; Ishizuka, M; Matsuda, A; Shibuya, K; Takahashi, K; Takeuchi, T; Umezawa, H, 1985) |
| "Twenty-seven patients with metastatic adenocarcinoma of the breast refractory to other chemotherapy were treated with mitomycin-C plus metronidazole." | 3.67 | Mitomycin-C plus metronidazole in advanced carcinoma of the breast. ( Crook, AF; Heringer, R; Lefebvre, B; Maroun, JA; Stewart, DJ, 1985) |
| "Nineteen patients with unresectable and metastatic adenocarcinoma of the pancreas and ampulla of Vater were treated with intermittent regional infusion of the celiac axis (CAI) with the combination of 5-fluorouracil, adriamycin, mitomycin-C, and streptozotocin (FAM-S)." | 3.66 | Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study. ( Bukowski, RM; Hewlett, JS; Livingston, RB; Theodors, A; Weick, JK, 1982) |
| "Following gastrectomy for locally advanced adenocarcinomas, three patients developed microangiopathic hemolytic anemia and renal failure shortly after completing courses of adjuvant chemotherapy with mitomycin and 5-FU." | 3.66 | Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome. ( Band, PR; Bettez, P; Giroux, L; Gruber, J; Jolivet, J; Laurin, S, 1983) |
| "Logothetis and von Eschenbach first 1981 reported encouraging preliminary results of the DMF regimen (Doxorubicine = Adriamycin, Mitomycin, 5 Fluorouracil) in hormone refractory adenocarcinoma of the prostate." | 3.66 | [Treatment of metastasizing prostatic carcinoma with DMF. Presentation of a prospective study]. ( Burk, K; Gropp, C; Rodeck, G, 1983) |
| "Sixty-two patients with metastatic hormonal refractory adenocarcinoma of the prostate received a combination of doxorubicin, mitomycin-C, and 5-fluorouracil (DMF)." | 3.66 | Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancer. ( Grant, C; Johnson, DE; Logothetis, CJ; Ogden, S; Samuels, ML; Trindade, A; von Eschenbach, AC, 1983) |
| "Fourteen patients with adenocarcinoma of the gastrointestinal tract and pancreas treated with mitomycin C(MMC) and 5-fluorouracil (5-FU) had renal impairment 6-11 months from the beginning of MMC therapy." | 3.66 | Renal disease after mitomycin C therapy. ( Hanna, WT; Krauss, S; Murphy, WM; Regester, RF, 1981) |
| "One hundred patients suffering from advanced breast cancers and resisting to one (15) or several (85) drugs previously administered have been treated by an association of mitomycin C, thiotepa and vindesine, given every 3 weeks." | 3.66 | [Chemotherapy associating mitomycin C, thiotepa and vindesine in advanced breast cancers. Study of 100 cases (author's transl)]. ( Brunet, R; Bui, BN; Chauvergne, J; Durand, M; Hoerni, B; Mauriac, L, 1981) |
| "Three women with adenocarcinoma of cardia, adenocarcinoma of liver or ileum carcinoid tumor, respectively, were treated with mitomycin C (MMC) and 5-fluoro-uracil (5-FU)." | 3.66 | [Mytomycin C nephrotoxicity. 3 new cases and review of the literature]. ( Ang, KS; Cledes, J; Hervé, JP; Leguy, P; Leroy, JP; Ramée, MP; Simon, P; Vignoud, J, 1982) |
| " A pharmacokinetic study was performed in 18 patients." | 2.84 | Mitomycin C hypoxic pelvic perfusion for unresectable recurrent rectal cancer: pharmacokinetic comparison of surgical and percutaneous techniques. ( Clementi, M; Fiorentini, G; Guadagni, S; Mambrini, A; Masedu, F; Palumbo, P, 2017) |
| "Cervical squamous carcinoma patients who were pathologically diagnosed with stage Ib-IIb from April 2012 to May 2013 in the general hospital of Chinese People's Libration Amy were enrolled." | 2.80 | A clinical Comparison of Lobaplatin or Cisplatin with Mitomycine and Vincristine in Treating Patients with Cervical Squamous Carcinoma. ( Chen, L; Li, WP; Liu, H; Yao, YQ; Zhao, EF, 2015) |
| "A total of 268 patients with stage II gastric cancer underwent D2 resection in our Cancer Center between January 1990 and December 2006 were recruited." | 2.76 | No survival benefit from postoperative adjuvant chemotherapy after D2 radical resection for the patients with stage II gastric cancer. ( Chen, S; Chen, YB; Feng, XY; Guan, YX; Li, W; Li, YF; Sun, XW; Xu, DZ; Zhan, YQ; Zhou, ZW, 2011) |
| "Postoperative complications were anastomotic leakage (2." | 2.75 | Effect of preoperative intraperitoneal injection of Sapylin in advanced gastric cancer. ( Du, P; Huang, YN; Liu, Y; Xu, YY; Yang, SJ; Yang, Y, 2010) |
| "The incidence of liver metastasis in group A was 34% which was lower than 50% in group B." | 2.74 | Effect of multiple-phase regional intra-arterial infusion chemotherapy on patients with resectable pancreatic head adenocarcinoma. ( Fu, DL; Jin, C; Long, J; Ni, QX; Xu, J; Yang, F; Yao, L; Yu, XJ, 2009) |
| "Thirty-four patients with gastric cancer, 16 after failure of first-line chemotherapy and 18 after failure of at least two prior chemotherapies, were included." | 2.73 | Mitomycin C plus infusional 5-fluorouracil in platinum-refractory gastric adenocarcinoma: an extended multicenter phase II study. ( Al-Batran, SE; Bokemeyer, C; Hartmann, JT; Horger, M; Jäger, E; Kanz, L; Königsrainer, A; Meisinger, I; Nehls, O; Pintoffl, JP; Quietzsch, D, 2007) |
| "Dipyridamole 75 mg was administered orally three times daily during the FU administration." | 2.73 | Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700. ( Barstis, JJ; Bendetti, JK; Isacoff, WH; Jazieh, AR; Macdonald, JS; Philip, PA, 2007) |
| "Patients with local/regional oesophageal cancer with adequate functional status should not be excluded from potentially curative treatment based on age alone." | 2.73 | Combined modality chemoradiation in elderly oesophageal cancer patients. ( Anderson, SE; Bains, M; Hummer, A; Ilson, DH; Kelsen, D; Minsky, BD, 2007) |
| "Stage III colon cancer patients were enrolled and were divided into two groups: Group W, in which the histologic type of both primary tumors and metastatic lymph nodes was well-differentiated adenocarcinoma; and Group U, in which the primary tumors and the metastatic lymph nodes were of any type other than well-differentiated." | 2.72 | Significance of histologic type of primary lesion and metastatic lymph nodes as a prognostic factor in stage III colon cancer. ( Hirota, T; Kodaira, S; Mori, T; Ohashi, Y, 2006) |
| "169 patients with radically resected gastric cancer were randomized to receive CPT-11 (180 mg/m2 day 1), leucovorin (100 mg/m2 days 1-2), FU (400-600 mg/m2 days 1-2, q 14; for four cycles; FOLFIRI regimen), followed by docetaxel (85 mg/m2 day 1), cisplatin (75 mg/m2 day 1, q 21; for three cycles; arm A), or MMC (8 mg/m2 days 1-2 as 2-hour infusion, q 42; for four cycles; arm B)." | 2.72 | Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial. ( Agostana, B; Aitini, E; Ardizzoia, A; Ardizzoni, A; Bajetta, E; Bochicchio, AM; Bordonaro, R; Botta, M; Buzzoni, R; Cicero, G; Comella, G; Di Bartolomeo, M; Duro, M; Fagnani, D; Ferrario, E; Gevorgyan, A; Katia, D; Kildani, B; Mantovani, G; Mariani, L; Marini, G; Massidda, B; Mozzana, R; Oliani, C; Palazzo, S; Pinotti, G; Reguzzoni, G; Schieppati, G; Villa, E; Zilembo, N, 2006) |
| "To evaluate the tolerance of peritonectomy procedures (PP) combined with intraperitoneal chemohyperthermia (IPCH) in patients with peritoneal carcinomatosis (PC), a phase II study was carried out from January 1998 to September 2001." | 2.71 | Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. ( Beaujard, AC; Francois, Y; Freyer, G; Gilly, FN; Glehen, O; Guertsch, P; Mithieux, F; Osinsky, D; Panteix, G; Peyrat, P; Vignal, J, 2003) |
| "A retrospective study of 46 patients treated for peritoneal carcinomatosis from colon adenocarcinoma was performed." | 2.71 | Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. ( Campana, L; Foletto, M; Lise, M; Mocellin, S; Nitti, D; Pilati, P; Rossi, CR, 2003) |
| "Secondary objectives were time to disease progression, response rates, evaluation of toxicity, disease-related symptoms, World Health Organization performance status (PS), and quality of life (QoL)." | 2.71 | Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma. ( Anderson, H; Ashcroft, L; Beresford, C; Burt, PA; Clemons, M; Danson, S; Dowd, I; Fairve-Finn, C; Hassan, J; Middleton, MR; O'Byrne, KJ; Ranson, M; Stout, R; Thatcher, N, 2003) |
| "The aim of this study was to define the maximum tolerated dose (MTD) of bolus mitomycin C (MMC) in combination with 24 h-continuous infusion of 5-flourouracil (FU) plus folinic acid, and to assess the toxicity and activity in patients with previously treated colorectal and gastric cancer." | 2.71 | Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study. ( Bokemeyer, C; Hartmann, JT; Hofheinz, RD; Honecker, F; Käfer, G; Kanz, L; Köhne, CH; Nehls, O; Oechsle, K; Quietzsch, D; Wein, A, 2003) |
| "Mitomycin C (MMC) in combination with infusional 5-fluorouracil (FU) plus folinic acid (FA) is an effective treatment for metastatic gastrointestinal cancer." | 2.71 | Pegylated liposomal doxorubicin in combination with mitomycin C, infusional 5-fluorouracil and sodium folinic acid. A phase-I-study in patients with upper gastrointestinal cancer. ( Gnad, U; Hartmann, JT; Hehlmann, R; Hochhaus, A; Hofheinz, RD; Kreil, S; Saussele, S; Weisser, A; Willer, A, 2004) |
| " In the present study, local injection of mitomycin C bound to activated carbon (M-CH) combined with i." | 2.70 | Local injection of M-CH combined with i.p. hyperthermic hypo-osmolar infusion is an effective therapy in advanced gastric cancer. ( Fan, Y; Hagiwara, A; Huang, Y; Ma, D; Qi, X; Su, G; Wang, W, 2002) |
| "Because of the poor response of pancreatic cancer to conventional therapy, the authors performed a phase II pilot study to evaluate whether beta-interferon and retinoids, added to active chemotherapeutic agents, could increase response rate and survival in a group of patients who had metastatic disease." | 2.69 | Advanced carcinoma of the pancreas: phase II study of combined chemotherapy, beta-interferon, and retinoids. ( Casucci, D; Frati, L; Gulino, A; Rea, S; Recchia, F; Sica, G, 1998) |
| "To assess the effect and mechanism of composite Xiansu Capsule (CXSC) combined with chemotherapy in treating gastric carcinoma of mid-late stage." | 2.69 | [Clinical study on treatment of mid-late stage gastric carcinoma by composite xiansu capsule combined with chemotherapy]. ( Hua, B; Wang, A, 1999) |
| "40813) on adjuvant chemotherapy in gastric cancer, results obtained after administration of the FAM2 regimen (fluorouracil [5-FU], doxorubicin, and mitomycin) were compared with results obtained after surgery alone to assess the effect of this regimen on overall survival, time to progression, and disease-free interval." | 2.68 | Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer. ( Buyse, M; Dos Santos, JG; Duez, N; Fiorentino, M; Labianca, R; Lise, M; Marchet, A; Nitti, D; Rougier, P; Sahmoud, T, 1995) |
| " The aim of this phase I study was to determine the toxicity profile and the optimal dosage of KW-2149." | 2.68 | Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149. ( Ardiet, C; Catimel, G; De Bruijn, E; Dirix, L; Dumortier, A; Evene, E; Joossens, E; Koier, I; Provè, A; Schrijvers, D, 1995) |
| "There were 51 patients with colorectal cancer and 130 patients with appendiceal cancer." | 2.68 | Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. ( Jablonski, KA; Sugarbaker, PH, 1995) |
| "12." | 2.68 | Adjuvant immunotherapy with interleukin 2 and lymphokine-activated killer cells after noncurative resection of primary lung cancer. ( Kimura, H; Yamaguchi, Y, 1995) |
| "Mitomycin C was infused over 25 minutes followed by 5-FU over 10 minutes." | 2.68 | Regional chemotherapy for inoperable pancreatic carcinoma. ( George, WJ; Muchmore, JH; Preslan, JE, 1996) |
| "Etoposide is a topoisomerase II inhibitor with evidence for phase-specific and schedule-dependent activity." | 2.68 | A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tract. ( Boardman, P; Braybrooke, JP; Ganesan, TS; Harris, AL; O'Byrne, KJ; Propper, DJ; Salisbury, AJ; Saunders, MP; Talbot, DC; Taylor, M, 1997) |
| "We studied how gastric cancer tissues and cells changed as a result of preoperative chemotherapy." | 2.68 | [Influence of preoperative on gastric cancer tissues and cells]. ( Chen, Z; Li, G; Liu, F, 1997) |
| "Chemoradiation for duodenal cancer has produced a complete pathologic response in all patients and survival has been excellent, suggesting efficacy of this regimen for duodenal cancer." | 2.67 | Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum. ( Coia, L; Eisenberg, B; Hanks, G; Hoffman, J; Paul, A; Scher, R; Solin, L; Weese, J; Weiner, L, 1994) |
| " No severe side effects appeared in either of the groups, and a long-term administration was safe." | 2.67 | [Multihospital co-operative study of post-operative adjuvant chemotherapy in the treatment of gastric cancer-(Part 3). Comparisons between tegafur and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy]. ( Abe, R; Arima, S; Fukuyama, N; Hisatsugu, T; Nakamura, Y; Ohkuma, R; Ohsato, K; Taira, A; Yamamoto, H; Yamanouchi, A, 1991) |
| "Twenty-seven pts with squamous cell carcinoma were randomized between regimen PMP (CDDP 60 mg/m2, d 1, MMC 6 mg/m2, d 3, d 10 and PEP 5 mg/m2, d 3-7) and regimen PM (CDDP 60 mg/m2, d 1 and MMC 6 mg/m2, d 3, d 10)." | 2.66 | [A randomized trial with various combinations of cis-platinum (CDDP), mitomycin C (MMC), peplomycin (PEP) and ftorafur (FT) in the treatment of non-small cell lung cancer]. ( Abe, S; Miyamoto, H; Nakabayashi, T; Ohosaki, Y; Yasuda, S, 1986) |
| "140 patients with advanced gastric cancer confirmed by pathology were treated by UFT (Uracil, FT-207) and mitomycin C (MMC) from Sept." | 2.66 | [Combined UFTM for 140 patients with advanced gastric cancer]. ( Jin, ML, 1989) |
| " During the past eleven years, we have used postoperative chemotherapy in three ways over three different periods: in the earliest period, short-term combined chemotherapy (STCC) was used, in the middle period, intermittent long-term combined chemotherapy (ILTCC) was used in combination with immunotherapy for a randomized group, and in the latest period, when continuous long-term combined chemotherapy (CLTCC) with immunotherapy was employed." | 2.66 | [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy]. ( Hashizume, Y; Ichihashi, T; Iida, S; Kimoto, H; Kobayashi, H; Sato, H; Shimizu, J; Tsunamura, Y; Watanabe, Y; Yamada, T, 1985) |
| "positive cases in gastric cancer (4/40)." | 2.65 | [Sex hormone dependency and endocrine therapy in diffuse carcinoma of the stomach]. ( Kitaoka, H, 1983) |
| "Advanced extramammary Paget's disease is also adenocarcinoma of the skin." | 2.40 | [Chemotherapy for advanced adenocarcinoma of the skin: experience with combination chemotherapy and a review of the literature]. ( Yamazaki, N, 1997) |
| "A 42-year-old female with stage III gastric cancer underwent radical gastrectomy and was given mitomycin-C at 10 mg/m2 intravenously every four weeks as adjuvant therapy." | 2.40 | Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review. ( Chen, LT; Chen, YM; Liu, JM; Liu, SM; Whang-Peng, J; Wu, DC; Yang, S, 1997) |
| "Five-year survival rates were 57% for squamous cell carcinoma, 63% for adenocarcinoma, and 33% for melanoma." | 2.40 | Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. ( Klas, JV; Madoff, RD; Rothenberger, DA; Wong, WD, 1999) |
| "Mitomycin (MMC) was part of the treatment regimen in 84 patients; all but nine received a cumulative dose greater than 60 mg." | 2.38 | Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry. ( Arbus, M; Chiazze, L; Erickson, B; Keller, J; Korec, S; Lesesne, JB; Rothschild, N; Schein, PS; Sisk, R; Woolley, PV, 1989) |
| "Management of the superficial bladder cancer patient consists of two complementary but separate therapeutic goals: treatment of the existing tumor(s) and prevention of tumor recurrence." | 2.37 | The biology and treatment of superficial bladder cancer. ( Lum, BL; Torti, FM, 1984) |
| " This study evaluated the efficacy and safety of cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of PPSC." | 1.43 | Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for the treatment of primary peritoneal serous carcinoma: Results of a Chinese retrospective study. ( Ji, ZH; Li, Y; Peng, KW; Sun, JH; Wu, HT; Yonemura, Y; Zhang, Q, 2016) |
| "Capecitabine is an established treatment alternative to intravenous 5-fluorouracil (5-FU) for patients with rectal cancer receiving chemoradiotherapy." | 1.40 | Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option. ( Beijnen, JH; Cats, A; Dewit, L; Meulendijks, D; Schellens, JH; Tomasoa, NB; van Tinteren, H, 2014) |
| "Treatment with mitomycin C decreased MRP expression at high concentrations and hyperthermia intensified these effects." | 1.39 | The exposure of cancer cells to hyperthermia, iron oxide nanoparticles, and mitomycin C influences membrane multidrug resistance protein expression levels. ( Franke, K; Hilger, I; Kaiser, WA; Kettering, M; Lange, K, 2013) |
| "Mitomycin C (MMC) has been widely used in this context, and despite good tolerability, there are doubts regarding its true benefit." | 1.38 | A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer. ( Costa, FP; Ferrarotto, R; Hoff, PM; Kopetz, S; Machado, K; Mak, MP; Overman, MJ; Shah, N; Takahashi, TK, 2012) |
| "Data of all patients diagnosed with squamous cell carcinoma (SCC) and adenocarcinoma (AC) of the oesophagus, treated between 1983 and 2007 in the department of radiation oncology of the LMU, were obtained." | 1.38 | Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre. ( Belka, C; Hölzel, D; Schmidt, M; Wolf, MC; Zehentmayr, F, 2012) |
| "Unresectable intrahepatic cholangiocarcinoma has a poor prognosis, with a median survival of 5 to 8 months without treatment." | 1.37 | Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. ( Albert, M; Christians, K; Fraker, D; Kiefer, MV; McNally, M; Olthoff, K; Pappas, S; Rilling, W; Robertson, M; Soulen, MC; Sun, W, 2011) |
| "It includes 51 cases of squamous cell carcinoma, 6 cases of adenocarcinoma and 1 case of adenosquamous carcinoma." | 1.37 | [Evaluation of the efficacy of bronchial arterial infusion chemotherapy for the treatment of central non-small cell lung cancer]. ( Chen, Y; Li, H; Liu, DZ; Yan, D; Zeng, HY; Zhou, CW, 2011) |
| "298 patients with inoperable cancer of the esophagus were identified (16." | 1.36 | Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer. ( Belka, C; Ganswindt, U; Haimerl, W; Hölzel, D; Niyazi, M; Schmidt, M; Wolf, M; Zehentmayr, F, 2010) |
| " 60Co gamma-irradiation or 6MVX-ray with conventional fraction were used for radiotherapy with a total volume dosage of 55-70 Gy." | 1.34 | [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus]. ( Han, JQ; Li, XQ; Liang, RX; Liu, Q; Qu, FS; Sun, YH; Yan, TX, 2007) |
| "Thirty-five patients with gallbladder cancer were treated with superselective intra-arterial chemotherapy (SIAC) with mitomycin C during 1981-1996." | 1.33 | Intra-arterial chemotherapy with mitomycin C in gallbladder cancer: a follow-up study. ( Bode, MK; Leinonen, S; Mäkelä, JT; Perälä, J, 2005) |
| "These results suggest that gastric cancer,in which liver metastasis is considered to be a prognostic factor,can be effectively treated by combination therapy with hepatic arterial infusion therapy, followed by thermochemotherapy for the primary lesion." | 1.33 | [A case of gastric cancer with multiple liver metastases effectively treated by hepatic arterial infusion of MMC, TS-1/CDDP therapy, and thermotherapy]. ( Aoki, T; Hamaya, M; Kouno, T; Nishida, J; Ogata, T; Sato, S; Seo, K; Tsuchida, A; Yoshida, K, 2005) |
| "Valproic acid has been demonstrated to mediate cytotoxic effects against tumor cells by acting as a histone-deacetylase inhibitor." | 1.33 | Synergistic effects of valproic acid and mitomycin C in adenocarcinoma cell lines and fresh tumor cells of patients with colon cancer. ( Atmaca, A; Chow, KU; Friedmann, I; Jäger, E; Weidmann, E, 2006) |
| "To evaluate the effect of pirarubicin (THP) in combination with hyperthermia on gastric cancer tissues in vitro and explore the underlying mechanisms." | 1.33 | [Effects of pirarubicin chemotherapy combined with hyperthermia on gastric cancer in vitro]. ( Fu, J; Li, GX; Luo, RC; Wang, XG; Zheng, H, 2006) |
| "A 54-year-old man with colon cancer underwent hemicolectomy." | 1.32 | Therapy-related erythroleukemia caused by the administration of UFT and mitomycin C in a patient with colon cancer. ( Miyazaki, M; Nakamori, Y; Shinohara, K; Taguchi, A; Tominaga, T, 2003) |
| "In advanced gastric cancer, peritoneal recurrence is the main cause of death after curative surgical resection." | 1.32 | Application of molecular diagnosis for detection of peritoneal micrometastasis and evaluation of preoperative chemotherapy in advanced gastric carcinoma. ( Azama, T; Fujiwara, Y; Ishii, T; Monden, M; Mori, T; Sugita, Y; Takiguchi, S; Taniguchi, K; Yamazaki, K; Yano, M; Yasuda, T, 2004) |
| "Mitomycin and cisplatin were highly effective to prevent peritoneal carcinomatosis (direct application immediately after tumor cell transfer - 1 (st) treatment group)." | 1.32 | [Five cytostatic substances in animal studies for prevention and treatment of experimentally induced peritoneal carcinomatosis]. ( Fenske, A; Hribaschek, A; Krüger, S; Lippert, H; Meyer, F; Pross, M; Ridwelski, K, 2004) |
| "The use of neoadjuvant chemotherapy for pancreatic cancer has been advocated for its potential ability to optimize patient selection for surgical resection and to downstage locally advanced tumors, especially for patients with Stage IV b (Japan criteria)." | 1.32 | [Adjuvant chemotherapy for unresectable locally advanced pancreatic cancer in light of its characteristics]. ( Hirano, H; Ikuma, H; Imai, T; Kadowaki, S; Mitsui, Y; Miyashita, K; Murata, T; Nakamura, T; Nobuoka, Y; Tanigawa, K; Taoka, H; Umino, W; Yamashita, M; Yoshimine, S, 2004) |
| "We report a case of inoperable gastric cancer with multiple liver metastases, which responded significantly to the short-term administration of TS-1 following intravenous FMP therapy." | 1.31 | [Gastric cancer with multiple liver metastases, which responded significantly to oral administration of TS-1 following intravenous FMP therapy under hospitalization]. ( Chinzei, T; Okada, Y; Tasaka, K; Tomofuji, Y, 2002) |
| "In patients with pancreatic cancer, the overall response rate was 42% with a median survival of 8 months." | 1.31 | Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers - a new active regimen. ( Gallagher, CJ; Shamash, J; Slater, S; Slevin, ML; Wilson, P, 2002) |
| "Six patients with gastric cancer, stage IIIA to IV, received intraabdominal cisplatin (CDDP) at laporotomy." | 1.31 | [Postoperative adjuvant immunochemotherapy using Lentinan for advanced gastric carcinoma patients with metastasis in the regional lymph nodes and serosal invasion]. ( Kagawa, R; Nakayama, N; Sakata, S; Tada, M; Yamaguchi, T, 2002) |
| "Twenty-four patients with gastric cancers who underwent the intraoperative systemic chemotherapy were taken as controls." | 1.31 | [Clinical comparison between intraoperative local arterial infusion chemotherapy and systemic venous chemotherapy of gastric cancer]. ( Chen, D; Lai, Y; Peng, B; Xiao, Q; Zhang, S, 2001) |
| "112 cases of fresh human gastric cancer samples were obtained for drug sensitivity testing using MTT." | 1.31 | [Study on the chemosensitivity test of human gastric cancer using the MTT assay]. ( Chen, J; Chen, Z; Hu, J; Mao, Y; Yan, L; Zou, L, 2001) |
| " In order to promote the clinical response of chemotherapy for colorectal cancer using CPT-11, one of the most effective strategies is to use it in combination with other anticancer agents." | 1.31 | In vitro augmentation of antitumor effect in combination with CPT-11 and CDDP for human colorectal cancer. ( Hotta, T; Ishimoto, K; Iwahashi, M; Matsuda, K; Tanaka, H; Tani, M; Tanimura, H; Tsunoda, T; Yamaue, H, 2000) |
| "Data on 45 patients with colorectal cancer were analyzed." | 1.31 | Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas. ( Hinoshita, E; Kinukawa, N; Kuwano, M; Maehara, Y; Sugimachi, K; Taguchi, K; Tsuneyoshi, M; Uchiumi, T, 2000) |
| "Lymph node metastasis was not present." | 1.31 | [Lymph node and peritoneum metastases of bile duct cancer responding to chronochemotherapy--a case report]. ( Iesato, H; Morishita, Y; Nakagami, K; Ohwada, S; Ohya, T; Sasaki, T; Sugitani, K; Takahashi, T; Yokomori, T, 2000) |
| "We report a case of advanced rectal cancer accompanied by unresectable liver metastasis in which remission has been achieved for 7 years." | 1.31 | [A case of advanced rectal cancer with unresectable liver metastasis for which chemotherapy was markedly effective]. ( Baba, H; Kikunaga, H; Matsudo, A; Miura, H; Morisue, A; Nakai, H; Osakabe, Y; Sotome, K; Takao, M, 2000) |
| "A 67-year-old female with rectal cancer and multiple liver metastases underwent low anterior resection by total mesorectal excision (TME), cholecystectomy and hepatic arterial cannulation in June 1995." | 1.31 | [Long survival in a case of unresectable hepatic metastasis from rectal carcinoma treated with second-look hepatectomy plus pharmacokinetic modulating chemotherapy (PMC)]. ( Kusunoki, M; Noda, M; Yamamura, T; Yanagi, H; Yoshikawa, R, 2001) |
| "Expanded gammadeltaTILs from colorectal tumors demonstrated marked cytotoxicities to allogeneic human colon adenocarcinoma HR8348 and lymphoma Daudi cells, as well as xenogeneic murine thymoma EL-4 cell lines." | 1.31 | Antitumor activity of expanded human tumor-infiltrating gammadelta T lymphocytes. ( Ba, D; Chen, J; He, W; Niu, H, 2001) |
| "About one-third of patients with gastric cancer are unresectable at the time of diagnosis." | 1.30 | Retrospective comparison of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (modified FAM) combination chemotherapy versus palliative therapy in treatment of advanced gastric cancer. ( Cho, JY; Chung, HC; Kim, BS; Kim, CB; Kim, JH; Min, JS; Noh, SH; Park, JO; Rha, SY; Roh, JK; You, NC, 1997) |
| "Mitomycin C suppository was significantly less toxic compared with intravenous delivery, and higher rectal tissue concentrations were observed from 10 to 30 minutes (P < 0." | 1.30 | Suppository administration of chemotherapeutic drugs with concomitant radiation for rectal cancer. ( Ackerman, D; Galandiuk, S; Hofmeister, A; LaRocca, R; Lewis, RK; Myers, SR; Paris, KJ; Pokorny, RM; Wrightson, WR, 1997) |
| "The response rate was higher in squamous cell carcinomas (85%) than adenocarcinomas or adenosquamous carcinomas (67%)." | 1.30 | [Neoadjuvant chemotherapy for advanced cervical cancer]. ( Hongo, A; Ikuhashi, H; Kobashi, Y; Kodama, J; Kudo, T; Miyagi, Y; Mizutani, Y; Okuda, H; Yoshinouchi, M, 1999) |
| " To explain this tumor selectivity, the distribution of FK317 was investigated after dosing tumor-bearing mice with the 14C-labelled compound." | 1.30 | FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice. ( Fujiwara, T; Inami, M; Kawamura, I; Manda, T; Matsumoto, S; Naoe, Y; Nishigaki, F; Shimomura, K; Takagaki, S; Tsujimoto, S; Yamazaki, S, 1998) |
| "A total of 22 patients with primary colorectal cancer who underwent surgical treatment were examined for chemosensitivity with iable tumor samples using the Histoculture Drug Response Assay (HDRA)." | 1.30 | Clinical significance of serum p53 antibody detection on chemosensitivity assay in human colorectal cancer. ( Hayashi, H; Imaseki, H; Isono, K; Nakajima, K; Ochiai, T; Shimada, H; Suzuki, T; Takayama, W; Takeda, A, 1999) |
| "We report a 68-year-old man with rectal cancer and recurrent pulmonary metastasis treated with concomitant 5'-DFUR + MMC, which resulted in an extreme reduction of the lesion." | 1.30 | [Combination of 5'-DFUR and MMC for recurrent rectal cancer with pulmonary metastasis]. ( Aihara, S; Hiki, Y; Ishikawa, H; Kakita, A; Kanazawa, H; Ohtani, Y, 1999) |
| "The role in colorectal cancer is less clear, although there are some reports that suggest a benefit." | 1.30 | Peritonectomy and intraperitoneal chemotherapy in appendiceal and colorectal cancer. ( Clingan, P; Horsell, KW; King, DW; Merten, S; Morris, DL, 1999) |
| "A case of unresectable pancreatic cancer in a 76-year-old female was reported, in which a tumor had liver involvement." | 1.29 | [A case of pancreatic cancer surviving for 7 years 11 months following intra-arterial and portal infusion chemotherapy]. ( Endo, T; Ichikawa, J; Ishii, H; Kenmotsu, M; Tsunemitsu, K, 1995) |
| "A patient with advanced gastric cancer with multiple liver metastases was treated by reduction surgery at the primary site as well as by the intraarterial administration of mitomycin C (MMC) and cisplatin (CDDP) through a reservoir catheter inserted into the proper hepatic artery." | 1.29 | Combination chemotherapy with mitomycin C and cisplatin for advanced gastric cancer with multiple liver metastases. ( Furukawa, T; Ishibiki, K; Kitajima, M; Kubota, T; Kumai, K; Saikawa, Y; Yoshino, K, 1994) |
| "An anti-gastric cancer monoclonal antibody MGb2-mitomycin C conjugate via dextran T-70 as intermediate (MGb2-PAD-MMC) was produced, and 28-30 g molecules of MMC were introduced into 1 g molecule of MGb2." | 1.29 | [Effect of targeting treatment of mitomycin C immunoconjugate on stomach neoplasm]. ( Chen, LJ; Chen, M; Chen, XT; Li, S; Zhang, JL; Zhang, SY; Zhang, XY; Zhang, Z, 1993) |
| "A 67-year-old man with advanced gastric cancer with multiple liver metastases was treated by a new combination chemotherapy using 5-FU, THP and MMC (FTM)." | 1.29 | [A case of advanced gastric cancer with multiple liver metastases showing marked response to new combination chemotherapy using 5-FU, THP and MMC (FTM)]. ( Kusano, F; Maekawa, N; Sakai, Y; Sasaki, N; Tajiri, K; Tazawa, J; Yamamoto, C, 1994) |
| " 5-Fluorouracil is given in a dosage of 1000 mg/m2/day as a continuous 24-hour infusion for 4 days." | 1.29 | Concomitant preoperative radiochemotherapy in operable locally advanced rectal cancer. ( Cellini, N; Coco, C; De Franco, A; Magistrelli, P; Mattana, C; Netri, G; Picciocchi, A; Roncolini, G; Valentini, V; Vecchio, FM, 1994) |
| " The dosage was 14 mg/m2 (7 mg/m2 at second and following administrations) of MMC and 35 mg/m2 of CDDP and they were repeatedly administered in the abdominal cavity via the drug delivery system." | 1.29 | [Intraperitoneal repeated chemotherapy using CDDP combined with MMC for carcinomatous peritonitis]. ( Arai, K; Kitamura, M; Miyashita, K, 1993) |
| "A new dosage format (MMC-CH) of mitomycin C, which is composed of mitomycin C on activated carbon particles, was efficacious for prevention of peritoneal recurrence of gastric cancer." | 1.29 | [Four long-surviving cases of gastric cancer with peritoneal dissemination treated by intraperitoneal administration of mitomycin C adsorbed on activated carbon particles]. ( Hagiwara, A; Oyama, T; Ozaki, K; Sakakibara, T; Sakakura, C; Sasaki, S; Shimotsuma, M; Takahashi, T; Tsujimoto, H, 1993) |
| "This metastatic model of human stomach cancer shows that locally growing and metastatic tumors may have different chemosensitivities, and provides the opportunity to test both with various treatment regimens." | 1.29 | Differential chemosensitivity of local and metastatic human gastric cancer after orthotopic transplantation of histologically intact tumor tissue in nude mice. ( Furukawa, T; Hoffman, RM; Kitajima, M; Kubota, T; Kuo, TH; Watanabe, M, 1993) |
| " Pharmacokinetic examination after intravenous injection of low-dose MMC (0." | 1.29 | A case of advanced gastric cancer complicated by severe toxicity induced by a combination of tegafur, uracil and mitomycin C, and associated with abnormal pharmacokinetics. ( Boku, N; Ishii, H; Kaneko, K; Kusada, O; Muro, K; Muto, M; Ohkuwa, M; Ohtsu, A; Sasaki, Y; Tajiri, H; Yoshida, S, 1996) |
| "Metastatic bronchioloalveolar carcinoma is an aggressive disease that is associated with a poor prognosis, similar to metastatic adenocarcinoma of the lung." | 1.28 | Metastatic bronchioloalveolar carcinoma and metastatic adenocarcinoma of the lung: comparison of clinical manifestations, chemotherapeutic responses, and prognosis. ( Eagan, RT; Feldman, ER; Schaid, DJ, 1992) |
| "Twenty patients with rectal cancer underwent the preoperative regimen that consisted of 3,000 cGy delivered in 10 fractions over 12 days with concomitant 5-fluorouracil and mitomycin-C." | 1.28 | Advantages of the Papillon protocol in the preoperative treatment of rectal carcinoma. ( Broadwater, JR; Gocio, JC; Hutchins, LF; Klimberg, VS; Lang, NP; Langston, JD; Maners, A; Westbrook, KC, 1992) |
| "A 60-year-old woman with gastric cancer had undergone partial gastrectomy in September 1989." | 1.28 | Complete disappearance of metastatic abdominal tumors from gastric cancer after treatment with irsogladine maleate. ( Hosokawa, T; Kajiwara, T; Ogawa, K; Otani, Y, 1992) |
| "Mitomycin C was given on Day 1 (dose: 15 mg/m2 i." | 1.28 | Mitomycin C, 5-fluorouracil and radiation in advanced, locally recurrent rectal cancer. ( Dobrowsky, W, 1992) |
| "A 74-year-old man with advanced gastric cancer of Borrmann type III and liver metastasis was treated by combined administration of UFT (400 mg/day, p." | 1.28 | [A case of advanced gastric cancer with liver metastasis completely responding to a combined immunochemotherapy with UFT, mitomycin C and lentinan]. ( Hatayama, H; Kitamura, H; Mashiko, H; Satoh, J, 1992) |
| "We reported a case of metastatic liver cancer from rectal carcinoma, which was successfully treated by systemic continuous 5-Fluorouracil and intermittent Mitomycin C chemotherapy." | 1.28 | [A case report of complete remission of liver metastasis from rectal carcinoma treated with intra-arterial infusion chemotherapy]. ( Noguchi, S; Shibata, N, 1992) |
| "Mitomycin C was injected intermittently in the hepatic artery more than 10 times." | 1.28 | [Intra-arterial infusion chemotherapy using implantable reservoir for liver metastasis of the lung cancer--an effective case]. ( Ishihara, T; Kawamura, M; Kikuchi, K; Kobayashi, T; Mouri, M; Watanabe, M, 1992) |
| "The in vitro drug sensitivity of gastric cancer tissues obtained from 40 patients with advanced cancer was compared in terms of the pathological classifications which were assigned according to the General Rules for the Gastric Cancer Study in Surgery and Pathology in Japan." | 1.28 | Relationship between tumor histopathology and in vitro sensitivity to antitumor drugs in gastric cancer. ( Anai, H; Kusumoto, H; Maehara, Y; Sugimachi, K; Takahashi, I; Yoshida, M, 1992) |
| "Mitomycin C (10 mg/m2) was administered as a bolus injection on day 2." | 1.28 | Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. ( Coia, LR; Engstrom, PF; Hanks, GE; Paul, AR; Stafford, PM, 1991) |
| "A woman born in 1924 with colon cancer initially operated on approximately four years ago showed a second recurrence in the lung." | 1.28 | [A case of pulmonary metastasis from colon cancer responding completely to high-dose 5'-DFUR plus MMC combination chemotherapy]. ( Kawahara, T; Kikkawa, N; Kobayakawa, K; Tsuchiya, Y; Tsumura, I, 1991) |
| "Feasibility of utilizing human gastric cancers as first transplant generation xenografts in nude mice for determining tumor sensitivity to chemotherapeutic agents was demonstrated by applying subrenal capsule (SRC) assay." | 1.28 | Subrenal capsule assay using nude mice as a predictor of the response of the gastric cancer to chemotherapy. ( Akiyama, S; Ito, A; Ito, K; Kondo, K; Satta, T; Takagi, H; Watanabe, T; Yamauchi, M, 1991) |
| "A 55-year-old woman with gastric cancer underwent laparotomy and was found to have an unresectable tumor characterized by S3 (invasion of the pancreas), N3, P0 and H0." | 1.28 | [A long-term survival case of advanced gastric cancer undergoing radical gastrectomy by second-look operation after successful chemotherapy (CDDP, MMC, 5-FU)]. ( Azuma, S; Furuta, T; Kawata, R; Kunieda, K; Miya, K; Saji, S; Sugiyama, Y; Takao, H; Tanemura, H; Umemoto, T, 1991) |
| "A 59-year-old man with a gastric cancer underwent a laparotomy and was found to have an unresectable tumor that formed a large mass with metastatic lymph nodes around the aorta." | 1.28 | [An advanced gastric carcinoma which responded to combined administration of mitomycin C, FT-207, and lentinan immunochemotherapy]. ( Adachi, M; Kobori, O; Nomura, K; Sano, T, 1990) |
| "Forty-four patients with advanced gastric cancer were treated with a combination including 5-fluorouracil, 4-epi-doxorubicin and mitomycin C." | 1.28 | Open phase II with 5-fluorouracil, 4-epi-doxorubicin and mitomycin C (FEM) in advanced gastric cancer. ( Kolarić, K; Luetić, J; Roth, A; Zupanc, D, 1990) |
| "Mitomycin C (MMC) is an alkylating agent which has been associated with microangiopathic hemolytic anemia and acute renal failure, with an overall incidence between 2 and 10%." | 1.28 | Silent renal microangiography after mitomycin C therapy. ( Botey, A; Darnell, A; González-Clemente, JM; Poch, E; Revert, L; Torras, A, 1990) |
| "A conjugate of an anti-gastric cancer monoclonal antibody and mitomycin C linked by polyaldehyde dextran T-40 (MGb2-PAD-MMC) was prepared." | 1.28 | [Effects of immuno-drug conjugates on growth of human gastric cancer xenograft in subrenal capsule of nude mice]. ( Chen, LJ; Chen, XT; Li, S; Shu, YH; Zhang, SY; Zhang, XY, 1990) |
| "The effect on squamous cell carcinoma was more prominent than on other cell types." | 1.28 | Reappraisal of bronchial arterial infusion therapy for advanced lung cancer. ( Iwa, T; Kitagawa, M; Matsubara, F; Mizukami, Y; Murakami, S; Nonomura, A; Shimizu, J; Tsubota, M; Watanabe, Y; Yoshida, M, 1990) |
| "Histologically, 16 had squamous cell carcinoma, 11 adenocarcinoma, 3 small cell anaplastic carcinoma and 1 un-classified cancer." | 1.28 | [Bronchial arterial infusion chemotherapy with or without radiotherapy for advanced lung cancer]. ( Huang, DP, 1990) |
| "Mitomycin C was ineffective on the subcutaneous tumors, but effective on the tumors in the stomach wall and the inhibition rate was 52 and 63% at doses of 0." | 1.28 | [The drug sensitivity of human gastric cancer implanted into the subcutis and stomach wall of nude mice]. ( Yamashita, T, 1989) |
| "Of 25 patients with squamous cell carcinoma, 13 underwent esophagectomy." | 1.28 | Cisplatin, 5-fluorouracil, mitomycin C, and concurrent radiation therapy with and without esophogectomy for esophageal carcinoma. ( Daniel, TM; Hahn, SS; Harkins, BJ; Stewart, FM, 1989) |
| "Sixteen cases of gastric cancer with liver metastases (H2 less than) as group A, fifteen with distant peritoneal metastases (P2 less than) as group B, twenty-five with distant lymph nodes metastases (N3 less than) as group C, twenty-eight with two prognostic factors as group D, and seven with three factors as group E were treated." | 1.28 | [Comparative study of tegafur (p.o.) and mitomycin C (MMC) plus tegafur in cases of unresectable gastric cancer]. ( Ishiguro, E; Iwa, T; Kawaura, Y; Munemoto, Y; Omura, K; Sasaki, M; Sekido, N, 1989) |
| "A 58-year-old woman who was inoperable because of S3 (pancreas and colon) and P1 at the initial operation was treated with UFT, ADM and MMC at a dosage of 242." | 1.28 | [An unresectable gastric cancer radically resectable following UFT, ADM, MMC therapy]. ( Hayashi, S; Kamejima, N; Kasugai, T; Kataoka, M; Kureyama, Y; Masaoka, A; Mitsui, T; Taniwaki, S; Tsuji, H; Watarai, N, 1989) |
| "We report a case of advanced gastric cancer with Virchow's node metastasis which responded to concomitant plasma exchange and immunochemotherapy." | 1.28 | [A case of advanced gastric cancer with Virchow's node metastasis, responding to concomitant plasma exchange and immunochemotherapy]. ( Iga, C; Kawashima, Y; Nishimura, J; Okajima, K; Sakuramoto, K; Toyoda, M, 1989) |
| "A 68-year-old male, who had advanced rectal cancer with multiple pulmonary metastases, had undergone resection of rectal cancer operatively and was treated with a combination chemotherapy using 5'-DFUR (5'-deoxy-5-fluorouridine) and MMC (mitomycin C) for multiple pulmonary metastases." | 1.28 | [A case of multiple pulmonary metastases from rectal cancer which responded completely to combination chemotherapy using 5'-DFUR and MMC]. ( Baba, K; Kawano, H; Matsuda, M; Matsuoka, Y; Morinaga, H; Nagao, K; Nagase, H; Nishimura, R; Ueno, Y, 1989) |
| "In early gastric cancer and Stage I disease, the mean values of chemotaxis and CL were elevated in comparison to controls." | 1.27 | Changes in polymorphonuclear leukocyte motility under agarose and luminol-dependent chemiluminescence response in patients with gastric cancer. ( Hirano, T, 1984) |
| "A woman with pancreatic cancer developed acute interstitial infiltrates while receiving modest doses of two potential pulmonary toxins, mitomycin-C and chlorozotocin." | 1.27 | Combination chemotherapy pneumonitis: a case report of possible synergistic toxicity. ( Goedert, JJ; Smith, FP; Tsou, E; Weiss, RB, 1983) |
| "Retreatment of patients with colon cancer and liver metastases by hepatic arterial infusion of fluorodeoxyuridine and mitomycin C can result in significant prolongation of survival in patients with response to this treatment." | 1.27 | Effective retreatment of patients with colorectal cancer and liver metastases. ( Chuang, VP; Mavligit, G; Patt, YZ; Peters, RE; Wallace, S, 1983) |
| "Lymphocytes from patients with squamous cell carcinoma, large cell carcinoma and carcinoid exhibited positive activity levels of 11." | 1.27 | Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor. ( Fujisawa, T; Kadoyama, C; Kimura, H; Sato, N; Yamaguchi, Y, 1983) |
| "Thirty patients with advanced gastric cancer were treated with a combination chemotherapy consisting of adriamycin 20-30 mg/m2 iv day 1 q3wks, mitomycin C 2." | 1.27 | [Combination chemotherapy of advanced gastric cancer with adriamycin, mitomycin C, and ftorafur]. ( Ezaki, K; Horikoshi, N; Ikeda, K; Inagaki, J; Inoue, K; Miyamoto, H; Nakada, H; Ogawa, M; Okada, Y; Usui, N, 1983) |
| "The sensitivity of two human pancreatic adenocarcinomas (Capan-1 and Capan-2) to heat and heat combined with chemotherapy was studied using xenografts of the tumors in the foot of athymic nude mice." | 1.27 | Sensitivity of xenografts of human pancreatic adenocarcinoma in nude mice to heat and heat combined with chemotherapy. ( Cahan, A; Fogh, J; Fortner, JG; Shiu, MH, 1983) |
| "Metronidazole, 1." | 1.27 | Feasibility study of combining metronidazole with chemotherapy. ( Bélanger, R; Crook, AF; Heringer, R; Hopkins, HS; Hugenholtz, H; Maroun, JA; Richard, MT; Stewart, DJ; Yan, RC; Young, V, 1983) |
| "Tow cases of gastric cancer were reported." | 1.27 | [2 cases of solitary metastasis to the large intestine from gastric carcinoma]. ( Hattori, T; Matsuki, K; Nakano, A; Niimi, K; Tomoda, S; Yoshinaka, K, 1984) |
| "Eighty-four patients with advanced gastric cancer treated in four centres in Scotland between June 1980 and December 1982 were reviewed following treatment with 5-fluorouracil, adriamycin and mitomycin-C (FAM)." | 1.27 | Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C. ( Allan, SG; Calman, KC; Carter, DC; Cunningham, D; Hutcheon, AW; Kaye, SB; McArdle, CS; Sangster, G; Smyth, JF; Soukop, M, 1984) |
| " Although the dosage of the anticancer chemotherapy was quite small, this treatment may have promoted the regression of the tumor in conjunction with activated antitumor immunity of the host." | 1.27 | [A case of advanced gastric cancer which disappeared histopathologically after short-time chemotherapy]. ( Furuta, K; Hara, K; Kiyomitsu, Y; Nakazaki, S; Shinoda, M; Watanabe, K; Yajima, K; Yasuda, S; Yokoyama, T, 1984) |
| "Mitomycin C (10 mg/m2) was administered as a bolus injection on day 2." | 1.27 | Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy. ( Coia, LR; Engstrom, PF; Paul, A, 1987) |
| "Twenty-one patients with squamous carcinoma of the genital tract were treated with bleomycin, Oncovin, mitomycin-C, and cisplatin (BOMP)." | 1.27 | Bleomycin, vincristine, mitomycin-C, and cisplatin in the management of gynecological squamous cell carcinomas. ( Belinson, JL; McClure, M; Richards, AL; Stewart, JA, 1985) |
| "The chemosensitivity of human colorectal cancer was studied in relation to the biological features of the tumor using a human tumor/nude mouse in-vivo system." | 1.27 | Biological features and chemosensitivity of human colorectal cancer xenografted in nude mice. ( Yamada, K, 1987) |
| "For the response of advanced gastric cancer to chemotherapy in the National Cancer Center Hospital, the combined use of UFT and Mitomycin C gave the highest rate, 46%." | 1.27 | Radiation therapy for advanced gastric cancer. ( Akine, Y; Egawa, S; Hijikata, J; Kajiura, Y; Kitagawa, T; Ogino, T; Tsukiyama, I; Yamashita, K, 1988) |
| "The most frequent histology was squamous cell carcinoma found in 20 patients." | 1.27 | [Chemotherapy with mitomycin C, vindesine and ifosfamide in the treatment of inoperable non-small cell bronchial carcinoma]. ( Gatzemeier, U; Hossfeld, DK; Radenbach, D; Zschaber, R, 1985) |
| "A case of advanced gastric cancer associated with metastatic carcinomatosis of the bone marrow, microangiopathic hemolytic anemia (MAHA) and disseminated intravascular coagulation (DIC) was reported." | 1.27 | [Microangiopathic hemolytic anemia associated with gastric cancer]. ( Hattori, T; Kanou, T; Kuramoto, J; Miura, K; Niimoto, M; Nosou, Y; Yanagawa, E; Yoshinaka, K, 1986) |
| "An aged female patient with inoperable gastric cancer was treated with a combined chemotherapy using UFT and Mitomycin C." | 1.27 | [A case of an aged woman with advanced gastric cancer which dramatically responded to combined chemotherapy with UFT and mitomycin C]. ( Adachi, M; Sasaki, M, 1986) |
| " Based on the observed objective tumor response rate and median patient survival, further studies of these drugs in combination for the treatment of advanced gastric cancer are indicated." | 1.27 | Phase II clinical trial of triazinate in combination with mitomycin C for patients with advanced gastric cancer. ( Hahn, RG; Moertel, CG; O'Connell, MJ; Schutt, AJ, 1987) |
| "A 55-year-old woman with gastric cancer underwent laparotomy and was found to have an unresectable tumor at the MC region, characterized by S3 (invasion into the pancreas), N3, P0, H0, Borrmann-II and moderately differentiated tubular adenocarcinoma." | 1.27 | [Successful treatment of advanced gastric cancer by combined cisplatinum, mitomycin C and 5-FU administration. A case report]. ( Ando, T; Azuma, S; Furuta, T; Kawata, R; Ohashi, H; Saji, S; Shimokawa, K; Suzuki, M; Tanemura, H; Tsuya, H, 1987) |
| "When mitomycin C (MMC) was administered into the superior mesenteric vein 15 min after the inoculation of tumor cells, the number of metastatic foci in the liver was strongly inhibited; 81." | 1.27 | Liver metastasis of colon 26 cells implanted into the superior mesenteric vein in mice. ( Kitamura, M; Kosaki, G; Tominaga, T; Yoshida, Y, 1987) |
| "Persistent or recurrent peritoneal carcinomatosis (PC) documented at second-look surgery has proved relatively refractory to second-line therapy." | 1.27 | Intraperitoneal mitomycin C in the treatment of peritoneal carcinomatosis following second-look surgery. ( Alberts, DS; Graham, V; Monk, BJ; Surwit, EA, 1988) |
| " Intra-arterial chemotherapy combined with MMC and DSM was performed on eight cases of unresectable metastatic liver carcinoma." | 1.27 | [Intra-arterial chemotherapy combined with mitomycin C and degradable starch microspheres in unresectable metastatic liver carcinoma]. ( Arai, K; Awane, Y; Kitamura, M; Mori, T; Takahashi, T; Yoshikawa, T, 1988) |
| "A 75-year-old man with gastric cancer metastatic to the liver was treated by combined administration of Tegafur (800 mg/body/day), 5-fluorouracil (300 mg/body/day) and Mitomycin C (hepatic arterial infusion of 20 mg/body and intravenous infusion of 8 mg/body)." | 1.27 | [Complete response in a case of unresectable gastric cancer with a combination of tegafur, 5-fluorouracil and mitomycin C]. ( Ito, T; Nehashi, Y; Sasaki, J; Sasaki, Y, 1988) |
| "Chemical cholecystitis has been recognized recently as a complication of hepatic artery infusion chemotherapy." | 1.27 | Hepatobiliary scintigraphy in patients receiving hepatic artery infusion chemotherapy. ( Dakhil, SR; Housholder, DF; Hynes, HE; Marymont, JV, 1985) |
| "A 61-year-old man with double colon cancers and a solitary hepatic metastasis underwent right hemicolectomy and catheterization of the proper hepatic artery in April 1979." | 1.27 | [A long survival case of carcinoma of the colon with hepatic metastasis following intra-arterial infusion chemotherapy]. ( Itoh, J; Koyama, K; Masuda, T; Narisawa, T, 1985) |
| "Two patients who had advanced gastric cancer and metastatic liver tumors were treated with a combined chemotherapy using UFT and mitomycin C." | 1.27 | [A combined chemotherapy with UFT and mitomycin C in advanced gastric cancer; report of 2 cases]. ( Hanawa, S; Hara, S; Joya, K; Nakata, K; Sato, K; Shigemitsu, M, 1985) |
| " This three-drug combination appears to be an active regimen in the treatment of non-small-cell bronchogenic carcinoma; however, altered dosage schedules should be examined in order to decrease drug-related toxicity." | 1.27 | Combination chemotherapy with mitomycin-C, cisplatin, and vinblastine in the treatment of non-small-cell lung cancer. ( Griffin, JP; Niell, HB, 1985) |
| "Though two gastric cancer xenografts exhibited synergistic effects in combination of gamma-interferon with Mitomycin C, antagonistic effects, which was not found in combination of alpha-interferon with Mitomycin C, were observed in one gastric cancer and one colon cancer xenografts." | 1.27 | In vitro chemosensitivity tests on human tumor xenografts by clonogenic assay: the combined use of mitomycin C with alpha-interferon or gamma-interferon. ( Hattori, T; Hirabayashi, N; Niimoto, M; Nosoh, Y; Ohkita, T; Toge, T; Yoshinaka, K, 1985) |
| "At present hyperthermia shows great promise when combined with other modalities." | 1.27 | [Clinical application of local hyperthermia combined with antineoplastic agents]. ( Ishiwata, J; Iwamoto, S; Koike, M; Maeda, Y; Masuda, T; Sasaki, T; Takeshita, Y; Tanaka, Y, 1985) |
| "A 35-year-old woman tuffering from gastric cancer associated with disseminated carcinomatosis of the bone marrow is reported." | 1.27 | [Effective postoperative chemotherapy of gastric cancer associated with disseminated carcinomatosis of the bone marrow]. ( Akimoto, R; Asano, E; Higashino, Y; Kato, M; Mukawa, A; Nagakawa, T; Nakamura, T; Uchida, H, 1985) |
| "Nine patients with advanced cervical cancer were treated with a combination chemotherapy (MVP) consisting of mitomycin C 8 mg/m2 i." | 1.27 | [A combination chemotherapy using mitomycin C, vincristine and cisplatin (MVP) for advanced cervical cancer]. ( Adachi, K; Horikoshi, N; Ikeda, K; Inagaki, J; Inoue, K; Nakada, H; Ogawa, M; Tada, A; Usui, N; Yamazaki, H, 1985) |
| "For stage I and II gastric cancer, radical gastrectomy and postoperative immunotherapy for 3 months would be the best treatment." | 1.27 | Immunochemosurgery for gastric cancer. ( Kim, JP, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 225 (35.55) | 18.7374 |
| 1990's | 211 (33.33) | 18.2507 |
| 2000's | 135 (21.33) | 29.6817 |
| 2010's | 54 (8.53) | 24.3611 |
| 2020's | 8 (1.26) | 2.80 |
| Authors | Studies |
|---|---|
| El-Sayes, N | 1 |
| Vito, A | 1 |
| Salem, O | 1 |
| Workenhe, ST | 1 |
| Wan, Y | 1 |
| Mossman, K | 1 |
| Endo, Y | 1 |
| Kitago, M | 1 |
| Aiura, K | 2 |
| Shinoda, M | 2 |
| Yagi, H | 1 |
| Abe, Y | 1 |
| Oshima, G | 1 |
| Hori, S | 4 |
| Nakano, Y | 1 |
| Itano, O | 1 |
| Fukada, J | 1 |
| Masugi, Y | 1 |
| Kitagawa, Y | 3 |
| Bartlett, K | 1 |
| Derrington, S | 1 |
| Jariwala, N | 1 |
| Mai, C | 1 |
| Koo, B | 1 |
| Blum Murphy, M | 1 |
| Ikoma, N | 1 |
| Wang, X | 3 |
| Estrella, J | 2 |
| Roy-Chowdhuri, S | 1 |
| Das, P | 2 |
| Minsky, BD | 3 |
| Song, S | 1 |
| Mansfield, P | 2 |
| Ajani, J | 2 |
| Badgwell, B | 2 |
| Archid, R | 2 |
| Zieker, D | 2 |
| Weinreich, FJ | 1 |
| Hönes, F | 1 |
| Königsrainer, A | 3 |
| Quintanilla-Martínez, L | 1 |
| Reymond, MA | 1 |
| Solass, W | 1 |
| Bakkers, C | 2 |
| van Erning, FN | 1 |
| Rovers, KP | 2 |
| Nienhuijs, SW | 2 |
| Burger, JW | 1 |
| Lemmens, VE | 1 |
| Aalbers, AG | 1 |
| Kok, NF | 1 |
| Boerma, D | 2 |
| Brandt, AR | 1 |
| Hemmer, PH | 1 |
| van Grevenstein, WM | 1 |
| de Reuver, PR | 2 |
| Tanis, PJ | 2 |
| Tuynman, JB | 2 |
| de Hingh, IH | 2 |
| Sugarbaker, PH | 5 |
| Barrak, D | 1 |
| Desale, S | 1 |
| Yoon, JJ | 1 |
| Dugan, MM | 1 |
| Kodavanti, PP | 1 |
| Sampah, ME | 1 |
| Burger, JWA | 1 |
| Creemers, GM | 1 |
| Thijs, AMJ | 1 |
| Brandt-Kerkhof, ARM | 1 |
| Madsen, EVE | 1 |
| van Meerten, E | 1 |
| Kusters, M | 1 |
| Versteeg, KS | 1 |
| Aalbers, AGJ | 1 |
| Kok, NFM | 1 |
| Buffart, TE | 1 |
| Wiezer, MJ | 1 |
| Los, M | 1 |
| Bremers, AJA | 1 |
| Verheul, HMW | 1 |
| Kruijff, S | 1 |
| de Groot, DJA | 1 |
| Witkamp, AJ | 1 |
| van Grevenstein, WMU | 1 |
| Koopman, M | 1 |
| Nederend, J | 1 |
| Lahaye, MJ | 1 |
| Kranenburg, O | 1 |
| Fijneman, RJA | 1 |
| van 't Erve, I | 1 |
| Snaebjornsson, P | 1 |
| Hemmer, PHJ | 1 |
| Dijkgraaf, MGW | 1 |
| Punt, CJA | 1 |
| de Hingh, IHJT | 1 |
| Blum, M | 1 |
| Fournier, K | 1 |
| Royal, R | 1 |
| Guadagni, S | 1 |
| Fiorentini, G | 1 |
| Clementi, M | 1 |
| Palumbo, P | 1 |
| Mambrini, A | 1 |
| Masedu, F | 1 |
| Aziz, O | 1 |
| Jaradat, I | 1 |
| Chakrabarty, B | 1 |
| Selvasekar, CR | 1 |
| Fulford, PE | 1 |
| Saunders, MP | 2 |
| Renehan, AG | 1 |
| Wilson, MS | 1 |
| O'Dwyer, ST | 1 |
| Jones, CM | 1 |
| Adams, R | 1 |
| Downing, A | 1 |
| Glynne-Jones, R | 1 |
| Harrison, M | 1 |
| Hawkins, M | 1 |
| Sebag-Montefiore, D | 1 |
| Gilbert, DC | 1 |
| Muirhead, R | 1 |
| Wang, L | 1 |
| Li, PF | 1 |
| Geng, M | 1 |
| Cao, YC | 1 |
| Yin, YC | 1 |
| Law, R | 1 |
| Ravi, K | 1 |
| Alexander, JA | 1 |
| Werner, D | 1 |
| Atmaca, A | 2 |
| Pauligk, C | 1 |
| Pustowka, A | 1 |
| Jäger, E | 3 |
| Al-Batran, SE | 3 |
| Huddart, RA | 1 |
| Hall, E | 1 |
| Hussain, SA | 1 |
| Jenkins, P | 1 |
| Rawlings, C | 1 |
| Tremlett, J | 1 |
| Crundwell, M | 1 |
| Adab, FA | 1 |
| Sheehan, D | 1 |
| Syndikus, I | 1 |
| Hendron, C | 1 |
| Lewis, R | 1 |
| Waters, R | 1 |
| James, ND | 1 |
| Ozdemir, O | 1 |
| Ozdemir, P | 1 |
| Veral, A | 1 |
| Uluer, H | 1 |
| Ozhan, MH | 1 |
| Ueda, A | 1 |
| Hosokawa, A | 1 |
| Ogawa, K | 2 |
| Yoshita, H | 1 |
| Mihara, H | 1 |
| Ando, T | 2 |
| Kajiura, S | 1 |
| Fujinami, H | 1 |
| Nishikawa, J | 1 |
| Minemura, M | 1 |
| Terada, M | 1 |
| Kobayashi, T | 6 |
| Horikawa, N | 1 |
| Yabushita, K | 2 |
| Note, M | 1 |
| Sugiyama, T | 1 |
| McConnell, YJ | 2 |
| Mack, LA | 2 |
| Gui, X | 1 |
| Carr, NJ | 1 |
| Sideris, L | 1 |
| Temple, WJ | 2 |
| Dubé, P | 1 |
| Chandrakumaran, K | 1 |
| Moran, BJ | 1 |
| Cecil, TD | 1 |
| Miranda, MB | 1 |
| Hartmann, JT | 4 |
| Kripp, M | 1 |
| Gencer, D | 1 |
| Hochhaus, A | 3 |
| Hofheinz, RD | 4 |
| Merx, K | 1 |
| Thind, G | 1 |
| Johal, B | 1 |
| Follwell, M | 1 |
| Kennecke, HF | 1 |
| Song, X | 1 |
| Dilly, AK | 1 |
| Kim, SY | 2 |
| Choudry, HA | 1 |
| Lee, YJ | 1 |
| Randle, RW | 1 |
| Levine, EA | 4 |
| Clark, CJ | 1 |
| Stewart, JH | 3 |
| Shen, P | 3 |
| Votanopoulos, KI | 1 |
| Meulendijks, D | 1 |
| Dewit, L | 1 |
| Tomasoa, NB | 1 |
| van Tinteren, H | 1 |
| Beijnen, JH | 1 |
| Schellens, JH | 1 |
| Cats, A | 1 |
| Ahlgren, J | 1 |
| Patel, N | 1 |
| Simmens, S | 1 |
| Akin, E | 1 |
| Bishop, C | 1 |
| Kirkel, D | 1 |
| Siegel, P | 1 |
| Schuck, S | 1 |
| Guebre-Xabiher, H | 1 |
| Siegel, R | 1 |
| Vyas, O | 1 |
| Leung, K | 1 |
| Ledbetter, L | 1 |
| Kaley, K | 1 |
| Rodriguez, T | 1 |
| Garcon, MC | 1 |
| Saif, MW | 1 |
| Bhagwandin, S | 1 |
| Naffouje, S | 1 |
| Salti, G | 1 |
| Kang, SY | 1 |
| Ahn, MS | 1 |
| Song, GW | 1 |
| Choi, YW | 1 |
| Lee, HW | 1 |
| Jeong, SH | 1 |
| Park, JS | 1 |
| Cho, YK | 2 |
| Han, SU | 1 |
| Sheen, SS | 1 |
| Han, JH | 1 |
| Choi, JH | 2 |
| Gakis, G | 1 |
| Morgan, TM | 1 |
| Daneshmand, S | 1 |
| Keegan, KA | 1 |
| Todenhöfer, T | 1 |
| Mischinger, J | 1 |
| Schubert, T | 1 |
| Zaid, HB | 1 |
| Hrbacek, J | 1 |
| Ali-El-Dein, B | 1 |
| Clayman, RH | 1 |
| Galland, S | 1 |
| Olugbade, K | 1 |
| Rink, M | 1 |
| Fritsche, HM | 1 |
| Burger, M | 1 |
| Chang, SS | 1 |
| Babjuk, M | 1 |
| Thalmann, GN | 1 |
| Stenzl, A | 1 |
| Efstathiou, JA | 1 |
| Kemmel, V | 1 |
| Mercoli, HA | 1 |
| Meyer, N | 1 |
| Brumaru, D | 1 |
| Romain, B | 1 |
| Lessinger, JM | 1 |
| Brigand, C | 1 |
| Li, WP | 1 |
| Liu, H | 1 |
| Chen, L | 1 |
| Yao, YQ | 1 |
| Zhao, EF | 1 |
| Bouhadjari, N | 1 |
| Gabato, W | 1 |
| Calabrese, D | 1 |
| Msika, S | 1 |
| Keita, H | 1 |
| Schneider, CC | 1 |
| Fischer, N | 1 |
| Bühler, S | 1 |
| Venturelli, S | 1 |
| Berger, A | 1 |
| Burkard, M | 1 |
| Kirschniak, A | 1 |
| Bachmann, R | 1 |
| Glatzle, J | 1 |
| Cereda, S | 1 |
| Milella, M | 1 |
| Cordio, S | 1 |
| Leone, F | 1 |
| Aprile, G | 1 |
| Galiano, A | 1 |
| Mosconi, S | 1 |
| Vasile, E | 2 |
| Santini, D | 1 |
| Belli, C | 1 |
| Auriemma, A | 1 |
| Novarino, A | 1 |
| Vaccaro, V | 1 |
| Martines, C | 1 |
| Marino, D | 1 |
| Lutrino, SE | 1 |
| Palazzo, V | 1 |
| Reinach, B | 1 |
| Aldrighetti, L | 1 |
| Reni, M | 2 |
| Sun, JH | 1 |
| Ji, ZH | 1 |
| Peng, KW | 1 |
| Wu, HT | 1 |
| Zhang, Q | 3 |
| Yonemura, Y | 7 |
| Li, Y | 3 |
| Massalou, D | 1 |
| Benizri, E | 1 |
| Chevallier, A | 1 |
| Duranton-Tanneur, V | 1 |
| Pedeutour, F | 1 |
| Benchimol, D | 1 |
| Béréder, JM | 1 |
| Konski, A | 1 |
| Li, T | 1 |
| Sigurdson, E | 1 |
| Cohen, SJ | 2 |
| Small, W | 1 |
| Spies, S | 1 |
| Yu, JQ | 1 |
| Wahl, A | 1 |
| Stryker, S | 1 |
| Meropol, NJ | 2 |
| Yang, XJ | 2 |
| al-shammaa Hassan, AH | 1 |
| Yang, GL | 2 |
| Liu, SY | 1 |
| Lu, YL | 1 |
| Zhang, JW | 1 |
| Ota, K | 2 |
| Kurita, S | 2 |
| Nishimura, M | 4 |
| Ogawa, M | 4 |
| Kamei, Y | 1 |
| Imai, K | 1 |
| Ariyoshi, Y | 2 |
| Kataoka, K | 1 |
| Murakami, M | 2 |
| Oyama, A | 2 |
| Hoshino, A | 1 |
| Amo, H | 1 |
| Kato, T | 3 |
| Jin, C | 1 |
| Yao, L | 1 |
| Long, J | 1 |
| Fu, DL | 1 |
| Yu, XJ | 1 |
| Xu, J | 3 |
| Yang, F | 1 |
| Ni, QX | 1 |
| Lee, S | 1 |
| Oh, SY | 1 |
| Kim, BG | 1 |
| Kwon, HC | 1 |
| Kim, SH | 1 |
| Rho, MH | 1 |
| Kim, YH | 2 |
| Rho, MS | 1 |
| Jeong, JS | 1 |
| Kim, HJ | 1 |
| Shi, D | 1 |
| Shi, G | 1 |
| Huang, G | 1 |
| Zhang, J | 2 |
| Lartigau, E | 1 |
| Li, M | 1 |
| Wang, D | 1 |
| Zhong, B | 1 |
| Tucker, S | 1 |
| Lu, C | 1 |
| Cheng, J | 1 |
| Cao, C | 1 |
| Pan, H | 1 |
| Takada, J | 1 |
| Kenno, S | 1 |
| Aoki, T | 3 |
| Hamada, H | 1 |
| Katsuki, Y | 1 |
| Kanagavel, D | 1 |
| Pokataev, IA | 1 |
| Fedyanin, MY | 1 |
| Tryakin, AA | 1 |
| Bazin, IS | 1 |
| Narimanov, MN | 1 |
| Yakovleva, ES | 1 |
| Garin, AM | 1 |
| Tjulandin, SA | 1 |
| Liu, Y | 1 |
| Huang, YN | 1 |
| Yang, Y | 1 |
| Xu, YY | 1 |
| Yang, SJ | 1 |
| Du, P | 1 |
| Lustberg, MB | 1 |
| Bekaii-Saab, T | 1 |
| Young, D | 1 |
| Otterson, G | 1 |
| Burak, W | 1 |
| Abbas, A | 1 |
| McCracken-Bussa, B | 1 |
| Lustberg, ME | 1 |
| Villalona-Calero, MA | 1 |
| Wolf, M | 1 |
| Zehentmayr, F | 2 |
| Niyazi, M | 1 |
| Ganswindt, U | 1 |
| Haimerl, W | 1 |
| Schmidt, M | 2 |
| Hölzel, D | 2 |
| Belka, C | 4 |
| Lowery, M | 1 |
| Shah, MA | 1 |
| Smyth, E | 1 |
| Epstein, A | 1 |
| Segal, A | 1 |
| Rosengarten, O | 1 |
| Isacson, R | 1 |
| Drukker, L | 1 |
| Keinan, A | 1 |
| Rachkiman, M | 1 |
| Reissman, P | 1 |
| Gabizon, A | 1 |
| Kelsen, D | 2 |
| O'Reilly, EM | 1 |
| Chen, S | 1 |
| Chen, YB | 1 |
| Zhou, ZW | 1 |
| Li, W | 1 |
| Sun, XW | 1 |
| Xu, DZ | 1 |
| Li, YF | 1 |
| Guan, YX | 1 |
| Feng, XY | 1 |
| Zhan, YQ | 1 |
| Bakrin, N | 1 |
| Cotte, E | 1 |
| Sayag-Beaujard, A | 1 |
| Raudrant, D | 1 |
| Isaac, S | 1 |
| Mohamed, F | 1 |
| Gilly, FN | 4 |
| Glehen, O | 2 |
| Kang, EJ | 1 |
| Choi, YJ | 1 |
| Kim, JS | 2 |
| Kim, ST | 1 |
| Park, KH | 1 |
| Choi, IK | 1 |
| Oh, SC | 1 |
| Seo, JH | 1 |
| Shin, SW | 1 |
| Kim, K | 1 |
| Chie, EK | 1 |
| Jang, JY | 1 |
| Kim, SW | 1 |
| Han, SW | 1 |
| Oh, DY | 1 |
| Im, SA | 1 |
| Kim, TY | 2 |
| Bang, YJ | 2 |
| Ha, SW | 1 |
| Kiefer, MV | 1 |
| Albert, M | 1 |
| McNally, M | 1 |
| Robertson, M | 1 |
| Sun, W | 1 |
| Fraker, D | 1 |
| Olthoff, K | 1 |
| Christians, K | 1 |
| Pappas, S | 1 |
| Rilling, W | 1 |
| Soulen, MC | 1 |
| Huang, CQ | 1 |
| Suo, T | 1 |
| Mei, LJ | 1 |
| Cheng, FL | 1 |
| Zhou, YF | 1 |
| Xiong, B | 1 |
| Meyer, J | 1 |
| Balch, G | 1 |
| Willett, C | 1 |
| Czito, B | 1 |
| Yan, D | 1 |
| Zhou, CW | 1 |
| Liu, DZ | 1 |
| Chen, Y | 1 |
| Zeng, HY | 1 |
| Li, H | 1 |
| Roy, P | 1 |
| Serra, S | 1 |
| Kennedy, E | 1 |
| Chetty, R | 1 |
| Fornaro, L | 1 |
| Masi, G | 1 |
| Loupakis, F | 1 |
| Baldi, GG | 1 |
| Allegrini, G | 1 |
| Salvatore, L | 1 |
| Cremolini, C | 1 |
| Cupini, S | 1 |
| Cortesi, E | 1 |
| Tuzi, A | 1 |
| Granetto, C | 1 |
| Brunetti, IM | 1 |
| Ricci, S | 2 |
| Falcone, A | 1 |
| Krane, LS | 1 |
| Kader, AK | 1 |
| Ferrarotto, R | 1 |
| Machado, K | 1 |
| Mak, MP | 1 |
| Shah, N | 1 |
| Takahashi, TK | 1 |
| Costa, FP | 1 |
| Overman, MJ | 1 |
| Kopetz, S | 1 |
| Hoff, PM | 1 |
| Wolf, MC | 1 |
| Kim, KK | 1 |
| Lange, TS | 1 |
| Singh, RK | 1 |
| Brard, L | 1 |
| Moore, RG | 1 |
| Glockzin, G | 1 |
| von Breitenbuch, P | 1 |
| Schlitt, HJ | 1 |
| Piso, P | 1 |
| Francis, WP | 1 |
| Ho, T | 1 |
| Klaver, YL | 1 |
| Chua, TC | 1 |
| Verwaal, VJ | 1 |
| Morris, DL | 3 |
| Pacelli, F | 1 |
| Sanchez, AM | 1 |
| Covino, M | 1 |
| Tortorelli, AP | 1 |
| Bossola, M | 1 |
| Valentini, V | 3 |
| Gambacorta, MA | 1 |
| Doglietto, GB | 1 |
| Franke, K | 1 |
| Kettering, M | 1 |
| Lange, K | 1 |
| Kaiser, WA | 1 |
| Hilger, I | 1 |
| Hartung, G | 1 |
| Samel, S | 1 |
| Pichlmeier, U | 1 |
| Post, S | 1 |
| Hehlmann, R | 2 |
| Queisser, W | 1 |
| Gundappa, RK | 1 |
| Sud, K | 1 |
| Kohli, HS | 1 |
| Gupta, KL | 1 |
| Joshi, K | 1 |
| Sakhuja, V | 1 |
| Tasaka, K | 1 |
| Okada, Y | 2 |
| Tomofuji, Y | 1 |
| Chinzei, T | 1 |
| Slater, S | 1 |
| Shamash, J | 1 |
| Wilson, P | 1 |
| Gallagher, CJ | 1 |
| Slevin, ML | 1 |
| Ruiz-Gómez, MJ | 2 |
| de la Peña, L | 1 |
| Prieto-Barcia, MI | 1 |
| Pastor, JM | 1 |
| Gil, L | 3 |
| Martínez-Morillo, M | 2 |
| Chang, HM | 2 |
| Jung, KH | 1 |
| Kim, WS | 1 |
| Yang, HK | 1 |
| Lee, KU | 1 |
| Choe, KJ | 1 |
| Heo, DS | 1 |
| Kim, NK | 1 |
| Kagawa, R | 1 |
| Nakayama, N | 1 |
| Yamaguchi, T | 2 |
| Sakata, S | 1 |
| Tada, M | 1 |
| Ochiai, T | 2 |
| Maruyama, M | 1 |
| Ebuchi, M | 1 |
| Nagahama, T | 1 |
| Takashima, I | 1 |
| Hasegawa, K | 1 |
| Natsui, S | 1 |
| Sakoma, T | 1 |
| Xiao, Q | 1 |
| Peng, B | 1 |
| Lai, Y | 1 |
| Zhang, S | 1 |
| Chen, D | 1 |
| Xiao, QM | 1 |
| Zhang, WD | 1 |
| Zhou, JH | 1 |
| Nakamori, Y | 2 |
| Miyazaki, M | 1 |
| Tominaga, T | 2 |
| Taguchi, A | 1 |
| Shinohara, K | 2 |
| Mithieux, F | 1 |
| Osinsky, D | 1 |
| Beaujard, AC | 1 |
| Freyer, G | 1 |
| Guertsch, P | 1 |
| Francois, Y | 1 |
| Peyrat, P | 1 |
| Panteix, G | 3 |
| Vignal, J | 1 |
| Lorvidhaya, V | 3 |
| Chitapanarux, I | 1 |
| Sangruchi, S | 1 |
| Lertsanguansinchai, P | 1 |
| Kongthanarat, Y | 1 |
| Tangkaratt, S | 1 |
| Visetsiri, E | 1 |
| Nakagawa, Y | 1 |
| Todoroki, T | 1 |
| Koike, N | 1 |
| Kawamoto, T | 1 |
| Grau, JJ | 2 |
| Martín, M | 1 |
| Fuster, J | 2 |
| Pera, M | 2 |
| García-Valdecasas, JC | 2 |
| Bombí, JA | 1 |
| Bordas, JM | 1 |
| Alcobendas, F | 1 |
| Grande, L | 1 |
| Estapé, J | 1 |
| Chen, Z | 2 |
| Hu, J | 1 |
| Chen, J | 2 |
| Yan, L | 1 |
| Mao, Y | 1 |
| Zou, L | 1 |
| Pilati, P | 1 |
| Mocellin, S | 1 |
| Rossi, CR | 1 |
| Foletto, M | 1 |
| Campana, L | 1 |
| Nitti, D | 4 |
| Lise, M | 4 |
| Sheryka, E | 1 |
| Wheeler, MA | 1 |
| Hausladen, DA | 1 |
| Weiss, RM | 1 |
| Bamias, A | 1 |
| Papamichael, D | 1 |
| Syrigos, K | 1 |
| Pavlidis, N | 1 |
| Danson, S | 1 |
| Middleton, MR | 1 |
| O'Byrne, KJ | 2 |
| Clemons, M | 1 |
| Ranson, M | 1 |
| Hassan, J | 1 |
| Anderson, H | 1 |
| Burt, PA | 1 |
| Fairve-Finn, C | 1 |
| Stout, R | 1 |
| Dowd, I | 1 |
| Ashcroft, L | 2 |
| Beresford, C | 1 |
| Thatcher, N | 2 |
| Tokunaga, T | 1 |
| Sumimura, J | 1 |
| Yoshidome, K | 1 |
| Fujita, S | 1 |
| Tsuji, K | 2 |
| Oota, F | 1 |
| Tsuboyama, N | 1 |
| Nagai, I | 1 |
| Annino, DJ | 1 |
| Goguen, LA | 1 |
| THIELE, EH | 1 |
| ARISON, RN | 1 |
| BOXER, GE | 1 |
| CENTARO, A | 1 |
| GASPARRI, F | 1 |
| MAIJNELLI, M | 1 |
| PERITI, P | 2 |
| Oechsle, K | 1 |
| Quietzsch, D | 2 |
| Wein, A | 1 |
| Honecker, F | 1 |
| Nehls, O | 2 |
| Köhne, CH | 1 |
| Käfer, G | 1 |
| Kanz, L | 2 |
| Bokemeyer, C | 2 |
| Mori, T | 5 |
| Fujiwara, Y | 1 |
| Sugita, Y | 1 |
| Azama, T | 1 |
| Ishii, T | 1 |
| Taniguchi, K | 3 |
| Yamazaki, K | 2 |
| Takiguchi, S | 1 |
| Yasuda, T | 1 |
| Yano, M | 2 |
| Monden, M | 2 |
| Saito, T | 2 |
| Takehara, M | 3 |
| Tanaka, R | 1 |
| Lee, R | 1 |
| Horie, M | 1 |
| Wataba, K | 1 |
| Ito, E | 2 |
| Kudo, R | 3 |
| Hirao, K | 2 |
| Hirasaki, S | 2 |
| Tsuzuki, T | 2 |
| Kajiwara, T | 3 |
| Hyodo, I | 2 |
| Price, TJ | 1 |
| Ross, PJ | 1 |
| Hickish, T | 1 |
| Tait, D | 1 |
| Norman, AR | 1 |
| Ford, HE | 1 |
| Middleton, G | 1 |
| Sumpter, K | 1 |
| Hill, M | 1 |
| Oates, J | 1 |
| Cunningham, D | 3 |
| Willer, A | 1 |
| Weisser, A | 1 |
| Gnad, U | 1 |
| Saussele, S | 1 |
| Kreil, S | 1 |
| Tabata, T | 1 |
| Nishiura, K | 1 |
| Yanoh, K | 1 |
| Okugawa, T | 1 |
| Obata, H | 1 |
| Tanaka, K | 2 |
| Toyoda, N | 1 |
| Domingo-Domenech, J | 1 |
| Morente, V | 1 |
| Bombí, A | 1 |
| Mellado, B | 1 |
| Albanell, J | 1 |
| Gascón, P | 1 |
| Steffens, F | 1 |
| Yin, F | 1 |
| Hu, WH | 1 |
| Qiao, TD | 1 |
| Fan, DM | 1 |
| Hribaschek, A | 2 |
| Pross, M | 2 |
| Ridwelski, K | 2 |
| Meyer, F | 1 |
| Fenske, A | 1 |
| Krüger, S | 1 |
| Lippert, H | 2 |
| Sasson, AR | 1 |
| Wetherington, RW | 1 |
| Hoffman, JP | 3 |
| Ross, EA | 1 |
| Cooper, H | 1 |
| Freedman, G | 1 |
| Pingpank, JF | 1 |
| Eisenberg, BL | 3 |
| Nishina, T | 1 |
| Moriwaki, T | 1 |
| Tubouchi, E | 1 |
| Nasu, J | 1 |
| Masumoto, T | 1 |
| Kubo, Y | 2 |
| Kurita, A | 1 |
| Taoka, H | 1 |
| Hirano, H | 1 |
| Mitsui, Y | 1 |
| Umino, W | 1 |
| Nobuoka, Y | 1 |
| Yamashita, M | 1 |
| Tanigawa, K | 1 |
| Yoshimine, S | 1 |
| Imai, T | 1 |
| Kadowaki, S | 1 |
| Miyashita, K | 2 |
| Ikuma, H | 1 |
| Nakamura, T | 2 |
| Murata, T | 2 |
| Hara, K | 4 |
| Iwasaka, T | 3 |
| Panucci, MG | 1 |
| Passoni, P | 1 |
| Bonetto, E | 1 |
| Nicoletti, R | 1 |
| Ronzoni, M | 1 |
| Zerbi, A | 1 |
| Staudacher, C | 1 |
| Di Carlo, V | 1 |
| Villa, E | 2 |
| Gibson, MK | 1 |
| Holcroft, CA | 1 |
| Kvols, LK | 1 |
| Haller, D | 1 |
| Edwards, JP | 1 |
| Rodenberg, B | 1 |
| Niles, SD | 1 |
| Ploessl, J | 1 |
| Yamazaki, S | 3 |
| Sekine, I | 1 |
| Matsuno, Y | 2 |
| Takei, H | 1 |
| Yamamoto, N | 1 |
| Kunitoh, H | 1 |
| Ohe, Y | 1 |
| Tamura, T | 1 |
| Kodama, T | 1 |
| Asamura, H | 1 |
| Tsuchiya, R | 1 |
| Saijo, N | 5 |
| Bode, MK | 1 |
| Perälä, J | 1 |
| Mäkelä, JT | 1 |
| Leinonen, S | 1 |
| Dobelbower, R | 1 |
| Lipsitz, S | 1 |
| Catalano, PJ | 1 |
| Sischy, B | 2 |
| Smith, TJ | 1 |
| Haller, DG | 1 |
| Sadahiro, S | 3 |
| Mitomi, T | 1 |
| Noto, T | 1 |
| Kumada, K | 1 |
| Hiki, Y | 2 |
| Yamakawa, T | 1 |
| Amano, T | 1 |
| Oki, S | 1 |
| Otani, Y | 3 |
| Oka, H | 1 |
| Takahashi, T | 9 |
| Takemiya, S | 1 |
| Nishiyama, K | 1 |
| Yamamura, T | 2 |
| Tsuchiya, S | 3 |
| Ogawa, N | 1 |
| Sawada, T | 1 |
| Hirose, K | 2 |
| Polyzos, A | 1 |
| Koulentianos, E | 1 |
| Tzianoumis, L | 1 |
| Sfikakis, P | 1 |
| Giuliani, F | 1 |
| Molica, S | 1 |
| Maiello, E | 1 |
| Battaglia, C | 1 |
| Gebbia, V | 2 |
| Di Bisceglie, M | 1 |
| Vinciarelli, G | 1 |
| Gebbia, N | 1 |
| Colucci, G | 1 |
| Ogata, T | 1 |
| Nishida, J | 1 |
| Seo, K | 1 |
| Hamaya, M | 1 |
| Kouno, T | 1 |
| Sato, S | 2 |
| Yoshida, K | 2 |
| Tsuchida, A | 1 |
| Morise, Z | 1 |
| Sugioka, A | 1 |
| Kato, R | 1 |
| Fujita, J | 1 |
| Hoshimoto, S | 1 |
| Mizushima, T | 1 |
| Sugiura, T | 2 |
| Ito, T | 2 |
| Mizuno, H | 1 |
| Hoki, M | 1 |
| Souma, Y | 1 |
| Kainuma, S | 1 |
| Yamanaka, H | 1 |
| Ozawa, H | 1 |
| Kanou, T | 2 |
| Iwase, K | 1 |
| Hirota, T | 2 |
| Ohashi, Y | 1 |
| Kodaira, S | 5 |
| Mitchell, J | 1 |
| Keung, YK | 1 |
| Pelz, JO | 1 |
| Doerfer, J | 1 |
| Dimmler, A | 1 |
| Hohenberger, W | 2 |
| Meyer, T | 1 |
| Takeda, S | 3 |
| Funakoshi, Y | 1 |
| Kadota, Y | 1 |
| Koma, M | 1 |
| Maeda, H | 1 |
| Kawamura, S | 1 |
| Matsubara, Y | 1 |
| Yan, TD | 1 |
| Chu, F | 1 |
| Links, M | 1 |
| Kam, PC | 1 |
| Glenn, D | 1 |
| Peng, WZ | 1 |
| Yu, JC | 1 |
| Liu, YQ | 1 |
| Kang, WM | 1 |
| Fan, YP | 1 |
| Guo, WD | 1 |
| Kaira, K | 1 |
| Mori, M | 2 |
| Gillespie, MB | 1 |
| Day, TA | 1 |
| Sharma, AK | 1 |
| Brodsky, MB | 1 |
| Martin-Harris, B | 1 |
| Friedmann, I | 1 |
| Chow, KU | 1 |
| Weidmann, E | 1 |
| Haraguchi, Y | 1 |
| Ueno, S | 1 |
| Sakamoto, F | 1 |
| Toyoyama, H | 1 |
| Ikeda, N | 1 |
| Kamikado, C | 1 |
| Aikou, T | 1 |
| Watanabe, M | 5 |
| Tsuchiya, M | 1 |
| Takita, W | 1 |
| Otsuka, Y | 2 |
| Tamura, A | 1 |
| Koshino, H | 1 |
| Kurihara, A | 1 |
| Kaneko, H | 1 |
| Teramoto, T | 1 |
| Shah, R | 1 |
| Beem, E | 1 |
| Sautina, L | 1 |
| Zharikov, SI | 1 |
| Segal, MS | 1 |
| Wang, XG | 1 |
| Fu, J | 1 |
| Zheng, H | 1 |
| Li, GX | 1 |
| Luo, RC | 1 |
| Tamura, M | 1 |
| Doba, S | 1 |
| Funaki, K | 1 |
| Sasaki, S | 2 |
| Michiwa, Y | 2 |
| Kurosaka, Y | 1 |
| Takekawa, S | 1 |
| Kiriyama, M | 1 |
| Kojima, Y | 1 |
| Kita, T | 1 |
| Kawashima, A | 1 |
| da Silva, RG | 1 |
| Cho, BC | 1 |
| Jeung, HC | 1 |
| Choi, HJ | 1 |
| Rha, SY | 2 |
| Hyung, WJ | 1 |
| Cheong, JH | 1 |
| Noh, SH | 2 |
| Chung, HC | 2 |
| McQuellon, RP | 2 |
| Danhauer, SC | 1 |
| Russell, GB | 2 |
| Fenstermaker, J | 1 |
| Koo, DH | 1 |
| Lee, JL | 1 |
| Kim, TW | 1 |
| Ryu, MH | 1 |
| Yook, JH | 1 |
| Oh, ST | 1 |
| Kim, BS | 2 |
| Lee, JS | 1 |
| Kang, YK | 1 |
| Babiak, A | 1 |
| Hetzel, J | 1 |
| Godde, F | 1 |
| König, HH | 1 |
| Pietsch, M | 1 |
| Hetzel, M | 1 |
| Liu, YL | 1 |
| Song, XR | 1 |
| Wang, XW | 1 |
| Wei, L | 1 |
| Li, DP | 1 |
| Pintoffl, JP | 1 |
| Meisinger, I | 1 |
| Horger, M | 1 |
| Isacoff, WH | 1 |
| Bendetti, JK | 1 |
| Barstis, JJ | 1 |
| Jazieh, AR | 1 |
| Macdonald, JS | 4 |
| Philip, PA | 1 |
| Chen, YW | 1 |
| Yen, SH | 1 |
| Chen, SY | 1 |
| Huang, PI | 1 |
| Shiau, CY | 1 |
| Liu, YM | 1 |
| Lin, JK | 1 |
| Wang, LW | 1 |
| Nabhan, C | 1 |
| Ragam, A | 1 |
| Samuels, B | 1 |
| Milton, DT | 1 |
| Prasad, L | 1 |
| Hooberman, A | 1 |
| Hartsell, W | 1 |
| Anthony, A | 1 |
| Weisman, R | 1 |
| Bitran, JD | 1 |
| Anderson, SE | 1 |
| Bains, M | 1 |
| Hummer, A | 1 |
| Ilson, DH | 1 |
| Kuo, LJ | 1 |
| Liu, MC | 1 |
| Jian, JJ | 1 |
| Horng, CF | 1 |
| Cheng, TI | 1 |
| Chen, CM | 1 |
| Fang, WT | 1 |
| Chung, YL | 1 |
| Vormittag, L | 1 |
| Kornek, GV | 3 |
| Gruhsmann, B | 1 |
| Lenauer, A | 1 |
| Föger, A | 1 |
| Depisch, D | 2 |
| Lang, F | 2 |
| Scheithauer, W | 3 |
| Di Bartolomeo, M | 1 |
| Buzzoni, R | 1 |
| Mariani, L | 1 |
| Ferrario, E | 1 |
| Katia, D | 1 |
| Gevorgyan, A | 1 |
| Zilembo, N | 1 |
| Bordonaro, R | 1 |
| Bochicchio, AM | 1 |
| Massidda, B | 1 |
| Ardizzoia, A | 1 |
| Ardizzoni, A | 1 |
| Marini, G | 1 |
| Aitini, E | 1 |
| Schieppati, G | 1 |
| Comella, G | 1 |
| Pinotti, G | 1 |
| Palazzo, S | 1 |
| Cicero, G | 1 |
| Bajetta, E | 1 |
| Fagnani, D | 1 |
| Reguzzoni, G | 1 |
| Agostana, B | 1 |
| Oliani, C | 1 |
| Kildani, B | 1 |
| Duro, M | 1 |
| Botta, M | 1 |
| Mozzana, R | 1 |
| Mantovani, G | 1 |
| Booton, R | 1 |
| Ward, T | 1 |
| Morris, J | 1 |
| Heighway, J | 1 |
| Han, JQ | 1 |
| Liu, Q | 1 |
| Liang, RX | 1 |
| Qu, FS | 1 |
| Yan, TX | 1 |
| Sun, YH | 1 |
| Li, XQ | 1 |
| Dvoránková, B | 1 |
| Lacina, L | 1 |
| Smetana, K | 1 |
| Lensch, M | 1 |
| Manning, JC | 1 |
| André, S | 1 |
| Gabius, HJ | 1 |
| Saunders, W | 1 |
| Sakata, K | 2 |
| Sakurai, H | 1 |
| Suzuki, Y | 2 |
| Katoh, S | 1 |
| Ohno, T | 1 |
| Toita, T | 1 |
| Kataoka, M | 2 |
| Tanaka, E | 1 |
| Kaneyasu, Y | 2 |
| Uno, T | 1 |
| Harima, Y | 2 |
| Nakano, T | 1 |
| Chalasani, P | 1 |
| Kurtin, S | 1 |
| Dragovich, T | 1 |
| Steffensrud, S | 1 |
| Erichsen, H | 1 |
| Røysland, P | 1 |
| Halvorsen, TB | 1 |
| Klepp, R | 1 |
| Klepp, O | 1 |
| Wünsch, E | 1 |
| Petersen, H | 1 |
| Niell, HB | 2 |
| Griffin, JP | 2 |
| West, WH | 1 |
| Neely, CL | 1 |
| Hirano, T | 2 |
| Fujii, M | 2 |
| Okabe, K | 2 |
| Ishikawa, M | 2 |
| Toki, H | 2 |
| Fujita, Y | 1 |
| Araki, Y | 1 |
| Goto, T | 1 |
| Furuta, I | 1 |
| Urata, A | 2 |
| Fukushima, M | 1 |
| Okuma, K | 1 |
| Shinkai, T | 3 |
| Tominaga, K | 3 |
| Eguchi, K | 3 |
| Shimizu, E | 4 |
| Takahashi, K | 2 |
| Sasaki, Y | 5 |
| Ohkura, H | 2 |
| Fukuoka, M | 1 |
| Takada, M | 1 |
| Tamai, S | 1 |
| Negoro, S | 1 |
| Matsui, K | 1 |
| Ryu, S | 1 |
| Sakai, N | 1 |
| Sakaguchi, K | 1 |
| Asamoto, H | 1 |
| Hisa, T | 1 |
| Sawano, T | 1 |
| Sakai, K | 1 |
| Kitamura, S | 1 |
| Matsushita, N | 1 |
| Kokura, M | 1 |
| Satake, H | 1 |
| Kawakami, I | 1 |
| Saito, H | 3 |
| Nomura, F | 2 |
| Kawatsu, H | 1 |
| Sakai, S | 2 |
| Shimokata, K | 2 |
| Bukowski, RM | 7 |
| Schacter, LP | 1 |
| Groppe, CW | 1 |
| Hewlett, JS | 2 |
| Weick, JK | 3 |
| Livingston, RB | 2 |
| Gahbauer, R | 2 |
| Rodriquez-Antunez, A | 1 |
| Hermann, R | 1 |
| Theodors, A | 2 |
| Goedert, JJ | 1 |
| Smith, FP | 4 |
| Tsou, E | 2 |
| Weiss, RB | 1 |
| Patt, YZ | 1 |
| Peters, RE | 1 |
| Chuang, VP | 1 |
| Wallace, S | 1 |
| Mavligit, G | 1 |
| Ritch, PS | 1 |
| Louie, AC | 1 |
| Kimura, H | 3 |
| Yamaguchi, Y | 4 |
| Kadoyama, C | 1 |
| Sato, N | 1 |
| Fujisawa, T | 2 |
| Bakowski, MT | 1 |
| Crouch, JC | 1 |
| Kaneto, E | 1 |
| Sasaki, H | 1 |
| Tamura, I | 1 |
| Kurimura, O | 1 |
| Kurimura, T | 1 |
| Salvati, F | 1 |
| Cruciani, AR | 1 |
| De Marinis, A | 1 |
| Nunziati, F | 1 |
| Portalone, L | 1 |
| Sternberg, CN | 1 |
| Magill, GB | 1 |
| Sordillo, PP | 1 |
| Cheng, EW | 1 |
| Jolivet, J | 1 |
| Giroux, L | 1 |
| Laurin, S | 1 |
| Gruber, J | 1 |
| Bettez, P | 1 |
| Band, PR | 1 |
| Perry, DJ | 1 |
| Tashiro, T | 2 |
| Fujimoto, S | 1 |
| Inaba, M | 2 |
| Miyamoto, H | 2 |
| Inagaki, J | 2 |
| Horikoshi, N | 3 |
| Ezaki, K | 1 |
| Inoue, K | 5 |
| Ikeda, K | 2 |
| Usui, N | 2 |
| Nakada, H | 2 |
| Shiu, MH | 1 |
| Cahan, A | 1 |
| Fogh, J | 1 |
| Fortner, JG | 1 |
| Spremulli, EN | 1 |
| Leith, JT | 1 |
| Bliven, SF | 1 |
| Campbell, DE | 1 |
| Dexter, DL | 1 |
| Glicksman, AS | 1 |
| Calabresi, P | 1 |
| Ekholm, S | 1 |
| Albrechtsson, U | 1 |
| Tylén, U | 1 |
| Thomas, SD | 1 |
| Uchida, A | 2 |
| Micksche, M | 1 |
| Wakui, A | 2 |
| Taguchi, T | 3 |
| Burk, K | 1 |
| Gropp, C | 2 |
| Rodeck, G | 1 |
| Kitaoka, H | 1 |
| Suga, S | 3 |
| Kimura, K | 1 |
| Yokoyama, Y | 1 |
| Stewart, DJ | 2 |
| Maroun, JA | 2 |
| Young, V | 1 |
| Crook, AF | 2 |
| Hopkins, HS | 1 |
| Yan, RC | 1 |
| Richard, MT | 1 |
| Hugenholtz, H | 1 |
| Bélanger, R | 1 |
| Heringer, R | 2 |
| Logothetis, CJ | 2 |
| Samuels, ML | 2 |
| von Eschenbach, AC | 1 |
| Trindade, A | 1 |
| Ogden, S | 2 |
| Grant, C | 1 |
| Johnson, DE | 1 |
| Hakuta, Y | 1 |
| Kimura, T | 1 |
| Ashizawa, I | 1 |
| Hara, T | 2 |
| Nakazima, K | 1 |
| DiBella, NJ | 1 |
| Garfield, D | 1 |
| Fink, K | 1 |
| Anderson, P | 1 |
| Speer, J | 1 |
| Murphy, J | 1 |
| Tajiri, H | 2 |
| Kitahara, T | 1 |
| Yoshimori, M | 1 |
| Nakamura, K | 1 |
| Hijikata, A | 1 |
| Ozaki, H | 3 |
| Panettiere, FJ | 1 |
| Haas, C | 1 |
| McDonald, B | 1 |
| Costanzi, JJ | 1 |
| Talley, RW | 1 |
| Athens, J | 1 |
| Oishi, N | 2 |
| Heilbrun, LK | 1 |
| Chen, TT | 1 |
| Torti, FM | 1 |
| Lum, BL | 1 |
| Smith, BJ | 1 |
| Evans, M | 1 |
| Hellmann, K | 1 |
| Jones, R | 1 |
| Newton, K | 1 |
| Peters, N | 1 |
| Phillips, RH | 1 |
| Kakizoe, T | 1 |
| Matsumoto, K | 4 |
| Nishio, Y | 1 |
| Ohtani, M | 1 |
| Miyazawa, N | 2 |
| Nosoh, Y | 2 |
| Yoshinaka, K | 5 |
| Yamaguchi, M | 1 |
| Tani, T | 1 |
| Toge, T | 4 |
| Niimoto, M | 5 |
| Hattori, T | 7 |
| Nakada, M | 1 |
| Tseng, MH | 1 |
| Luch, J | 1 |
| Mittelman, A | 1 |
| Douglass, HO | 1 |
| Lavin, PT | 1 |
| Goudsmit, A | 1 |
| Klaassen, DJ | 1 |
| Paul, AR | 4 |
| Niimi, K | 1 |
| Matsuki, K | 1 |
| Tomoda, S | 1 |
| Nakano, A | 1 |
| Lagomarsino Caprino, MC | 1 |
| Mazzei, T | 1 |
| De Vecchis, L | 1 |
| Popoli, P | 1 |
| Ochi, K | 1 |
| Takeshita, K | 1 |
| Sunagawa, M | 1 |
| Habu, H | 1 |
| Hoshi, K | 1 |
| Tanaka, N | 3 |
| Babaian, RJ | 1 |
| Hsu, SD | 1 |
| Soukop, M | 2 |
| McArdle, CS | 1 |
| Carter, DC | 1 |
| Smyth, JF | 4 |
| Allan, SG | 1 |
| Kaye, SB | 1 |
| Sangster, G | 1 |
| Calman, KC | 1 |
| Hutcheon, AW | 1 |
| Haim, N | 1 |
| Epelbaum, R | 1 |
| Cohen, Y | 1 |
| Robinson, E | 1 |
| Waldhorn, RE | 1 |
| Kerwin, DM | 1 |
| Haas, CD | 1 |
| Mansfield, CM | 1 |
| Leichman, LP | 2 |
| Considine, B | 1 |
| Gunderson, LL | 1 |
| Hoskins, RB | 1 |
| Cohen, AC | 1 |
| Kaufman, S | 1 |
| Wood, WC | 1 |
| Carey, RW | 1 |
| Yokoyama, T | 1 |
| Furuta, K | 1 |
| Yajima, K | 1 |
| Yasuda, S | 2 |
| Nakazaki, S | 1 |
| Kiyomitsu, Y | 1 |
| Watanabe, K | 1 |
| Nomori, H | 1 |
| Garcia-Herreros, P | 1 |
| Hoshi, A | 2 |
| Conroy, JF | 1 |
| Roda, PI | 1 |
| Brodsky, I | 1 |
| Kahn, SB | 1 |
| Bulova, SI | 1 |
| Pequignot, E | 1 |
| Hanna, WT | 1 |
| Krauss, S | 1 |
| Regester, RF | 1 |
| Murphy, WM | 1 |
| Chauvergne, J | 1 |
| Durand, M | 2 |
| Brunet, R | 3 |
| Bui, BN | 1 |
| Hoerni, B | 1 |
| Mauriac, L | 2 |
| Reich, SD | 1 |
| Chang, BK | 1 |
| Gutman, R | 1 |
| Sugiura, K | 1 |
| Schmid, F | 1 |
| Otter, G | 1 |
| Stock, CC | 1 |
| Satomi, Y | 1 |
| Takai, S | 1 |
| Nakahashi, M | 1 |
| Furuhata, A | 1 |
| Simon, P | 1 |
| Hervé, JP | 1 |
| Ramée, MP | 1 |
| Leroy, JP | 1 |
| Ang, KS | 1 |
| Leguy, P | 1 |
| Vignoud, J | 1 |
| Cledes, J | 1 |
| Havemann, K | 1 |
| Shindo, M | 1 |
| Machida, T | 1 |
| Masuda, F | 1 |
| Shibuya, M | 1 |
| Shimabukuro, Z | 1 |
| Konishi, K | 1 |
| Tsugawa, K | 1 |
| Kuroda, Y | 1 |
| Tsuji, M | 1 |
| Demachi, H | 1 |
| Kenmotsu, M | 1 |
| Endo, T | 1 |
| Ishii, H | 2 |
| Ichikawa, J | 1 |
| Tsunemitsu, K | 1 |
| Souquet, PJ | 1 |
| Fournel, P | 1 |
| Jorda, M | 1 |
| Laennec, E | 1 |
| Piperno, D | 1 |
| Trillet, V | 1 |
| Rebattu, P | 1 |
| Bernard, JP | 1 |
| Testa, A | 1 |
| Valenza, R | 1 |
| Latteri, M | 1 |
| Bajardi, G | 1 |
| Mastrandrea, G | 1 |
| Cipolla, C | 1 |
| Pischedda, G | 1 |
| Curto, G | 1 |
| Cannata, G | 1 |
| Saikawa, Y | 4 |
| Kubota, T | 7 |
| Furukawa, T | 6 |
| Kumai, K | 1 |
| Yoshino, K | 1 |
| Ishibiki, K | 6 |
| Kitajima, M | 5 |
| Hayakawa, O | 1 |
| Kudo, C | 1 |
| Saito, M | 1 |
| Yoshida, T | 1 |
| Jacquet, P | 1 |
| Averbach, AM | 1 |
| Stephens, AD | 1 |
| Hyogo, H | 1 |
| Ito, K | 3 |
| Kido, S | 1 |
| Yamamoto, K | 1 |
| Kida, M | 1 |
| Matsuda, M | 3 |
| Kojima, K | 1 |
| Matsuura, M | 2 |
| Nakajima, N | 2 |
| Akiyama, J | 1 |
| Iwasaki, Y | 1 |
| Kitamura, M | 4 |
| Arai, K | 3 |
| Marchet, A | 2 |
| Sahmoud, T | 2 |
| Buyse, M | 2 |
| Duez, N | 3 |
| Fiorentino, M | 1 |
| Dos Santos, JG | 2 |
| Labianca, R | 2 |
| Rougier, P | 2 |
| Hisatomi, K | 1 |
| Nakano, S | 3 |
| Okamoto, K | 1 |
| Nagafuchi, Y | 1 |
| Itoh, H | 1 |
| Ohsato, K | 2 |
| Tonusin, A | 2 |
| Sukthomya, W | 1 |
| Changwiwit, W | 2 |
| Nimmolrat, A | 1 |
| Turk, PS | 1 |
| Belliveau, JF | 1 |
| Darnowski, JW | 1 |
| Weinberg, MC | 1 |
| Leenen, L | 1 |
| Wanebo, HJ | 1 |
| Ma, LW | 4 |
| Moan, J | 4 |
| Steen, HB | 4 |
| Iani, V | 1 |
| Dirix, L | 1 |
| Catimel, G | 1 |
| Koier, I | 1 |
| Provè, A | 1 |
| Schrijvers, D | 1 |
| Joossens, E | 1 |
| De Bruijn, E | 1 |
| Ardiet, C | 1 |
| Evene, E | 1 |
| Dumortier, A | 1 |
| Matsuo, N | 1 |
| Nakao, Y | 2 |
| Yokoyama, M | 2 |
| Yamasaki, F | 1 |
| Mvula, M | 1 |
| Sugimori, H | 2 |
| Algan, O | 1 |
| Coia, LR | 4 |
| Keller, SM | 2 |
| Engstrom, PF | 4 |
| Weiner, LM | 1 |
| Schultheiss, TE | 1 |
| Hanks, GE | 2 |
| Miura, T | 1 |
| Villa, R | 1 |
| Zaffaroni, N | 1 |
| Orlandi, L | 1 |
| Bearzatto, A | 1 |
| Costa, A | 1 |
| Silvestrini, R | 1 |
| Sauter, ER | 1 |
| Secco, GB | 1 |
| Fardelli, R | 1 |
| Campora, E | 1 |
| Sertoli, MR | 1 |
| De Caro, G | 1 |
| Cariati, A | 1 |
| Zoli, S | 1 |
| Gianquinto, D | 1 |
| Tsuji, Y | 2 |
| Ikuta, H | 1 |
| Shibagaki, F | 1 |
| Jablonski, KA | 1 |
| Caudry, M | 1 |
| Bonnel, C | 1 |
| Floquet, A | 1 |
| Marsault, C | 1 |
| Quétin, P | 1 |
| Pujol, J | 1 |
| Maton, O | 1 |
| Dujols, JP | 1 |
| Caudry, Y | 1 |
| Skawinski, P | 1 |
| Weese, JL | 2 |
| Solin, LJ | 2 |
| Agarwal, P | 1 |
| Engstrom, P | 1 |
| Scher, R | 2 |
| Litwin, S | 2 |
| Watts, P | 1 |
| Masutani, S | 1 |
| Kawasaki, T | 1 |
| Ishida, H | 1 |
| Kimura, F | 1 |
| Okuyama, M | 1 |
| Yamada, M | 1 |
| Ishikawa, K | 1 |
| Tatsuta, M | 1 |
| Satomi, T | 1 |
| Hirama, K | 1 |
| Mikami, Y | 1 |
| Nishi, T | 1 |
| Suzuki, H | 2 |
| Sugiyama, Y | 2 |
| Konn, M | 1 |
| Khansur, T | 1 |
| Allred, C | 1 |
| Tavassoli, M | 1 |
| Tajima, H | 1 |
| Matsuki, N | 1 |
| Takeda, T | 1 |
| Horichi, H | 1 |
| Kumaki, T | 1 |
| Shima, K | 2 |
| Bradley, C | 1 |
| Selby, P | 1 |
| Shchepotin, IB | 1 |
| Buras, RR | 1 |
| Nauta, RJ | 1 |
| Shabahang, M | 1 |
| Evans, SR | 1 |
| Chen, LJ | 2 |
| Zhang, SY | 2 |
| Zhang, JL | 1 |
| Zhang, Z | 1 |
| Li, S | 2 |
| Chen, M | 1 |
| Zhang, XY | 2 |
| Chen, XT | 2 |
| Carrillo Hernández, JF | 1 |
| Ernesto de Obaldía Castillo, G | 1 |
| Ramírez Ortega, C | 1 |
| Frías Mendivil, M | 1 |
| Pardo, M | 1 |
| Kawahara, H | 1 |
| Hirai, K | 1 |
| Ashikaga, K | 1 |
| Yamada, Y | 3 |
| Kimura, C | 1 |
| Kuroda, H | 2 |
| Sato, K | 2 |
| Ono, M | 1 |
| Sakai, Y | 1 |
| Kusano, F | 1 |
| Yamamoto, C | 1 |
| Maekawa, N | 1 |
| Sasaki, N | 1 |
| Tajiri, K | 1 |
| Tazawa, J | 1 |
| Liao, ML | 1 |
| Carry, PY | 2 |
| Sayag, AC | 2 |
| Brachet, A | 2 |
| Salle, B | 2 |
| Bienvenu, J | 2 |
| Burgard, G | 2 |
| Guibert, B | 1 |
| Banssillon, V | 2 |
| Kuo, TH | 4 |
| Kase, S | 3 |
| Tanino, H | 3 |
| Isobe, Y | 1 |
| Arimori, M | 1 |
| Inoue, Y | 1 |
| Nakamura, H | 1 |
| Akashi, H | 1 |
| Mizumoto, S | 1 |
| Yamasaki, K | 1 |
| Kato, H | 1 |
| Wakasugi, H | 1 |
| Yokota, M | 1 |
| Furukawa, M | 1 |
| Mukuta, T | 1 |
| Funakoshi, A | 1 |
| Coia, L | 1 |
| Hoffman, J | 1 |
| Weese, J | 1 |
| Solin, L | 1 |
| Weiner, L | 1 |
| Eisenberg, B | 1 |
| Paul, A | 2 |
| Hanks, G | 1 |
| Suematsu, T | 1 |
| Kawabata, S | 1 |
| Kodama, I | 2 |
| Koufuji, K | 1 |
| Aoyagi, K | 2 |
| Tanaka, T | 4 |
| Maruiwa, M | 2 |
| Ohta, J | 2 |
| Kumegawa, H | 2 |
| Metzger, U | 1 |
| Laffer, U | 1 |
| Egeli, R | 1 |
| Arma, S | 1 |
| Aeberhard, P | 1 |
| Barras, JP | 1 |
| Martinoli, S | 1 |
| Müller, W | 1 |
| Castiglione, M | 1 |
| Schroeder, R | 1 |
| Cummings, J | 3 |
| Allan, L | 1 |
| Köhne-Wömpner, CH | 1 |
| Schöffski, P | 1 |
| Schmoll, HJ | 1 |
| Kumazawa, H | 1 |
| Hess, M | 1 |
| Koldovsky, P | 1 |
| Miyazaki, N | 1 |
| Kajimura, N | 1 |
| Okazaki, N | 2 |
| Kato, K | 1 |
| Koike, A | 1 |
| Koide, T | 1 |
| Kojima, T | 1 |
| Kawai, Y | 1 |
| Takeshige, K | 1 |
| Matsunaga, H | 1 |
| Katano, M | 1 |
| Saita, T | 1 |
| Yamamoto, H | 2 |
| Prewitt, TW | 1 |
| Matthews, W | 1 |
| Chaudhri, G | 1 |
| Pogrebniak, HW | 1 |
| Pass, HI | 1 |
| Dong, QG | 1 |
| Gong, LL | 1 |
| Wang, HJ | 1 |
| Wang, EZ | 1 |
| Picciocchi, A | 2 |
| Coco, C | 2 |
| Magistrelli, P | 1 |
| Roncolini, G | 1 |
| Netri, G | 1 |
| Mattana, C | 2 |
| Cellini, N | 2 |
| De Franco, A | 1 |
| Vecchio, FM | 1 |
| Blumenstein, B | 1 |
| Crawford, ED | 1 |
| Saiers, JH | 1 |
| Stephens, RL | 2 |
| Rivkin, SE | 1 |
| Coltman, CA | 1 |
| Kofuji, K | 1 |
| Takeda, J | 1 |
| Kakegawa, T | 1 |
| Koh, WJ | 1 |
| Wallace, HJ | 1 |
| Greer, BE | 1 |
| Cain, J | 1 |
| Stelzer, KJ | 1 |
| Russell, KJ | 1 |
| Tamimi, HK | 1 |
| Figge, DC | 1 |
| Russell, AH | 1 |
| Griffin, TW | 1 |
| Sakakibara, T | 1 |
| Oyama, T | 1 |
| Ozaki, K | 1 |
| Tsujimoto, H | 1 |
| Sakakura, C | 1 |
| Shimotsuma, M | 1 |
| Hagiwara, A | 2 |
| Ishikawa, A | 1 |
| Ozawa, M | 1 |
| Suzuki, K | 1 |
| Toyama, K | 1 |
| Yeung, RS | 1 |
| Kowalyshyn, MJ | 1 |
| Murren, JR | 1 |
| Ganpule, S | 1 |
| Papac, R | 1 |
| Son, YH | 1 |
| Peschel, RE | 1 |
| Durivage, H | 1 |
| Buzaid, AC | 1 |
| Lamb, L | 1 |
| Makuch, R | 1 |
| Hait, WN | 1 |
| Tsumura, I | 2 |
| Kikkawa, N | 2 |
| Fleming, TR | 4 |
| Taylor, SA | 1 |
| Baker, LH | 1 |
| Darnton, SJ | 5 |
| Allen, SM | 3 |
| Edwards, CW | 1 |
| Matthews, HR | 5 |
| Xing, FY | 1 |
| Liu, WH | 1 |
| Dong, W | 1 |
| Zhang, SL | 1 |
| Gu, BW | 1 |
| Okazaki, K | 1 |
| Naito, H | 1 |
| Inoue, T | 1 |
| Wu, JT | 1 |
| Tamura, S | 2 |
| Brockmann, WP | 1 |
| Wiegel, T | 1 |
| Sommer, K | 1 |
| Steiner, P | 1 |
| Hübener, KH | 1 |
| Kiyohashi, A | 1 |
| Kurihara, M | 3 |
| Yoshida, S | 3 |
| Ohkubo, T | 1 |
| Berg, K | 3 |
| Peng, Q | 3 |
| Chan, A | 1 |
| Wong, A | 1 |
| Langevin, J | 1 |
| Khoo, R | 2 |
| Schnall, S | 1 |
| Topham, C | 1 |
| Glees, J | 1 |
| Coombes, RC | 2 |
| Ashizawa, T | 1 |
| Okabe, M | 1 |
| Gomi, K | 1 |
| Hirata, T | 1 |
| Hoffman, RM | 1 |
| Jenner, K | 1 |
| Steyn, RS | 1 |
| Ferry, DR | 2 |
| Yumoto, Y | 1 |
| Okuda, T | 2 |
| Shimizu, S | 1 |
| Kawase, K | 1 |
| Peterson, RF | 1 |
| Berenberg, JL | 1 |
| McClure, S | 1 |
| Chapman, RA | 1 |
| Eyre, HJ | 1 |
| Solanki, D | 1 |
| Cruz, AB | 1 |
| Gagliano, R | 1 |
| Fornasiero, A | 2 |
| Lasser, P | 1 |
| Gignoux, M | 1 |
| Duffy, JP | 1 |
| Cullen, MH | 2 |
| Kinoshita, T | 2 |
| Kosuge, T | 3 |
| Yamamoto, J | 2 |
| Shimada, K | 2 |
| Koyama, Y | 2 |
| Mukai, K | 2 |
| Sun, X | 1 |
| Ross, D | 1 |
| Muchmore, JH | 1 |
| Preslan, JE | 1 |
| George, WJ | 1 |
| Hori, K | 1 |
| Kimura, S | 1 |
| Takagaki, M | 1 |
| Koumoto, T | 1 |
| Andou, T | 1 |
| Spanswick, VJ | 2 |
| Christie, DR | 1 |
| Bull, CA | 1 |
| Gebski, V | 1 |
| Langlands, AO | 1 |
| Mark, HF | 1 |
| Naram, R | 1 |
| Santoro, K | 1 |
| Bland, KI | 1 |
| Watts, PL | 1 |
| Plumb, JA | 1 |
| Courtney, JM | 1 |
| Scott, R | 1 |
| Katayama, K | 2 |
| Nagano, H | 1 |
| Taguchi, S | 3 |
| Niimoto, S | 1 |
| Yamaguchi, A | 2 |
| Nakagawara, G | 1 |
| Ikeba, K | 1 |
| Ohokubo, T | 1 |
| Sodemoto, T | 1 |
| Yamamoto, T | 1 |
| Takagi, A | 1 |
| Hayashi, N | 1 |
| Kinoshita, K | 1 |
| Boku, N | 1 |
| Ohtsu, A | 1 |
| Muro, K | 1 |
| Kaneko, K | 1 |
| Muto, M | 1 |
| Ohkuwa, M | 1 |
| Kusada, O | 1 |
| Yamazaki, N | 1 |
| Chan, AK | 1 |
| Wong, AO | 1 |
| Langevin, JM | 1 |
| Jenken, DA | 1 |
| Heine, JA | 1 |
| Buie, WD | 1 |
| Johnson, DR | 1 |
| Braybrooke, JP | 1 |
| Propper, DJ | 1 |
| Salisbury, AJ | 1 |
| Boardman, P | 1 |
| Taylor, M | 1 |
| Ganesan, TS | 1 |
| Talbot, DC | 1 |
| Harris, AL | 1 |
| Wu, DC | 1 |
| Liu, JM | 1 |
| Chen, YM | 1 |
| Yang, S | 1 |
| Liu, SM | 1 |
| Chen, LT | 1 |
| Whang-Peng, J | 1 |
| Yoshioka, T | 2 |
| Takahashi, H | 1 |
| Oikawa, H | 1 |
| Maeda, S | 1 |
| Ido, T | 1 |
| Akaizawa, T | 1 |
| Fukuda, H | 1 |
| Kanamaru, R | 2 |
| Kogure, A | 1 |
| Ishii, S | 1 |
| Kakefuda, T | 1 |
| Arisawa, Y | 2 |
| Nakagawa, M | 1 |
| Shirasugi, N | 1 |
| Noga, K | 1 |
| Miura, M | 2 |
| Terashima, Y | 1 |
| Ikeyama, S | 1 |
| Sasaki, K | 1 |
| Taki, S | 1 |
| Fukuda, Y | 2 |
| Yogita, S | 1 |
| Tashiro, S | 1 |
| Solic, N | 1 |
| Davies, DE | 1 |
| Rakovitch, E | 1 |
| Fyles, AW | 1 |
| Pintilie, M | 1 |
| Leung, PM | 1 |
| Tomita, H | 1 |
| Fukunari, H | 1 |
| Shibata, M | 1 |
| Iwasaki, A | 1 |
| Sanada, K | 1 |
| Enomoto, M | 1 |
| Ichikawa, W | 1 |
| Kitago, K | 1 |
| Nihei, Z | 1 |
| Miyagawa, T | 1 |
| Toyoda, H | 1 |
| Uesato, K | 1 |
| Asanuma, F | 1 |
| Park, JO | 1 |
| Cho, JY | 1 |
| You, NC | 1 |
| Kim, JH | 1 |
| Kim, CB | 1 |
| Min, JS | 1 |
| Roh, JK | 1 |
| Fushiki, H | 2 |
| Hidaka, T | 2 |
| Fujimura, M | 2 |
| Yamakawa, Y | 2 |
| Izumi, R | 1 |
| Okawa, MK | 1 |
| Kokubo, N | 1 |
| Karasawa, K | 1 |
| Fukuhara, N | 1 |
| Toda, J | 1 |
| Okawa, T | 2 |
| Kawabata, K | 1 |
| Nio, Y | 2 |
| Imamura, M | 1 |
| Pokorny, RM | 1 |
| Wrightson, WR | 1 |
| Lewis, RK | 1 |
| Paris, KJ | 1 |
| Hofmeister, A | 1 |
| LaRocca, R | 1 |
| Myers, SR | 1 |
| Ackerman, D | 1 |
| Galandiuk, S | 1 |
| Ubhi, SS | 1 |
| McCulloch, P | 1 |
| Veitch, PS | 1 |
| O'Hagan, S | 1 |
| Diamond, T | 1 |
| Roversi, R | 1 |
| Rossi, G | 1 |
| Roversi, M | 1 |
| Cavallo, G | 1 |
| Rossi, I | 1 |
| Nicoletti, G | 1 |
| Landuzzi, L | 1 |
| Frabetti, F | 1 |
| De Giovanni, C | 1 |
| Nanni, P | 1 |
| Musiani, P | 1 |
| Ferrantini, M | 1 |
| Belardelli, F | 1 |
| Lollini, PL | 1 |
| Kan, K | 1 |
| Naitoh, K | 1 |
| Tsuruta, A | 1 |
| Mizuta, N | 1 |
| Ohmori, K | 1 |
| Kawachi, H | 1 |
| Amaike, H | 1 |
| Yanada, M | 1 |
| Ohmori, Y | 1 |
| Kobayashi, I | 1 |
| Yokomori, T | 2 |
| Iesato, H | 2 |
| Ouya, T | 1 |
| Ohwada, S | 2 |
| Morishita, Y | 2 |
| Genovesi, D | 1 |
| Mantini, G | 1 |
| Barbaro, B | 1 |
| Cogliandolo, S | 1 |
| Ambesi-Impiombato, F | 1 |
| Tedesco, M | 1 |
| Cosimelli, M | 1 |
| Takayanagi, N | 1 |
| Danjo, Y | 1 |
| Recchia, F | 2 |
| Sica, G | 2 |
| Casucci, D | 1 |
| Rea, S | 2 |
| Gulino, A | 1 |
| Frati, L | 1 |
| Schiebe, ME | 1 |
| Hoffmann, W | 1 |
| Bamberg, M | 1 |
| Ono, I | 1 |
| Kuwae, C | 1 |
| Kaneko, M | 1 |
| Ishibashi, T | 1 |
| Minaguchi, R | 1 |
| Kohyama, A | 1 |
| Kitada, H | 1 |
| Ohtsuka, H | 1 |
| Rosen, HR | 1 |
| Jatzko, G | 1 |
| Repse, S | 1 |
| Potrc, S | 1 |
| Neudorfer, H | 1 |
| Sandbichler, P | 1 |
| Zacherl, J | 1 |
| Rabl, H | 1 |
| Holzberger, P | 1 |
| Lisborg, P | 1 |
| Czeijka, M | 1 |
| Fukuda, K | 1 |
| Uchiyama, M | 1 |
| Blaszkowsky, L | 1 |
| Ritchie, AA | 1 |
| Park, HC | 1 |
| Yoon, C | 1 |
| Yoon, HJ | 1 |
| Choi, YM | 1 |
| Cho, KS | 1 |
| Rendina, EA | 1 |
| Venuta, F | 1 |
| De Giacomo, T | 1 |
| Ciccone, AM | 1 |
| Ruvolo, G | 1 |
| Coloni, GF | 1 |
| Ricci, C | 1 |
| Petrowsky, H | 1 |
| Heinrich, S | 1 |
| Staib-Sebler, E | 1 |
| Gog, C | 1 |
| Janshon, G | 1 |
| Lorenz, M | 1 |
| Fass, J | 1 |
| Jansen, M | 1 |
| Zengel, K | 1 |
| Reinecke, T | 1 |
| Asshoff, G | 1 |
| Schumpelick, V | 1 |
| Ducreux, M | 1 |
| Gil-Delgado, M | 1 |
| André, T | 1 |
| Ychou, M | 1 |
| de Gramond, A | 1 |
| Khayat, D | 1 |
| Kodama, J | 1 |
| Ikuhashi, H | 1 |
| Hongo, A | 1 |
| Mizutani, Y | 1 |
| Miyagi, Y | 1 |
| Yoshinouchi, M | 1 |
| Kobashi, Y | 1 |
| Okuda, H | 2 |
| Kudo, T | 1 |
| Su, MY | 1 |
| Wang, Z | 1 |
| Nalcioglu, O | 1 |
| Naoe, Y | 2 |
| Kawamura, I | 2 |
| Inami, M | 2 |
| Matsumoto, S | 2 |
| Nishigaki, F | 2 |
| Tsujimoto, S | 2 |
| Manda, T | 2 |
| Shimomura, K | 2 |
| Takagaki, S | 1 |
| Fujiwara, T | 1 |
| Klas, JV | 1 |
| Rothenberger, DA | 1 |
| Wong, WD | 1 |
| Madoff, RD | 1 |
| Oyama, K | 1 |
| Fushida, S | 2 |
| Bando, E | 2 |
| Fujita, H | 1 |
| Fujimura, T | 3 |
| Nishimura, G | 3 |
| Miwa, K | 2 |
| Mantovani, F | 1 |
| Banks, L | 1 |
| Li, G | 1 |
| Liu, F | 1 |
| Takeda, A | 1 |
| Nakajima, K | 3 |
| Shimada, H | 2 |
| Imaseki, H | 1 |
| Takayama, W | 1 |
| Hayashi, H | 1 |
| Suzuki, T | 2 |
| Isono, K | 1 |
| Ohtani, Y | 1 |
| Ishikawa, H | 2 |
| Aihara, S | 1 |
| Kanazawa, H | 1 |
| Kakita, A | 1 |
| Horsell, KW | 1 |
| Merten, S | 1 |
| Clingan, P | 1 |
| King, DW | 1 |
| Usuki, N | 1 |
| Hirokawa, K | 1 |
| Saiwai, S | 1 |
| Miyamoto, T | 1 |
| Baraz, L | 1 |
| Kotler, M | 1 |
| Condiotti, R | 1 |
| Nagler, A | 1 |
| Tsunoda, T | 1 |
| Tanimura, H | 1 |
| Hotta, T | 1 |
| Tani, M | 1 |
| Iwahashi, M | 1 |
| Ishimoto, K | 1 |
| Tanaka, H | 2 |
| Matsuda, K | 1 |
| Yamaue, H | 1 |
| Minari, Y | 1 |
| Endo, S | 1 |
| Yano, S | 1 |
| Itakura, M | 1 |
| Yamasawa, K | 1 |
| Tamura, K | 2 |
| Minatoya, T | 1 |
| Hayashi, T | 1 |
| Ajisaka, H | 1 |
| Musha, N | 1 |
| Nihei, T | 1 |
| Watanabe, N | 1 |
| Sunami, E | 1 |
| Sasaki, M | 3 |
| Sando, N | 1 |
| Oka, K | 1 |
| Wu, Q | 1 |
| Kreienberg, R | 1 |
| Runnebaum, IB | 1 |
| Saito, S | 1 |
| Yoshimasu, T | 1 |
| Oura, S | 1 |
| Maebeya, S | 1 |
| Bessho, T | 1 |
| Arimoto, J | 1 |
| Sakurai, T | 1 |
| Matsuyama, K | 1 |
| Naito, Y | 1 |
| Yano, T | 1 |
| Suzuma, T | 1 |
| Hirai, I | 1 |
| Nishioka, Y | 1 |
| Baba, T | 1 |
| Hinoshita, E | 1 |
| Uchiumi, T | 1 |
| Taguchi, K | 1 |
| Kinukawa, N | 1 |
| Tsuneyoshi, M | 1 |
| Maehara, Y | 3 |
| Sugimachi, K | 3 |
| Kuwano, M | 1 |
| Ruiz Gómez, MJ | 1 |
| Souviron, A | 2 |
| Martínez Morillo, M | 1 |
| Shimizu, Y | 1 |
| Konno, H | 1 |
| Baba, M | 1 |
| Kanai, T | 2 |
| Kamiya, K | 1 |
| Ohba, K | 1 |
| Nakamura, S | 3 |
| Tokuuye, K | 1 |
| Fukushima, N | 2 |
| Wexler, EJ | 1 |
| Gravallese, EM | 1 |
| Czerniak, PM | 1 |
| Devenny, JJ | 1 |
| Longtine, J | 1 |
| Wong, MK | 1 |
| Slee, AM | 1 |
| Kerr, JS | 1 |
| Park, IC | 1 |
| Park, MJ | 1 |
| Hwang, CS | 1 |
| Rhee, CH | 1 |
| Whang, DY | 1 |
| Jang, JJ | 1 |
| Choe, TB | 1 |
| Hong, SI | 1 |
| Lee, SH | 1 |
| Nakagami, K | 1 |
| Sugitani, K | 1 |
| Sasaki, T | 2 |
| Ohya, T | 1 |
| Kikunaga, H | 1 |
| Sotome, K | 1 |
| Morisue, A | 1 |
| Matsudo, A | 1 |
| Baba, H | 1 |
| Nakai, H | 1 |
| Takao, M | 1 |
| Osakabe, Y | 1 |
| Miura, H | 1 |
| Nakagawa, K | 1 |
| Toshima, T | 1 |
| Momono, S | 1 |
| Teshima, T | 1 |
| Engels, IH | 1 |
| Stepczynska, A | 1 |
| Stroh, C | 1 |
| Lauber, K | 1 |
| Berg, C | 1 |
| Schwenzer, R | 1 |
| Wajant, H | 1 |
| Jänicke, RU | 1 |
| Porter, AG | 1 |
| Gregor, M | 1 |
| Schulze-Osthoff, K | 1 |
| Wesselborg, S | 1 |
| Kastl, S | 1 |
| Brunner, T | 1 |
| Herrmann, O | 1 |
| Riepl, M | 1 |
| Fietkau, R | 1 |
| Grabenbauer, G | 1 |
| Sauer, R | 1 |
| Klein, P | 1 |
| Chakravarthy, A | 1 |
| Abrams, RA | 1 |
| Yeo, CJ | 1 |
| Korman, LT | 1 |
| Donehower, RC | 1 |
| Hruban, RH | 1 |
| Zahurek, ML | 1 |
| Grochow, LB | 1 |
| O'Reilly, S | 1 |
| Hurwitz, H | 1 |
| Jaffee, EM | 1 |
| Lillemoe, KD | 1 |
| Cameron, JL | 1 |
| Ida, K | 1 |
| Kamiya, T | 1 |
| Pötter, R | 1 |
| Selzer, E | 1 |
| Schratter, A | 1 |
| Ulrich-Pur, H | 1 |
| Rogy, M | 1 |
| Kraus, G | 1 |
| Noda, M | 1 |
| Kusunoki, M | 1 |
| Yanagi, H | 1 |
| Yoshikawa, R | 1 |
| Gerhardt, P | 1 |
| Kasahara, K | 1 |
| Shuin, T | 1 |
| Ishizaki, M | 1 |
| Akiyama, N | 1 |
| Tanaka, S | 1 |
| Motegi, M | 1 |
| Sasamoto, H | 1 |
| Osawa, H | 1 |
| Wada, W | 1 |
| Nakajima, M | 1 |
| Gupta, S | 1 |
| Raina, V | 1 |
| Jain, P | 1 |
| Gujral, S | 1 |
| Kumar, R | 1 |
| Chen, JS | 1 |
| Lin, YC | 1 |
| Jan, YY | 1 |
| Liau, CT | 1 |
| Simamura, E | 1 |
| Hirai, KI | 1 |
| Koyama, J | 1 |
| De Filippis, S | 1 |
| Rosselli, M | 1 |
| Pompili, PL | 1 |
| Niu, H | 1 |
| He, W | 1 |
| Ba, D | 1 |
| Archer, VR | 1 |
| Mulholland, PJ | 1 |
| Stocken, DD | 1 |
| Hishikawa, Y | 1 |
| Kohno, H | 1 |
| Ueda, S | 1 |
| Kimoto, T | 1 |
| Dhar, DK | 1 |
| Kubota, H | 1 |
| Tachibana, M | 1 |
| Koji, T | 1 |
| Nagasue, N | 1 |
| Kuhn, R | 1 |
| Halangk, W | 1 |
| Boltze, C | 1 |
| Tamamori, Y | 1 |
| Nishino, H | 1 |
| Yamada, N | 1 |
| Nishihara, T | 1 |
| Nakazawa, K | 1 |
| Hirakawa, K | 2 |
| Varvarigos, N | 1 |
| Kamaradou, H | 1 |
| Kourti, A | 1 |
| Papavasiliou, ED | 1 |
| Papaioannou, H | 1 |
| Migdalis, IN | 1 |
| Galanis, C | 1 |
| Hua, B | 1 |
| Wang, A | 1 |
| Seitz, JF | 1 |
| Duffaud, F | 1 |
| Dahan, L | 1 |
| Ries, P | 1 |
| Ville, E | 1 |
| Laugier, R | 1 |
| Brugger, S | 1 |
| Ullrich-Pur, H | 1 |
| Valencak, J | 1 |
| Raderer, M | 1 |
| Fiebiger, W | 1 |
| Kovats, E | 1 |
| Atagi, S | 1 |
| Kawahara, M | 1 |
| Hosoe, S | 1 |
| Ogawara, M | 1 |
| Kawaguchi, T | 1 |
| Okishio, K | 1 |
| Naka, N | 1 |
| Sunami, T | 1 |
| Mitsuoka, S | 1 |
| Akira, M | 1 |
| Yachida, S | 1 |
| Sakamoto, M | 1 |
| Hirohashi, S | 1 |
| Huang, Y | 1 |
| Wang, W | 1 |
| Su, G | 1 |
| Qi, X | 1 |
| Ma, D | 1 |
| Fan, Y | 1 |
| Fujimoto, T | 1 |
| Zhang, B | 1 |
| Minami, S | 1 |
| Takahashi, Y | 2 |
| Mai, M | 1 |
| Lim, HY | 1 |
| Joo, HJ | 1 |
| Kim, HS | 1 |
| Yi, JW | 1 |
| Kim, HC | 1 |
| Kim, MW | 1 |
| Lee, KB | 1 |
| Luh, KT | 1 |
| Yang, PC | 1 |
| Kuo, SH | 1 |
| Chang, DB | 1 |
| Yu, CJ | 1 |
| Lee, LN | 1 |
| Feldman, ER | 1 |
| Eagan, RT | 1 |
| Schaid, DJ | 1 |
| Athanassiades, P | 1 |
| Athanassiades, H | 1 |
| Psychogiou, E | 1 |
| Kokolakis, N | 1 |
| Giannioti, E | 1 |
| Manchon, M | 1 |
| Hashimoto, T | 2 |
| Araki, H | 1 |
| Yasui, K | 1 |
| Kodama, M | 1 |
| Fujii, S | 1 |
| Klimberg, VS | 1 |
| Langston, JD | 1 |
| Maners, A | 1 |
| Gocio, JC | 1 |
| Hutchins, LF | 1 |
| Lang, NP | 1 |
| Westbrook, KC | 1 |
| Broadwater, JR | 1 |
| Broder, LE | 1 |
| Sridhar, KS | 1 |
| Selawry, OS | 1 |
| Charyulu, KN | 1 |
| Rao, RK | 1 |
| Saldana, MJ | 1 |
| Lenz, C | 1 |
| Saether, H | 1 |
| Rimington, C | 1 |
| Antonakopoulos, GN | 1 |
| Newman, J | 1 |
| Kubota, S | 1 |
| Takezawa, T | 1 |
| Mori, Y | 1 |
| Takakuwa, T | 1 |
| Nemoto, K | 1 |
| Sugawara, Y | 1 |
| Ogino, M | 1 |
| Mae, T | 1 |
| Abe, F | 2 |
| Takeuchi, T | 2 |
| Hosokawa, T | 1 |
| Kikuchi, H | 2 |
| Dobrowsky, W | 2 |
| Kunimura, T | 1 |
| Morohoshi, T | 1 |
| Sato, M | 2 |
| Kanda, M | 1 |
| Hatta, Y | 1 |
| Miura, K | 2 |
| Kobayashi, K | 1 |
| Takemoto, T | 1 |
| Hino, M | 2 |
| Hayashihara, K | 1 |
| Nakahiro, K | 1 |
| Wasai, S | 1 |
| Niitani, H | 1 |
| Ramsay, JR | 1 |
| Bleehen, NM | 1 |
| Dennis, I | 1 |
| Workman, P | 1 |
| Ward, R | 1 |
| Falk, SJ | 1 |
| Bedford, P | 1 |
| Wootton, R | 1 |
| Nethersell, AB | 1 |
| Bécouarn, Y | 2 |
| Ravaud, A | 1 |
| Bussières, E | 2 |
| Lagarde, P | 1 |
| Mashiko, H | 1 |
| Satoh, J | 1 |
| Hatayama, H | 1 |
| Kitamura, H | 1 |
| Shibata, N | 1 |
| Noguchi, S | 1 |
| Kawamura, M | 1 |
| Kikuchi, K | 1 |
| Ishihara, T | 1 |
| Mouri, M | 1 |
| Mohiuddin, M | 2 |
| Rosato, F | 1 |
| Barbot, D | 2 |
| Schuricht, A | 1 |
| Biermann, W | 2 |
| Cantor, R | 1 |
| Nguyen, HN | 1 |
| Sevin, BU | 1 |
| Averette, HE | 1 |
| Perras, J | 1 |
| Donato, D | 1 |
| Penalver, M | 1 |
| Kusumoto, H | 2 |
| Yoshida, M | 2 |
| Takahashi, I | 1 |
| Anai, H | 2 |
| Benedetti Panici, P | 1 |
| Scambia, G | 1 |
| Greggi, S | 1 |
| Salerno, G | 1 |
| Cento, R | 1 |
| Mancuso, S | 1 |
| Stafford, PM | 1 |
| Sakata, Y | 1 |
| Chiba, Y | 1 |
| Sato, T | 1 |
| Kimura, M | 1 |
| Fukushi, G | 1 |
| Matsukawa, M | 1 |
| Wada, K | 1 |
| Aoyama, H | 1 |
| Sawada, Y | 1 |
| Fukushi, M | 1 |
| Nishibori, H | 1 |
| Walker, SJ | 1 |
| Steel, A | 1 |
| Nakagawa, A | 1 |
| Hiramatsu, Y | 1 |
| Kitade, H | 1 |
| Ogura, T | 1 |
| Yoshioka, K | 1 |
| Takada, H | 1 |
| Hioki, K | 1 |
| Yamamoto, M | 1 |
| Franchi, F | 1 |
| Barone, C | 1 |
| Seminara, P | 1 |
| Codacci-Pisanelli, G | 1 |
| Codacci-Pisanelli, M | 1 |
| Ferri, GM | 1 |
| Garufi, C | 1 |
| Grieco, A | 1 |
| Pagani, V | 1 |
| Yagi, M | 1 |
| Ohtagaki, S | 1 |
| Toi, M | 1 |
| Tsuchiya, Y | 1 |
| Kobayakawa, K | 1 |
| Kawahara, T | 1 |
| Kashimoto, S | 2 |
| Kajikawa, F | 1 |
| Nakata, K | 3 |
| Arima, S | 1 |
| Hisatsugu, T | 1 |
| Ohkuma, R | 1 |
| Abe, R | 1 |
| Nakamura, Y | 2 |
| Fukuyama, N | 1 |
| Yamanouchi, A | 1 |
| Taira, A | 1 |
| Yamagishi, M | 1 |
| Furukawa, H | 1 |
| Taniguchi, T | 1 |
| Yamauchi, M | 1 |
| Satta, T | 1 |
| Ito, A | 1 |
| Kondo, K | 1 |
| Akiyama, S | 1 |
| Watanabe, T | 1 |
| Takagi, H | 1 |
| Tanemura, H | 3 |
| Azuma, S | 3 |
| Saji, S | 3 |
| Kawata, R | 3 |
| Furuta, T | 3 |
| Miya, K | 1 |
| Umemoto, T | 1 |
| Kunieda, K | 1 |
| Takao, H | 1 |
| Shimizu, T | 1 |
| Nakagoe, T | 1 |
| Kusano, H | 1 |
| Kajiwara, K | 1 |
| Ifuku, M | 1 |
| Kawaguchi, A | 1 |
| Shiraishi, E | 1 |
| Kakizaki, K | 1 |
| Yamauchi, H | 1 |
| Wong, CS | 1 |
| Cummings, BJ | 1 |
| Keane, TJ | 1 |
| O'Sullivan, B | 1 |
| Catton, CN | 1 |
| Kemeny, N | 1 |
| Armstrong, JG | 1 |
| Reichman, B | 1 |
| Botet, J | 1 |
| Avril, A | 1 |
| Dilhuydy, JM | 1 |
| Abad, A | 1 |
| Rosell, R | 1 |
| Barnadas, A | 1 |
| Carles, J | 1 |
| Ribelles, N | 1 |
| Solano, V | 1 |
| Okada, S | 1 |
| Sano, T | 1 |
| Nomura, K | 1 |
| Adachi, M | 2 |
| Kobori, O | 1 |
| Kambhu, SA | 1 |
| Kelsen, DP | 1 |
| Fiore, J | 1 |
| Niedzwiecki, D | 1 |
| Chapman, D | 1 |
| Vinciguerra, V | 1 |
| Rosenbluth, R | 1 |
| Roth, A | 1 |
| Zupanc, D | 1 |
| Luetić, J | 1 |
| Kolarić, K | 1 |
| Hara, N | 1 |
| Ohta, M | 1 |
| Ichikawa, Y | 1 |
| Kanda, T | 1 |
| Hokama, M | 1 |
| Wagner, A | 1 |
| Waitz, W | 1 |
| Nicolás, JM | 1 |
| Villalta, J | 1 |
| González-Clemente, JM | 2 |
| Antúnez, E | 1 |
| Almirall, J | 1 |
| Bosch, J | 1 |
| Torras, A | 2 |
| Urbano-Márquez, A | 1 |
| Moriai, T | 2 |
| Takeba, T | 1 |
| Makino, I | 1 |
| Bouillet, T | 1 |
| Lepage, E | 1 |
| Gisselbrecht, C | 1 |
| Boiron, M | 1 |
| Nomura, M | 1 |
| Kudou, J | 1 |
| Ishibashi, O | 1 |
| Niho, Y | 1 |
| Tsuruo, T | 1 |
| Sudo, Y | 1 |
| Asami, N | 1 |
| Morimoto, M | 1 |
| Poch, E | 1 |
| Darnell, A | 1 |
| Botey, A | 1 |
| Revert, L | 1 |
| Shu, YH | 1 |
| Seydel, HG | 1 |
| Stablein, DM | 1 |
| Kinzie, JJ | 1 |
| Thomas, PR | 1 |
| Watanabe, S | 1 |
| Mayama, M | 1 |
| Oguro, M | 1 |
| Wakatsuki, S | 1 |
| Majima, H | 1 |
| Watanabe, Y | 2 |
| Shimizu, J | 2 |
| Murakami, S | 2 |
| Tsubota, M | 1 |
| Iwa, T | 2 |
| Kitagawa, M | 1 |
| Mizukami, Y | 1 |
| Nonomura, A | 1 |
| Matsubara, F | 1 |
| Kiyozaki, H | 1 |
| Teranaka, M | 1 |
| Cullinan, S | 1 |
| Moertel, CG | 3 |
| Wieand, HS | 1 |
| Schutt, AJ | 2 |
| Krook, JE | 3 |
| Foley, JF | 2 |
| Norris, BD | 1 |
| Kardinal, CG | 1 |
| Tschetter, LK | 1 |
| Barlow, JF | 1 |
| Schein, PS | 5 |
| Chilvers, CE | 1 |
| Wils, J | 1 |
| Beretta, G | 1 |
| Bliss, JM | 1 |
| Rutten, A | 1 |
| Amadori, D | 1 |
| Cortes-Funes, H | 1 |
| Villar-Grimalt, A | 1 |
| Huang, DP | 1 |
| Wright, JC | 1 |
| Yasui, Y | 1 |
| Suzumori, K | 1 |
| Asai, H | 1 |
| Yagami, Y | 1 |
| Nakabayashi, T | 1 |
| Abe, S | 1 |
| Ohosaki, Y | 1 |
| Yoshimoto, J | 2 |
| Ochi, J | 2 |
| Tanahashi, T | 1 |
| Nanba, K | 1 |
| Saegusa, M | 1 |
| Hara, M | 1 |
| Akagi, T | 1 |
| Obama, T | 2 |
| Tsushima, T | 2 |
| Ozaki, Y | 1 |
| Kunitomo, K | 1 |
| Kawahito, M | 1 |
| Komi, N | 1 |
| Inoue, F | 1 |
| Takeda, I | 1 |
| Miyake, M | 1 |
| Mimura, H | 1 |
| Orita, K | 1 |
| Milliken, ST | 1 |
| Tattersall, MH | 1 |
| Woods, RL | 1 |
| Coates, AS | 1 |
| Levi, JA | 1 |
| Fox, RM | 1 |
| Raghavan, D | 1 |
| Weiner, SA | 1 |
| Aristizabal, S | 1 |
| Alberts, DS | 2 |
| Surwit, EA | 2 |
| Deatherage-Deuser, K | 1 |
| Sawada, H | 1 |
| Nakatani, K | 1 |
| Miyagi, N | 1 |
| Ezaki, T | 1 |
| Sugisaki, T | 1 |
| Watanabe, A | 2 |
| Nishiwada, T | 1 |
| Okumura, T | 1 |
| Shiratori, T | 1 |
| Konishi, Y | 1 |
| Lele, SB | 1 |
| Piver, MS | 1 |
| Yamashita, T | 1 |
| Vaughn, C | 1 |
| Chapman, J | 1 |
| Chinn, B | 1 |
| Ward, D | 1 |
| Groshko, G | 1 |
| Maniscalco, B | 1 |
| Reznik, S | 1 |
| Piper, D | 1 |
| Herait, P | 1 |
| Theodore, C | 1 |
| Kac, JL | 1 |
| Droz, JP | 1 |
| Lagler, U | 1 |
| Gattiker, HH | 1 |
| Smith, DE | 2 |
| Muff, NS | 2 |
| Shetabi, H | 2 |
| Stutz, FH | 1 |
| Eiesland, H | 1 |
| Lesesne, JB | 1 |
| Rothschild, N | 1 |
| Erickson, B | 1 |
| Korec, S | 1 |
| Sisk, R | 1 |
| Keller, J | 1 |
| Arbus, M | 1 |
| Woolley, PV | 3 |
| Chiazze, L | 1 |
| Stewart, FM | 1 |
| Harkins, BJ | 1 |
| Hahn, SS | 1 |
| Daniel, TM | 1 |
| Sivanesaratnam, V | 1 |
| Jayalakshmi, P | 1 |
| Thomas, G | 1 |
| Dembo, A | 1 |
| DePetrillo, A | 1 |
| Pringle, J | 1 |
| Ackerman, I | 1 |
| Bryson, P | 1 |
| Balogh, J | 1 |
| Osborne, R | 1 |
| Rosen, B | 1 |
| Fyles, A | 1 |
| Kawaura, Y | 1 |
| Munemoto, Y | 1 |
| Omura, K | 1 |
| Ishiguro, E | 1 |
| Sekido, N | 1 |
| Senapad, S | 1 |
| Neungton, S | 1 |
| Usavajindawath, C | 1 |
| Vijatrasil, S | 1 |
| Thaithanaisawanya, V | 1 |
| Saito, K | 1 |
| Nomura, S | 1 |
| Watarai, N | 1 |
| Hayashi, S | 1 |
| Tsuji, H | 2 |
| Kasugai, T | 1 |
| Taniwaki, S | 1 |
| Kureyama, Y | 1 |
| Mitsui, T | 1 |
| Masaoka, A | 1 |
| Kamejima, N | 1 |
| Allum, WH | 2 |
| Hallissey, MT | 2 |
| Ward, LC | 1 |
| Hockey, MS | 1 |
| Sakuramoto, K | 1 |
| Okajima, K | 1 |
| Iga, C | 1 |
| Nishimura, J | 1 |
| Toyoda, M | 1 |
| Kawashima, Y | 1 |
| Nagao, K | 1 |
| Baba, K | 1 |
| Nishimura, R | 1 |
| Matsuoka, Y | 1 |
| Ueno, Y | 1 |
| Morinaga, H | 1 |
| Nagase, H | 1 |
| Kawano, H | 1 |
| Otsuka, S | 1 |
| Tsubuku, Y | 1 |
| Kenmizaki, H | 1 |
| Tatekawa, I | 1 |
| Jin, ML | 1 |
| Inada, T | 1 |
| Inoue, S | 1 |
| Kuzuoka, M | 1 |
| Suto, A | 1 |
| Abe, O | 4 |
| Soga, K | 1 |
| Turuya, T | 1 |
| Toshima, M | 1 |
| Shibasaki, K | 1 |
| Matugi, H | 1 |
| Kawai, C | 1 |
| Asakura, H | 1 |
| Kelly, KA | 1 |
| Yokoyama, K | 1 |
| Takashima, T | 1 |
| Nozaki, M | 1 |
| Kurokawa, A | 1 |
| Belinson, JL | 1 |
| Stewart, JA | 1 |
| Richards, AL | 1 |
| McClure, M | 1 |
| Cullinan, SA | 2 |
| Rubin, JR | 1 |
| Everson, LK | 2 |
| Windschitl, HE | 2 |
| Twito, DI | 1 |
| Marschke, RF | 2 |
| Mukaiyama, T | 1 |
| Kuraishi, Y | 1 |
| Splinter, TA | 1 |
| Obertop, H | 1 |
| Kok, TC | 1 |
| Jeekel, J | 1 |
| Treat, J | 1 |
| Falchuk, SC | 1 |
| Tremblay, C | 1 |
| Spielman, M | 1 |
| Rouesse, J | 1 |
| Sevin, D | 1 |
| Le Chevalier, T | 1 |
| Punpae, P | 1 |
| Charoeniam, V | 1 |
| Ployleumsang, D | 1 |
| Issariyodom, P | 1 |
| Yamada, K | 2 |
| Saka, H | 1 |
| Palmer, KC | 1 |
| Mooradian, DL | 1 |
| Diglio, CA | 1 |
| Yoshida, H | 2 |
| Oishi, Y | 1 |
| Yanagawa, T | 1 |
| Yura, Y | 1 |
| Azuma, M | 1 |
| Hayashi, Y | 1 |
| Tsukiyama, I | 1 |
| Akine, Y | 1 |
| Kajiura, Y | 1 |
| Ogino, T | 1 |
| Yamashita, K | 1 |
| Egawa, S | 1 |
| Hijikata, J | 1 |
| Kitagawa, T | 1 |
| Pan, XY | 1 |
| Li, FQ | 1 |
| Yu, RJ | 1 |
| Xie, GF | 1 |
| Wang, H | 1 |
| Zhao, LY | 1 |
| Mira, JG | 1 |
| Taylor, SL | 1 |
| Chen, T | 1 |
| Oster, MW | 1 |
| Gray, R | 1 |
| Panasci, L | 1 |
| Perry, MC | 1 |
| Yokota, T | 1 |
| Kitamura, K | 1 |
| Suzuyama, H | 1 |
| Honda, M | 1 |
| Otsuji, E | 1 |
| Sawai, K | 1 |
| Sakita, M | 1 |
| Kotanagi, H | 1 |
| Moore, M | 1 |
| Klein, E | 1 |
| Sato, H | 1 |
| Iida, S | 1 |
| Yamada, T | 1 |
| Kobayashi, H | 1 |
| Kimoto, H | 1 |
| Tsunamura, Y | 1 |
| Ichihashi, T | 1 |
| Hashizume, Y | 1 |
| Yano, H | 1 |
| Nishiwaki, Y | 1 |
| Hayashibe, A | 1 |
| Honda, R | 1 |
| Kitaya, T | 1 |
| Matsuyama, T | 1 |
| Kakinuma, R | 1 |
| Nabeshima, K | 1 |
| Iwahashi, N | 1 |
| Fujii, J | 1 |
| Hada, T | 1 |
| Higashino, K | 1 |
| Koike, S | 1 |
| Kawakami, T | 1 |
| Ogawa, T | 1 |
| Naito, M | 1 |
| Yamamoto, Y | 1 |
| Moriwaki, S | 1 |
| Sadamoto, M | 1 |
| Arai, Y | 1 |
| Kido, C | 1 |
| Kanzawa, F | 1 |
| Matsushima, Y | 1 |
| Gatzemeier, U | 1 |
| Hossfeld, DK | 1 |
| Radenbach, D | 1 |
| Zschaber, R | 1 |
| Nakano, H | 1 |
| Saito, R | 1 |
| Takise, A | 1 |
| Minato, K | 2 |
| Takehara, K | 1 |
| Saruya, T | 1 |
| Kuwabara, H | 1 |
| Fueki, R | 1 |
| Homma, T | 1 |
| Yoneda, S | 1 |
| Nakata, M | 1 |
| Noguchi, Y | 1 |
| Takao, S | 1 |
| Ishizawa, T | 1 |
| Shimazu, H | 1 |
| Shaw, MT | 1 |
| Shaw, MK | 1 |
| Cartei, G | 1 |
| Guimaraes dos Santos, J | 1 |
| Kim, JP | 2 |
| Nakagawa, S | 1 |
| Shiraishi, T | 1 |
| Harima, K | 1 |
| Sawada, S | 1 |
| Kobayashi, S | 1 |
| McCarthy, JT | 1 |
| Staats, BA | 1 |
| Takami, H | 2 |
| Okuda, K | 1 |
| Yamataka, K | 1 |
| Ishimura, Y | 1 |
| Chow, S | 1 |
| Roscoe, J | 1 |
| Cattran, DC | 1 |
| de Riese, W | 1 |
| Aeikens, B | 1 |
| Lenis, G | 1 |
| Schindler, E | 1 |
| Watase, M | 1 |
| Iijima, S | 1 |
| Umeshita, K | 1 |
| Sakon, M | 1 |
| Shimano, T | 1 |
| Okamura, J | 1 |
| Sheldon, R | 1 |
| Slaughter, D | 1 |
| Nosou, Y | 1 |
| Yanagawa, E | 1 |
| Kuramoto, J | 1 |
| Claycomb, CL | 1 |
| Berkovic, M | 1 |
| Pasterz, R | 1 |
| Savaraj, N | 1 |
| Burgess, M | 1 |
| Sohmura, Y | 1 |
| Takebe, T | 1 |
| Ohyama, K | 1 |
| Sekino, H | 1 |
| Sugiyama, K | 1 |
| Miyazaki, I | 2 |
| Hisazumi, H | 1 |
| Saitoh, Y | 2 |
| Kiura, K | 1 |
| O'Connell, MJ | 1 |
| Hahn, RG | 1 |
| Kondo, T | 1 |
| Imaizumi, M | 1 |
| Kitano, M | 1 |
| Suzuki, M | 2 |
| Shimokawa, K | 2 |
| Tsuya, H | 1 |
| Ohashi, H | 2 |
| Hostetter, AL | 1 |
| Tubbs, RR | 1 |
| Ziegler, T | 1 |
| Gephardt, GN | 1 |
| McMahon, JT | 1 |
| Schreiber, MJ | 1 |
| Lam, WK | 2 |
| So, SY | 2 |
| Kung, TM | 1 |
| Sham, MK | 1 |
| Ip, M | 2 |
| Yashige, H | 1 |
| Inazawa, J | 1 |
| Yokota, S | 1 |
| Nishigaki, H | 1 |
| Horiike, S | 1 |
| Taniwaki, M | 1 |
| Misawa, S | 1 |
| Abe, T | 1 |
| Sadamoto, Y | 1 |
| Haruma, K | 1 |
| Tokumo, K | 1 |
| Teshima, H | 1 |
| Sumii, K | 1 |
| Kajiyama, G | 1 |
| Yamashita, Y | 1 |
| Iwase, H | 1 |
| Morise, K | 1 |
| Ina, K | 1 |
| Masuda, T | 4 |
| Ohashi, M | 1 |
| Bush, JA | 1 |
| Long, BH | 1 |
| Catino, JJ | 1 |
| Bradner, WT | 1 |
| Tomita, K | 2 |
| Yasunaga, C | 1 |
| Komota, T | 1 |
| Mimura, K | 1 |
| Kinjyo, M | 1 |
| Sueishi, K | 1 |
| Hirose, T | 1 |
| Ishibashi, H | 1 |
| Nakajima, H | 1 |
| Ioka, J | 1 |
| Shirono, K | 1 |
| Tanabe, S | 1 |
| Ochiai, K | 1 |
| Yoshida, Y | 1 |
| Kosaki, G | 1 |
| D'Elia, JA | 1 |
| Aslani, M | 1 |
| Schermer, S | 1 |
| Cloud, L | 1 |
| Bothe, A | 1 |
| Dzik, W | 1 |
| Cantor, RJ | 1 |
| Weiss, SM | 1 |
| Rosato, FE | 1 |
| Sasai, T | 1 |
| Kamano, T | 1 |
| Fukuyama, E | 1 |
| Suwa, T | 1 |
| Miyoshi, K | 1 |
| Oda, K | 1 |
| Mergenthaler, HG | 1 |
| Binsack, T | 1 |
| Wilmanns, W | 1 |
| Tonouchi, H | 1 |
| Takeuchi, K | 1 |
| Iriyama, K | 1 |
| Toma, H | 1 |
| Nakamura, R | 1 |
| Onitsuka, S | 1 |
| Goya, N | 1 |
| Nakazawa, H | 1 |
| Uchiyama, K | 1 |
| Takada, T | 1 |
| Yasuda, H | 1 |
| Hasegawa, H | 1 |
| Misu, Y | 1 |
| Shikata, J | 1 |
| Kozakai, M | 1 |
| Marée, D | 1 |
| Monk, BJ | 1 |
| Graham, V | 1 |
| Shioda, Y | 1 |
| Koizumi, S | 1 |
| Furuya, S | 1 |
| Tokunaga, A | 1 |
| Onda, M | 1 |
| Yoshikawa, T | 1 |
| Awane, Y | 1 |
| Sasaki, J | 1 |
| Nehashi, Y | 1 |
| Omote, Y | 1 |
| Haghbin, M | 1 |
| Hinson, J | 1 |
| de Insausti, CL | 1 |
| Gutiérrez, LE | 1 |
| Nishiyama, M | 1 |
| Kim, R | 1 |
| Saeki, T | 1 |
| Takagami, S | 1 |
| Kirihara, Y | 1 |
| Jinushi, K | 1 |
| Hayano, K | 1 |
| Fukui, H | 1 |
| Hattori, S | 1 |
| Housholder, DF | 1 |
| Hynes, HE | 1 |
| Dakhil, SR | 1 |
| Marymont, JV | 1 |
| van der Gaast, A | 1 |
| Verweij, J | 1 |
| Planting, AS | 1 |
| Stoter, G | 1 |
| Kita, M | 1 |
| Ahlgren, JD | 2 |
| Cazap, E | 1 |
| Estevez, RA | 1 |
| Marantz, A | 1 |
| Wilcosky, T | 1 |
| Stein, J | 1 |
| Purvis, JD | 1 |
| Budd, GT | 1 |
| Finkelstein, DM | 1 |
| Ettinger, DS | 1 |
| Ruckdeschel, JC | 1 |
| Goldberg, RM | 1 |
| Ueno, W | 1 |
| Shinde, SR | 1 |
| Shaha, PB | 1 |
| Shetty, PA | 1 |
| Henderson, A | 1 |
| Shepherd, FA | 1 |
| Evans, WK | 1 |
| Burkes, R | 1 |
| Paul, K | 1 |
| DeBoer, G | 1 |
| Kasimis, BS | 1 |
| Miller, JB | 1 |
| Kaneshiro, CA | 1 |
| Forbes, KA | 1 |
| Moran, EM | 1 |
| Metter, GE | 1 |
| Jett, JR | 1 |
| Dalton, RJ | 1 |
| Brunk, FS | 1 |
| Laurie, JA | 1 |
| Hagin, GD | 1 |
| Jain, A | 1 |
| Wernz, JC | 1 |
| Kao, AK | 1 |
| Muggia, FM | 1 |
| Asbury, RF | 1 |
| Okuda, Y | 1 |
| Kreider, JW | 1 |
| Howell, LE | 1 |
| Bartlett, GL | 1 |
| Yu, DY | 1 |
| Cantrell, JE | 1 |
| Phillips, TM | 1 |
| Jewell, LD | 1 |
| Fields, AL | 1 |
| Murray, CJ | 1 |
| Thomson, AB | 1 |
| Shibuya, K | 1 |
| Ashizawa, J | 1 |
| Horinishi, H | 1 |
| Matsuda, A | 1 |
| Ishizuka, M | 1 |
| Umezawa, H | 1 |
| Miyata, R | 1 |
| Takegawa, S | 1 |
| Kamata, T | 1 |
| Sawa, T | 1 |
| Saito, Y | 1 |
| Lefebvre, B | 1 |
| Petras, RE | 1 |
| Hart, WR | 1 |
| Itoh, J | 1 |
| Narisawa, T | 1 |
| Koyama, K | 1 |
| Shigemitsu, M | 1 |
| Joya, K | 1 |
| Hara, S | 1 |
| Hanawa, S | 1 |
| Parker, EF | 1 |
| Marks, RD | 1 |
| Kratz, JM | 1 |
| Chaikhouni, A | 1 |
| Warren, ET | 1 |
| Bartles, DM | 1 |
| Moriya, Y | 1 |
| Shimoyama, M | 1 |
| Itabashi, M | 1 |
| Weber-Stadelmann, W | 1 |
| Takahashi, M | 1 |
| Hirabayashi, N | 1 |
| Ohkita, T | 1 |
| Ishiwata, J | 1 |
| Iwamoto, S | 1 |
| Koike, M | 1 |
| Maeda, Y | 1 |
| Takeshita, Y | 1 |
| Tanaka, Y | 1 |
| Higashino, Y | 1 |
| Kato, M | 1 |
| Asano, E | 1 |
| Akimoto, R | 1 |
| Uchida, H | 1 |
| Mukawa, A | 1 |
| Nagakawa, T | 1 |
| Nasu, Y | 1 |
| Matsumura, Y | 1 |
| Ohmori, H | 1 |
| Adachi, K | 1 |
| Yamazaki, H | 1 |
| Tada, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Perioperative Systemic Therapy and Cytoreductive Surgery With HIPEC Versus Upfront Cytoreductive Surgery With HIPEC Alone for Isolated Resectable Colorectal Peritoneal Metastases: a Multicentre, Open-label, Parallel-group, Phase II-III, Randomised Superio[NCT02758951] | Phase 2/Phase 3 | 358 participants (Anticipated) | Interventional | 2017-06-01 | Recruiting | ||
| A Phase II Study of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Gastric Carcinomatosis or Positive Cytology[NCT02092298] | Phase 2 | 21 participants (Actual) | Interventional | 2014-05-08 | Completed | ||
| Observational Study on Second Line Treatment of Colorectal Liver Metastases (KRas wt) by Hepatic Intra-arterial Chemoembolization With Dc Beads 70-150 μm Microspheres Preloaded With Irinotecan 200 Mgr Plus Systemic Cetuximab[NCT01891552] | 40 participants (Actual) | Observational [Patient Registry] | 2013-05-31 | Completed | |||
| Phase I Study of Daily RAD001 Administered Orally in Combination With Mitomycin C, Administered Every Three Weeks to Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric Junction[NCT01042782] | Phase 1 | 16 participants (Actual) | Interventional | 2008-01-31 | Completed | ||
| Diagnostic Value of Diffusion-weighted Magnetic Resonance Imaging for Detection of Peritoneal Recurrence in Patients With High-risk Colorectal and Appendiceal Neoplasms : a Pilot Study[NCT05623787] | 30 participants (Anticipated) | Interventional | 2022-09-01 | Recruiting | |||
| Cytoreductive Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy for the Treatment of Peritoneal Carcinomatosis From Gastrointestinal Cancer: an Open Label, Randomized, Prospective, Phase 2 Clinical Trial[NCT00454519] | Phase 2 | 60 participants (Anticipated) | Interventional | 2007-03-31 | Recruiting | ||
| Phase II Randomized Trial of Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer[NCT00201747] | Phase 2 | 80 participants (Actual) | Interventional | 2001-09-30 | Completed | ||
| A Prospective,Multicentral,Open-label,Randomized,Controlled,Phase III Clinical Trial to Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB.[NCT02736552] | Phase 3 | 0 participants (Actual) | Interventional | 2016-03-31 | Withdrawn | ||
| A Phase II Study of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Combined With Sintilimab in Gastric Cancer With Peritoneal Metastasis[NCT05648487] | Phase 2 | 46 participants (Anticipated) | Interventional | 2023-01-01 | Not yet recruiting | ||
| Randomized Controlled Trial of the Efficacy of Adjuvant Chemotherapy in Patients With Residual Lesions After Concurrent Radiochemotherapy for Locally Advanced Cervical Cancer[NCT04409860] | 120 participants (Anticipated) | Interventional | 2020-05-26 | Recruiting | |||
| A Pilot Study Using Neoadjuvant Proton Beam Radiation Therapy and Chemotherapy for Marginally Resectable Carcinoma of the Pancreas[NCT00763516] | 8 participants (Actual) | Interventional | 2009-02-28 | Completed | |||
| A Phase II Trial of Infusional 5-Fluorouracil (5-FU), Calcium Leucovorin (LV), Mitomycin-C (Mito-C), and Dipyridamole (D) in Patients With Locally Advanced Unresected Pancreatic Adenocarcinoma[NCT00003018] | Phase 2 | 54 participants (Actual) | Interventional | 1997-09-30 | Completed | ||
| A Prospective, Single-arm Study of Simultaneous Modulated Accelerated Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Carcinoma.[NCT02606916] | Phase 2 | 42 participants (Actual) | Interventional | 2015-07-31 | Completed | ||
| A Prospective, Multicentral, Open-label, Randomized, Controlled Clinical Trial to Investigation the Value of Extensive Intraoperative Peritoneal Lavage After Curative Gastrectomy for Locally Advanced Gastric Cancer[NCT02745509] | 508 participants (Actual) | Interventional | 2016-03-31 | Completed | |||
| Phase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal Seeding[NCT00539877] | Phase 1 | 17 participants (Actual) | Interventional | 2004-10-31 | Completed | ||
| A Multicenter Observational and Feasibility Study of Excision of Superficially Invasive Squamous Cell Carcinoma (SISCCA) of the Anal Canal and Perianus in HIV-Infected Persons[NCT02437851] | Phase 2 | 16 participants (Actual) | Interventional | 2015-04-30 | Active, not recruiting | ||
| Double Lung Transplant REgistry Aimed for Lung-limited Malignancies (DREAM) - a Prospective Observational Registry Study for Patients Undergoing Lung Transplantation for Medically Refractory Cancers Confined to the Lungs[NCT05671887] | 125 participants (Anticipated) | Observational [Patient Registry] | 2022-11-16 | Recruiting | |||
| A Study Using Photon/Proton Beam Radiation Therapy and Chemotherapy for Unresectable Carcinoma of the Pancreas[NCT00685763] | 13 participants (Actual) | Interventional | 2008-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Primary objective of study is to assess overall survival (OS) in subjects with stage IV gastric cancer representing positive cytology or imaging occult carcinomatosis after laparoscopic hyperthermic intraperitoneal chemotherapy administration. Overall survival measured from time of laparoscopic HIPEC. Patterns of tumor recurrence and survival assessed by reviewing routine surveillance CT scans. Overall survival time estimated using the Kaplan-Meier method. (NCT02092298)
Timeframe: Between the second and sixth week after treatment, up to 5 years
| Intervention | Months (Median) |
|---|---|
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | 30.2 |
Primary objective of study is to assess overall survival (OS) in subjects with stage IV gastric cancer representing positive cytology or imaging occult carcinomatosis after the first laparoscopic HIPEC. Patterns of tumor recurrence and survival assessed by reviewing routine surveillance CT scans. Overall survival time estimated using the Kaplan-Meier method. (NCT02092298)
Timeframe: From the day of surgery, until the last day of follow up, until death, up to 5 years
| Intervention | Months (Median) |
|---|---|
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | 20.3 |
(NCT00685763)
Timeframe: 1 year following the completion of radiation therapy
| Intervention | participants (Number) |
|---|---|
| Proton Radiation and Chemotherapy | 0 |
23 reviews available for mitomycin and Adenocarcinoma
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Appendiceal tumors with glandular and neuroendocrine features exhibiting peritoneal metastases - Critical evaluation of outcome following cytoreductive surgery with perioperative chemotherapy.
Topics: Adenocarcinoma; Administration, Intravenous; Adult; Aged; Antineoplastic Combined Chemotherapy Proto | 2021 |
Update on treatment advances in combined-modality therapy for anal and rectal carcinomas.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anus Neoplasms; Bevacizum | 2011 |
[Chemotherapy with mitomycin C, etoposide and cisplatin for adenocarcinoma of the uterine cervix].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; E | 2004 |
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Sm | 1983 |
The biology and treatment of superficial bladder cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; BCG Vaccine; Carcinoma, Squamous Cell; Carcinoma, Trans | 1984 |
Adjuvant therapy for colon adenocarcinoma: current status of clinical investigation.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Chemotherapy, Adjuvant; | 1994 |
Combined radiotherapy and chemotherapy in the management of local-regionally advanced vulvar cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cisplatin; Combined Modali | 1993 |
Mitomycin therapy in gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Humans; M | 1993 |
[Chemotherapy for advanced adenocarcinoma of the skin: experience with combination chemotherapy and a review of the literature].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Sch | 1997 |
Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Drug Administration Schedule; F | 1997 |
Treatment of advanced and metastatic pancreatic cancer.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cis | 1998 |
[Irinotecan in combination for colon cancer].
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; C | 1998 |
Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus | 1999 |
Chemotherapy of advanced or recurrent cervical carcinoma with a consecutive low-dose cisplatin combined with bleomycin, vincristine, and mitomycin-C (consecutive low-dose BOMP).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleo | 2000 |
[A case of gastric cancer with multiple liver metastases that were completely responsive to hepatic arterial infusion chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirub | 2001 |
[Systemic chemotherapy in metastatic colorectal adenocarcinomas].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Fem | 1992 |
[Uremic hemolytic syndrome induced by mitomycin C. Presentation of a series of 5 cases and review of the literature].
Topics: Adenocarcinoma; Aged; Female; Gastrointestinal Neoplasms; Hemolytic-Uremic Syndrome; Humans; Male; M | 1990 |
Update in cancer chemotherapy, Part III: Lung cancer, Part 1.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Bleomycin; Carcinoma; C | 1985 |
Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry.
Topics: Adenocarcinoma; Female; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Mitomycin; Mitomycins; | 1989 |
[5-Fluorouracil, adriamycin, and mitomycin C (FAM) combination chemotherapy in adenocarcinoma of the parotid gland].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Doxorubicin; | 1989 |
Hemolytic-uremic syndrome and acute renal failure in metastatic adenocarcinoma treated with mitomycin: case report and literature review.
Topics: Acute Kidney Injury; Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast N | 1987 |
Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy.
Topics: Adenocarcinoma; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasm | 1988 |
136 trials available for mitomycin and Adenocarcinoma
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Phase I Trial of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) with Cisplatin, Mitomycin, and Paclitaxel in Patients with Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Cisplatin; Combined M | 2020 |
Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical Trial.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Cap | 2021 |
Lessons learned from a phase II clinical trial of laparoscopic HIPEC for gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Cisplatin; Gastrectomy; Humans; Hyperthermia, Induced; Laparo | 2018 |
Mitomycin C hypoxic pelvic perfusion for unresectable recurrent rectal cancer: pharmacokinetic comparison of surgical and percutaneous techniques.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Squamous Cel | 2017 |
Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dose | 2013 |
Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK/01/004).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemo | 2013 |
Mitomycin C and capecitabine in pretreated patients with metastatic gastric cancer: a multicenter phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycyti | 2014 |
A clinical Comparison of Lobaplatin or Cisplatin with Mitomycine and Vincristine in Treating Patients with Cervical Squamous Carcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; | 2015 |
Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms | 2016 |
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma | 2009 |
Combination therapy with mitomycin C (NSC-26980), 5-fluorouracil (NSC-19893), and cytosine arabinoside (NSC-63878) for advanced cancer in man.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Colorectal | 1972 |
Effect of multiple-phase regional intra-arterial infusion chemotherapy on patients with resectable pancreatic head adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Gemcitabine | 2009 |
Second-line treatment with a combination of continuous 5-fluorouracil, doxorubicin, and mitomycin-C (conti-FAM) in gemcitabine-pretreated pancreatic and biliary tract cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms | 2009 |
A phase II study of intra-arterial chemotherapy of 5-fluorouracil, cisplatin, and mitomycin C for advanced nonresectable gastric cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; | 2009 |
A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring | 2010 |
Effect of preoperative intraperitoneal injection of Sapylin in advanced gastric cancer.
Topics: Adenocarcinoma; Aged; Anastomotic Leak; Antibiotics, Antineoplastic; Antineoplastic Agents; Biologic | 2010 |
Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Carcin | 2010 |
No survival benefit from postoperative adjuvant chemotherapy after D2 radical resection for the patients with stage II gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 2011 |
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 2011 |
Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Appendiceal Neoplasms; Chemotherapy, Adjuvant; Chemoth | 2013 |
High-dose 5-fluorouracil / folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. A phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Do | 2002 |
A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer.
Topics: Adenocarcinoma; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle | 2002 |
Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy | 2003 |
Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; B | 2003 |
Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cell Differe | 2003 |
Phase II study of irinotecan and mitomycin C in 5-fluorouracil-pretreated patients with advanced colorectal and gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chi-Squar | 2003 |
Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Carboplatin; C | 2003 |
Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Sch | 2003 |
Phase III study of mitomycin-C with protracted venous infusion or circadian-timed infusion of 5-fluorouracil in advanced colorectal carcinoma.
Topics: Adenocarcinoma; Antineoplastic Agents; Circadian Rhythm; Colorectal Neoplasms; Fluorouracil; Humans; | 2004 |
Pegylated liposomal doxorubicin in combination with mitomycin C, infusional 5-fluorouracil and sodium folinic acid. A phase-I-study in patients with upper gastrointestinal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cholangiocarcinoma; Dox | 2004 |
Low thymidylate synthase expression in the primary tumor predicts favorable clinical outcome in resected gastric cancer patients treated with adjuvant tegafur.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antimetabolites, A | 2004 |
Salvage chemotherapy with mitomycin, docetaxel, and irinotecan (MDI regimen) in metastatic pancreatic adenocarcinoma: a phase I and II trial.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytoge | 2004 |
Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Duodenal Neoplas | 2005 |
A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 2005 |
[Multicenter comparative study of the recurrence-inhibitory effect of oral fluoropyrimidine drugs in patients with colorectal cancer following curative resection].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Pr | 2005 |
Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Disease-F | 2005 |
Significance of histologic type of primary lesion and metastatic lymph nodes as a prognostic factor in stage III colon cancer.
Topics: Adenocarcinoma; Alkylating Agents; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colonic | 2006 |
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Antibiotics, Antineoplastic; Antineoplastic Combined Chemo | 2006 |
Mitomycin C and Vinorelbine for second-line chemotherapy in NSCLC--a phase II trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce | 2007 |
Mitomycin C plus infusional 5-fluorouracil in platinum-refractory gastric adenocarcinoma: an extended multicenter phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Do | 2007 |
Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dipy | 2007 |
Mitomycin-C/5-fluorouracil/leucovorin and hyperfractionated radiation therapy for rectal carcinoma: a phase II study with long-term follow-up.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dise | 2007 |
Combined modality chemoradiation in elderly oesophageal cancer patients.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 2007 |
Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptotheci | 2006 |
ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; | 2007 |
Treatment with secretin and a cholecystokinin-like peptide in patients with pancreatic cancer. A pilot study.
Topics: Adenocarcinoma; Aged; Alanine Transaminase; Alkaline Phosphatase; Amylases; Antineoplastic Combined | 1984 |
[Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Bleomycin; | 1984 |
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Sm | 1983 |
MIFA III (mitomycin-C, 5-fluorouracil, and adriamycin) chemotherapy for advanced adenocarcinoma of the pancreas.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Doxo | 1984 |
[Sex hormone dependency and endocrine therapy in diffuse carcinoma of the stomach].
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Male; Mice; | 1983 |
Randomized study of combination chemotherapy in unresectable gastric cancer. The Gastrointestinal Tumor Study Group.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Doxorubici | 1984 |
Drug combinations in the treatment of gastric adenocarcinoma: a randomized Southwest Oncology Group study.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Sch | 1984 |
An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Fl | 1984 |
Preliminary research on the evaluation of some prognostic factors in a randomized study of adjuvant immunochemotherapy in colorectal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Colonic Ne | 1984 |
Pharmaceutics: mitomycin C: a brief review.
Topics: Adenocarcinoma; Clinical Trials as Topic; Humans; Mitomycin; Mitomycins; Pancreatic Neoplasms; Stoma | 1982 |
[Results of a combination of platinum-vindesin-ametycin-bleomycin (CEMB) in the treatment of stage IV non-small-cell lung cancers].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, N | 1993 |
Combination chemotherapy of 5-fluorouracil, epidoxorubicin and mitomycin C in the palliative treatment of locally advanced and/or metastatic adenocarcinoma of the stomach.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Epir | 1994 |
Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Mod | 1995 |
Induction chemotherapy and irradiation in advanced carcinoma of the cervix.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined M | 1995 |
Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Biotransformation; Bone Marrow Diseases; Carcino | 1995 |
Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: results of sequential nonrandomized phase II studies.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Comb | 1995 |
Preoperative high-dose radiation and chemotherapy in adenocarcinoma of the esophagus and esophagogastric junction.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Eso | 1994 |
Preoperative intra-arterial mitomycin-C in the management of sigmoid adenocarcinoma: long-term results of a pilot study.
Topics: Adenocarcinoma; Adult; Aged; Chemotherapy, Adjuvant; Female; Humans; Incidence; Infusions, Intra-Art | 1994 |
Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Appendicea | 1995 |
A randomized study of bolus fluorouracil plus folinic acid versus 21-day fluorouracil infusion alone or in association with cyclophosphamide and mitomycin C in advanced colorectal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; C | 1995 |
[The usefulness of pre- and immediately postoperative chemotherapy in colorectal cancer].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, | 1994 |
Effectiveness of chemotherapy for advanced adenocarcinoma of the pancreas in combined modality therapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Autonomic Nerve Block; Celiac Plexus; Combined Modal | 1994 |
Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 1994 |
[Status of portal perfusion in colorectal cancer. Swiss Study Group for Clinical Cancer Research].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal N | 1994 |
Doxorubicin, mitomycin C and 5-fluorouracil in the treatment of hormone refractory adenocarcinoma of the prostate: a Southwest Oncology Group study.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Humans; M | 1993 |
Combined radiotherapy and chemotherapy in the management of local-regionally advanced vulvar cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cisplatin; Combined Modali | 1993 |
Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study.
Topics: Adenocarcinoma; Adult; Aged; Chemotherapy, Adjuvant; Combined Modality Therapy; Duodenal Neoplasms; | 1993 |
A phase II trial of mitomycin C, 5-fluorouracil and radiation therapy in the treatment of unresectable non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce | 1993 |
Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. A Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorourac | 1993 |
[The chemoradiotherapy of advanced colorectal carcinoma--the results and toxicity in a pilot study with 44 patients].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colo | 1993 |
Antitumor effect and survival benefit of chemotherapy for unresectable advanced gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Humans; Mitomycin; Stomach Neoplasms | 1993 |
Preoperative concurrent 5-fluorouracil infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Comb | 1993 |
Mitomycin therapy in gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Humans; M | 1993 |
Comparison of single-agent epirubicin and 5-fluorouracil/epirubicin/mitomycin in patients with advanced adenocarcinoma of the pancreas.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Flu | 1993 |
Adjuvant immunotherapy with interleukin 2 and lymphokine-activated killer cells after noncurative resection of primary lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce | 1995 |
Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherap | 1995 |
Prognostic factors in resectable gastric cancer: results of EORTC study no. 40813 on FAM adjuvant chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; | 1995 |
Phase II study of mitomycin, ifosfamide and cisplatin in adenocarcinoma of the oesophagus.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 1996 |
Regional chemotherapy for inoperable pancreatic carcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Infusi | 1996 |
Adjuvant chemo-immunotherapy after curative resection of Stage II and IIIA primary lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 1996 |
[Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 1996 |
A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tract.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemot | 1997 |
[Clinical evaluation of intra-arterial infusion chemotherapy for advanced or recurrent cervical cancer with or without radiotherapy].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamou | 1997 |
Advanced carcinoma of the pancreas: phase II study of combined chemotherapy, beta-interferon, and retinoids.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Diterpenes; Epirubicin; | 1998 |
Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology.
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Charcoal; Chemotherapy, Adjuvant; Disease-Free Su | 1998 |
Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology.
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Charcoal; Chemotherapy, Adjuvant; Disease-Free Su | 1998 |
Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology.
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Charcoal; Chemotherapy, Adjuvant; Disease-Free Su | 1998 |
Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology.
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Charcoal; Chemotherapy, Adjuvant; Disease-Free Su | 1998 |
OK-432 and 5-fluorouracil, doxorubicin, and mitomycin C (FAM-P) versus FAM chemotherapy in patients with curatively resected gastric carcinoma: a randomized Phase III trial.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-F | 1998 |
Induction chemotherapy for T4 centrally located non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce | 1999 |
[Results of intraperitoneal active charcoal-mitomycin C therapy of stomach carcinoma with serosa invasion].
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Charcoal; Chemotherapy, Cancer, Regional P | 1998 |
[Influence of preoperative on gastric cancer tissues and cells].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 1997 |
Neoadjuvant intraarterial infusion chemotherapy in patients with stage IB2-IIIB cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, S | 2000 |
Neoadjuvant radio-chemotherapy in advanced primarilynon-resectable carcinomas of the pancreas.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Dose Fractionation, Radiation; Fluor | 2000 |
Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deo | 2001 |
Mitomycin C with weekly 24-h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract and periampullar carcinomas.
Topics: Adenocarcinoma; Adult; Aged; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Bilia | 2001 |
Phase II study of epirubicin, mitomycin C, and 5-fluorouracil in hormone-refractory prostatic carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoembr | 2001 |
Combined results from three phase II trials of neoadjuvant chemotherapy in operable adenocarcinoma of the oesophagus.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisp | 2001 |
[Clinical study on treatment of mid-late stage gastric carcinoma by composite xiansu capsule combined with chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Caps | 1999 |
Randomized phase II study of irinotecan plus mitomycin C vs. oxaliplatin plus mitomycin C in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorecta | 2002 |
A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; | 2002 |
Local injection of M-CH combined with i.p. hyperthermic hypo-osmolar infusion is an effective therapy in advanced gastric cancer.
Topics: Adenocarcinoma; Charcoal; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Injectio | 2002 |
Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Immunity, | 1992 |
Carboplatin, vinblastine and mitomycin-C in the treatment of non-small cell bronchogenic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, | 1992 |
Treatment of malignant peritoneal effusion in digestive and ovarian cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Cisplati | 1992 |
A phase II clinical trial evaluating the use of two sequential, four-drug combination chemotherapy regimens in ambulatory bronchogenic adenocarcinoma patients.
Topics: Adenocarcinoma; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchog | 1992 |
Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzaldehydes; Drug Eva | 1992 |
[Comparative study of UFT plus mitomycin C and UFT plus doxorubicin in adenocarcinoma. Hirosaki Cooperative Group of Cancer Chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Proto | 1992 |
[Multihospital co-operative study of post-operative adjuvant chemotherapy in the treatment of gastric cancer-(Part 3). Comparisons between tegafur and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Admi | 1991 |
Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Pro | 1991 |
The benefit of cisplatin-based polychemotherapy for adenocarcinoma of the lung. The Kyushu Lung Cancer Chemotherapy Study Group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Tri | 1990 |
A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Proto | 1990 |
A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Combined Mo | 1990 |
[A randomized trial with various combinations of cis-platinum (CDDP), mitomycin C (MMC), peplomycin (PEP) and ftorafur (FT) in the treatment of non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, N | 1986 |
Metastatic adenocarcinoma of unknown primary site. A randomized study of two combination chemotherapy regimens.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; C | 1987 |
A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, S | 1988 |
Activity of 5-fluorouracil, mitomycin C, and methyl CCNU in inoperable adenocarcinoma of pancreas.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Alkylating Agents; Antineoplastic Combined Chemother | 1989 |
A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British Stomach Cancer Group.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Mo | 1989 |
[Combined UFTM for 140 patients with advanced gastric cancer].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Ch | 1989 |
Adjuvant chemotherapy in operable gastric cancer. 5 year follow-up of first British Stomach Cancer Group trial.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy | 1989 |
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Costs and | 1985 |
Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Fl | 1986 |
Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Admin | 1986 |
[Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Ca | 1985 |
Phase-III clinical trial of adjuvant FAM2 (5-FU, adriamycin and mitomycin C) vs control in resectable gastric cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topi | 1988 |
Immunochemosurgery as a new approach to reasonable treatment of advanced cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Clinical Trials | 1988 |
5-fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy in advanced adenocarcinoma of the lung: comparison of two dosage schedules.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Admin | 1987 |
Combined modality treatment of localized unresectable adenocarcinoma of the pancreas.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Clinical Trials as To | 1988 |
[UFT + MMC and UFT + ACNU therapy in advanced gastric cancer].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; C | 1988 |
FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the Pan American Health Organization.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topi | 1987 |
Cyclophosphamide versus 5-fluorouracil, doxorubicin, and mitomycin C (FAM') in the treatment of hormone-resistant metastatic carcinoma of the prostate: a preliminary report of a randomized trial.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; | 1985 |
A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, S | 1985 |
The need for pilot studies and surgery-only controls in adjuvant therapy trials for large-bowel cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topi | 1985 |
478 other studies available for mitomycin and Adenocarcinoma
| Article | Year |
|---|---|
A Combination of Chemotherapy and Oncolytic Virotherapy Sensitizes Colorectal Adenocarcinoma to Immune Checkpoint Inhibitors in a cDC1-Dependent Manner.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Basic-Leucine Zipper Transcription Factors; Cell Lin | 2022 |
Efficacy and safety of preoperative 5-fluorouracil, cisplatin, and mitomycin C in combination with radiotherapy in patients with resectable and borderline resectable pancreatic cancer: a long-term follow-up study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2019 |
Scrotal ulceration: a complication of hyperthermic intraperitoneal chemotherapy and subsequent treatment with dimethyl sulfoxide.
Topics: Adenocarcinoma; Administration, Cutaneous; Antibiotics, Antineoplastic; Appendiceal Neoplasms; Dimet | 2019 |
shRNA-mediated inhibition of PhosphoGlycerate Kinase 1 (PGK1) enhances cytotoxicity of intraperitoneal chemotherapy in peritoneal metastasis of gastric origin.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Fluorou | 2020 |
Long-term survival after hyperthermic intraperitoneal chemotherapy using mitomycin C or oxaliplatin in colorectal cancer patients with synchronous peritoneal metastases: A nationwide comparative study.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antineoplastic Agents; Colorectal Neoplasms; Cytored | 2020 |
Peritoneal carcinomatosis of unknown primary site, a study of 25 patients over 30 years.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; | 2020 |
Predicting Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendix Adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Appendiceal Neoplasms; Colectomy; Cytoredu | 2018 |
Toxicity, Tolerability, and Compliance of Concurrent Capecitabine or 5-Fluorouracil in Radical Management of Anal Cancer With Single-dose Mitomycin-C and Intensity Modulated Radiation Therapy: Evaluation of a National Cohort.
Topics: Adenocarcinoma; Aged; Anus Neoplasms; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy; Coh | 2018 |
Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Agents; Biomarke | 2013 |
A rash decision?
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Diagnosis, Differential; Esophageal Neoplasms; Exanthem | 2013 |
ERCC1 expression does not predict survival and treatment response in advanced stage non-small cell lung cancer cases treated with platinum based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carb | 2013 |
Non-randomized comparison between irinotecan plus mitomycin C and irinotecan alone in patients with advanced gastric cancer refractory to fluoropyrimidine and platinum.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptotheci | 2013 |
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: an emerging treatment option for advanced goblet cell tumors of the appendix.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Appendiceal Neoplasms; Carcinoembryonic Antigen; Carcin | 2014 |
Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus | 2014 |
Rapamycin-enhanced mitomycin C-induced apoptotic death is mediated through the S6K1-Bad-Bak pathway in peritoneal carcinomatosis.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Apoptosis; bcl-2 Homologous Antagonist-Killer | 2014 |
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for gallbladder cancer: a retrospective review.
Topics: Abdominal Cavity; Abdominal Neoplasms; Adenocarcinoma; Adult; Antineoplastic Agents; Chemotherapy, C | 2014 |
Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus | 2014 |
O-MAX chemotherapy: high activity in metastatic esophagogastric adenocarcinoma and possible relation to subclinical hemolysis.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycyti | 2014 |
Clinical outcomes in pancreatic adenocarcinoma associated with BRCA-2 mutation.
Topics: Adenocarcinoma; Antineoplastic Agents; BRCA2 Protein; Enzyme Inhibitors; Female; Humans; Jews; Male; | 2015 |
Utility of Chemoresponse Assay in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytoreductio | 2015 |
Does the timing of adjuvant chemotherapy for gastric cancer influence patient outcome?
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Mod | 2015 |
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma.
Topics: Adenocarcinoma; Aged; Albumin-Bound Paclitaxel; Antineoplastic Combined Chemotherapy Protocols; Carb | 2015 |
Mitomycin C Pharmacokinetics as Predictor of Severe Neutropenia in Hyperthermic Intraperitoneal Therapy.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Proto | 2015 |
Hyperthermic intraperitoneal chemotherapy with cisplatin: Amifostine prevents acute severe renal impairment.
Topics: Acute Kidney Injury; Adenocarcinoma; Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy P | 2016 |
Metabolic alteration--Overcoming therapy resistance in gastric cancer via PGK-1 inhibition in a combined therapy with standard chemotherapeutics.
Topics: Adenocarcinoma; Adenoviridae; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug | 2015 |
Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for the treatment of primary peritoneal serous carcinoma: Results of a Chinese retrospective study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; China; | 2016 |
Peritoneal carcinomatosis of colorectal cancer: novel clinical and molecular outcomes.
Topics: Adenocarcinoma; Adult; Aged; Body Mass Index; Chemotherapy, Cancer, Regional Perfusion; Colonic Neop | 2017 |
Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation.
Topics: Adenocarcinoma; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; | 2009 |
Chemosensitivity of radioresistant cells in the multicellular spheroids of A549 lung adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Ca | 2009 |
[A case in which intra-arterial chemotherapy for simultaneous hepatic metastases markedly improved AFP-producing gastric cancer].
Topics: Adenocarcinoma; Aged; alpha-Fetoproteins; Antibiotics, Antineoplastic; Antimetabolites, Antineoplast | 2009 |
Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2010 |
A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Cisplatin; Deox | 2011 |
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of recurrent endometrial carcinoma confined to the peritoneal cavity.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Endometrial Neopl | 2010 |
Mitomycin-C, 5-fluorouracil, and leucovorin as a salvage therapy in patients with metastatic colorectal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; F | 2010 |
Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
Topics: Adenocarcinoma; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; B | 2012 |
Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile | 2011 |
[Evaluation of the efficacy of bronchial arterial infusion chemotherapy for the treatment of central non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Car | 2011 |
The prognostic value of grade of regression and oncocytic change in rectal adenocarcinoma treated with neo-adjuvant chemoradiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chem | 2012 |
Outcome of second-line treatment after first-line chemotherapy with the GONO FOLFOXIRI regimen.
Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplast | 2012 |
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis secondary to urachal adenocarcinoma.
Topics: Adenocarcinoma; Adolescent; Adult; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Chemotherapy | 2012 |
A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined | 2012 |
Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2012 |
Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bl | 2012 |
Treatment-related morbidity and toxicity of CRS and oxaliplatin-based HIPEC compared to a mitomycin and doxorubicin-based HIPEC protocol in patients with peritoneal carcinomatosis: a matched-pair analysis.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; | 2013 |
HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; | 2013 |
Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antine | 2013 |
The exposure of cancer cells to hyperthermia, iron oxide nanoparticles, and mitomycin C influences membrane multidrug resistance protein expression levels.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast | 2013 |
Mitomycin-C induced hemolytic uremic syndrome: a case report.
Topics: Adenocarcinoma; Alkylating Agents; Antibiotics, Antineoplastic; Colonic Neoplasms; Diagnosis, Differ | 2002 |
[Gastric cancer with multiple liver metastases, which responded significantly to oral administration of TS-1 following intravenous FMP therapy under hospitalization].
Topics: Adenocarcinoma; Administration, Oral; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combine | 2002 |
Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers - a new active regimen.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma | 2002 |
Influence of 1 and 25 Hz, 1.5 mT magnetic fields on antitumor drug potency in a human adenocarcinoma cell line.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Division; Cell Survival; Cisplatin; Colonic N | 2002 |
[Postoperative adjuvant immunochemotherapy using Lentinan for advanced gastric carcinoma patients with metastasis in the regional lymph nodes and serosal invasion].
Topics: Adenocarcinoma; Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcin | 2002 |
[A case report of intra-hepatic arterial infusion of mitomycin C with degradable starch microspheres for liver metastases of sigmoid colon carcinoma].
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Biodegradation, Enviro | 2002 |
[Clinical comparison between intraoperative local arterial infusion chemotherapy and systemic venous chemotherapy of gastric cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Doxo | 2001 |
[Clinical efficacy of the combination chemotherapy of high-dose epirubicin in non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce | 2001 |
Therapy-related erythroleukemia caused by the administration of UFT and mitomycin C in a patient with colon cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, | 2003 |
[A successful combination therapy with resection and infusion chemotherapy for a patient with metastases from cancer of unknown origin].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dox | 2003 |
Impact of adjuvant chemotherapy in the long-term outcome of patients with resected gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antine | 2003 |
[Study on the chemosensitivity test of human gastric cancer using the MTT assay].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Cisplatin; Drug Screening Assays, Antitumor; Fem | 2001 |
Urinary interleukin-8 levels are elevated in subjects with transitional cell carcinoma.
Topics: Adenocarcinoma; Administration, Intravesical; Aged; Antineoplastic Agents, Alkylating; BCG Vaccine; | 2003 |
[A case report of complete remission of liver metastases from colorectal cancer treated with continuous hepatic arterial infusion].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modal | 2003 |
Mitomycin C for the treatment of pharyngoesophageal stricture after total laryngopharyngectomy and microvascular free tissue reconstruction.
Topics: Adenocarcinoma; Administration, Topical; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; | 2003 |
ONCOLYSIS BY CLOSTRIDIA. III. EFFECTS OF CLOSTRIDIA AND CHEMOTHERAPEUTIC AGENTS ON RODENT TUMORS.
Topics: Adenocarcinoma; Animals; Antimetabolites; Antineoplastic Agents; Aziridines; Bacteriological Techniq | 1964 |
[PRESENT POSSIBILITIES OF CHEMOPROPHYLAXIS, COMPLEMENTARY AND PALLIATIVE CHEMOTHERAPY IN ASSOCIATION WITH SURGERY IN THE TREATMENT OF UTERINE NEOPLASMS].
Topics: Adenocarcinoma; Antineoplastic Agents; Aziridines; Chemoprevention; Female; Fluorouracil; Humans; Mi | 1964 |
Application of molecular diagnosis for detection of peritoneal micrometastasis and evaluation of preoperative chemotherapy in advanced gastric carcinoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; C | 2004 |
Correlation between responsiveness of neoadjuvant chemotherapy and apoptosis-associated proteins for cervical adenocarcinoma.
Topics: Aclarubicin; Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; | 2004 |
Unresectable alpha fetoprotein-producing gastric cancer successfully treated with irinotecan and mitomycin C after S-1 failure.
Topics: Adenocarcinoma; Aged; alpha-Fetoproteins; Antimetabolites, Antineoplastic; Antineoplastic Agents, Ph | 2004 |
A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Comb | 2004 |
[Mitomycin-induced hemolytic uremia syndrome].
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Do | 2004 |
[Multidrug resistant effect of alternative splicing form of MAD2 gene-MAD2beta on human gastric cancer cell].
Topics: Adenocarcinoma; Alternative Splicing; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic | 2004 |
[Five cytostatic substances in animal studies for prevention and treatment of experimentally induced peritoneal carcinomatosis].
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplasti | 2004 |
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: analysis of histopathology and outcome.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deox | 2003 |
[Clinical study of irinotecan therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorecta | 2004 |
[Adjuvant chemotherapy for unresectable locally advanced pancreatic cancer in light of its characteristics].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Deoxyc | 2004 |
Hemicolectomy with concomitant heated intraperitoneal chemotherapy: a case study.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Chemotherapy, Cancer, Regional Perfusion; Colectomy; Co | 2005 |
Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; | 2005 |
Intra-arterial chemotherapy with mitomycin C in gallbladder cancer: a follow-up study.
Topics: Adenocarcinoma; Adult; Antibiotics, Antineoplastic; Combined Modality Therapy; Drug Administration S | 2005 |
[Long-term survival in a case of large bowel cancer--efficacy of CPT-11-based chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Color | 2005 |
Increased dosage of epirubicin and mitomycin-C for the treatment of metastatic adenocarcinoma of unknown primary site.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Biopsy; Dose-Response Relationship, Drug; Epirubicin; H | 1989 |
[A case of gastric cancer with multiple liver metastases effectively treated by hepatic arterial infusion of MMC, TS-1/CDDP therapy, and thermotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy | 2005 |
Transarterial chemoembolization with degradable starch microspheres, irinotecan, and mitomycin-C in patients with liver metastases.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineo | 2006 |
[A case of postoperative liver metastasis from bile duct carcinoma responding to transarterial chemoembolization].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Chemoembo | 2006 |
Acute myeloid leukemia following intraperitoneal hyperthermic mitomycin C.
Topics: Acute Disease; Adenocarcinoma; Adult; Chromosome Inversion; Chromosomes, Human, Pair 16; Female; Hum | 2006 |
Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Cell Survival; Chemotherapy, Cancer, Regi | 2006 |
Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication?
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbon Monoxide; Carcinoma, La | 2006 |
[Effect of combination of glutamine and mitomycin C on human gastric carcinoma cell strain MGC-803].
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Cell Line, Tumor; Dose-Response Relationship, Drug; Dru | 2006 |
Intrapericardial instillation of mitomycin C in recurrent cardiac tamponade due to malignant pericardial effusion.
Topics: Adenocarcinoma; Antineoplastic Agents; Cardiac Tamponade; Deoxycytidine; Fatal Outcome; Female; Gemc | 2006 |
Role of mitomycin in upper digestive tract stricture.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Degl | 2007 |
Synergistic effects of valproic acid and mitomycin C in adenocarcinoma cell lines and fresh tumor cells of patients with colon cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Colonic Neoplasms; | 2006 |
[A case of effective multidisciplinary treatment with hepatic resection for synchronous multiple liver metastases from rectal cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubic | 2006 |
[Case report of a liver metastasis from rectal cancer achieving complete response (CR) by a combination of intra-hepatic arterial infusion of irinotecan (CPT-11) with degradable starch microspheres (DSM) and weekly high-dose intra-hepatic arterial chemoth
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administrat | 2006 |
Mitomycin- and calcineurin-associated HUS, endothelial dysfunction and endothelial repair: a new paradigm for the puzzle?
Topics: Adenocarcinoma; Adult; Antibiotics, Antineoplastic; Antigens, CD34; Biomarkers; Burkitt Lymphoma; Ca | 2007 |
[Effects of pirarubicin chemotherapy combined with hyperthermia on gastric cancer in vitro].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cell Survival; Cisplatin; Dox | 2006 |
[A case of non-small cell lung cancer in which complete response was achieved with chemotherapy including cisplatin, vinorelbine, mitomycin C, followed by additional cisplatin, etoposide and concurrent radiotherapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality | 2006 |
Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal | 2006 |
Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Pro | 2007 |
Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis.
Topics: Activities of Daily Living; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplas | 2007 |
Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 2007 |
[Prolonged hypoxia induces GST-pi expression and drug resistance in lung adenocarcinoma cell line SPCA1].
Topics: Adenocarcinoma; Cell Hypoxia; Cell Line, Tumor; Drug Resistance, Neoplasm; Epirubicin; Glutathione S | 2007 |
Anus-preservation treatment for anal cancer: retrospective analysis at a single institution.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Pro | 2007 |
Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Comb | 2007 |
UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer - a retrospective analysis.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colonic Neo | 2007 |
[Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Comb | 2007 |
Human galectin-2: nuclear presence in vitro and its modulation by quiescence/stress factors.
Topics: 3T3 Cells; Adenocarcinoma; Animals; Biological Transport; Biomarkers; Cell Line, Tumor; Cell Nucleus | 2008 |
Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin.
Topics: Activities of Daily Living; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplas | 2008 |
Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy | 2008 |
Response to a third-line mitomycin C (MMC)-based chemotherapy in a patient with metastatic pancreatic adenocarcinoma carrying germline BRCA2 mutation.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Female; Genes, BRCA | 2008 |
Combination chemotherapy with mitomycin C, methotrexate, cisplatin, and vinblastine in the treatment of non-small cell lung cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcino | 1984 |
Changes in polymorphonuclear leukocyte motility under agarose and luminol-dependent chemiluminescence response in patients with gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Chemotaxis, Leukoc | 1984 |
[Combination chemotherapy consisting of cis-platinum and adriamycin in non-small cell carcinoma of the lung].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, S | 1984 |
[Clinical study of combination chemotherapy with continuously infused peplomycin (PEP), cis-dichlorodiammineplatinum (II) (CDDP) and mitomycin C (MMC) (PPM therapy)].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, S | 1983 |
[The value of carcinoembryonic antigens in patients with advanced lung cancer: in relation to chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carbazilquinone; Carcinoe | 1984 |
[CDDP-containing combination chemotherapy for advanced lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, S | 1984 |
[Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Ce | 1984 |
Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Doxorubicin; Drug Evaluation; Drug Therapy, Comb | 1982 |
Mixed beam radiotherapy and combination chemotherapy in localized pancreatic adenocarcinoma-preliminary results.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Elementary Particles; | 1982 |
Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study.
Topics: Adenocarcinoma; Aged; Ampulla of Vater; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineop | 1982 |
Combination chemotherapy pneumonitis: a case report of possible synergistic toxicity.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Drug Synergism; Drug Therapy, Combination; Female; Huma | 1983 |
Effective retreatment of patients with colorectal cancer and liver metastases.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Colonic Neoplasms; Drug Resistan | 1983 |
Skin rash following therapy with mitomycin C.
Topics: Adenocarcinoma; Adult; Drug Eruptions; Humans; Lung Neoplasms; Male; Mitomycin; Mitomycins | 1984 |
Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Carcinoid Tumor; C | 1983 |
[Transfer factor immunochemotherapy for primary lung cancer--evaluation of histologic types].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; | 1983 |
Interferon-alpha in serum and carcinomatous pleural effusion after repeated intrapleural injections of antitumor agents.
Topics: Adenocarcinoma; Aged; Biological Products; Carcinoma, Small Cell; Drug Therapy, Combination; Female; | 1983 |
Ftorafur, adriamycin and mitomycin C (FAM II) for extensive bronchogenic adenocarcinoma and large cell carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Br | 1984 |
Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome.
Topics: Adenocarcinoma; Adult; Anemia, Hemolytic; Drug Therapy, Combination; Female; Fluorouracil; Humans; K | 1983 |
Reversible microangiopathic hemolytic anemia after mitomycin C.
Topics: Adenocarcinoma; Aged; Anemia, Hemolytic; Antibiotics, Antineoplastic; Humans; Male; Mitomycin; Mitom | 1983 |
[Experimental study on the evaluation of antineoplastic effects in the human cancer/nude mouse system].
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Cyclo | 1983 |
[Combination chemotherapy of advanced gastric cancer with adriamycin, mitomycin C, and ftorafur].
Topics: Adenocarcinoma; Adult; Aged; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; M | 1983 |
Sensitivity of xenografts of human pancreatic adenocarcinoma in nude mice to heat and heat combined with chemotherapy.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line; Cisplatin; Fluorouracil; Hot Temperature; | 1983 |
Response of a human colon adenocarcinoma (DLD-1) to X irradiation and mitomycin C in vivo.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Colonic Neoplasms; Humans; Mice; Mice, Nude; M | 1983 |
Bronchial artery infusion of mitomycin C in carcinoma of the lung.
Topics: Adenocarcinoma; Aged; Bronchial Arteries; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Female; | 1983 |
Mixed adenocarcinoma and anaplastic transitional cell carcinoma of the urinary bladder.
Topics: Adenocarcinoma; Aged; Carcinoma, Transitional Cell; Humans; Male; Mitomycin; Mitomycins; Urinary Bla | 1983 |
Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
Topics: Adenocarcinoma; Adult; Aged; Biological Products; Cytotoxicity, Immunologic; Dactinomycin; Female; H | 1983 |
[Analysis of factors affecting clinical cancer chemotherapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Female; Fluorouraci | 1983 |
[Treatment of metastasizing prostatic carcinoma with DMF. Presentation of a prospective study].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Humans; M | 1983 |
[Chemotherapy of Borrmann's type IV diffuse carcinoma of the stomach].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Fema | 1983 |
Feasibility study of combining metronidazole with chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma, Sq | 1983 |
Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Doxorubicin; Drug Ev | 1983 |
[A gastric cancer patient who underwent curative resection by angiotension-induced hypertension cancer chemotherapy].
Topics: Adenocarcinoma; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Doxo | 1984 |
Combination chemotherapy with BCNU, vincristine, mitomycin-C and prednisone in refractory breast carcinoma. A pilot study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carmu | 1984 |
[An autopsy report of pancreatic carcinoma following the achievement of significant prolongation of survival, despite the lack of a definitive diagnosis].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Lymphatic Metastasis | 1984 |
Inefficacy of dacarbazine, mitomycin C, and hepatic irradiation in patients with metastatic adenocarcinoma of the gastrointestinal tract.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 1984 |
Chemotherapy by bronchial arterial infusion for pulmonary metastases of renal cell carcinoma.
Topics: Adenocarcinoma; Antineoplastic Agents; Carbazilquinone; Doxorubicin; Female; Humans; Infusions, Intr | 1984 |
[Increased cytotoxic effects of various anticancer drugs by alpha-interferon (HLBI) on human tumor xenografts in nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Syner | 1984 |
[Chemosensitivity to mitomycin C and cell kinetics of human tumor xenografts serially transplanted into nude mice].
Topics: Adenocarcinoma; Animals; Cell Cycle; Cell Survival; Humans; Male; Mice; Mice, Nude; Mitomycin; Mitom | 1984 |
Regional intra-arterial mitomycin C infusion in previously treated patients with metastatic colorectal cancer and concomitant measurement of serum drug level.
Topics: Adenocarcinoma; Aged; Bone Marrow; Colonic Neoplasms; Female; Humans; Infusions, Intra-Arterial; Mal | 1984 |
[2 cases of solitary metastasis to the large intestine from gastric carcinoma].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Cyclophosphamide; | 1984 |
Sequential changes in nuclear DNA content by chemotherapy observed in experimental canine gastric cancer.
Topics: Adenocarcinoma; Animals; Carcinogens; Cell Nucleus; DNA, Neoplasm; Dogs; Flow Cytometry; Methylnitro | 1984 |
Chemotherapy of hormone-refractory carcinoma of prostate with 5-fluorouracil, adriamycin, and mitomycin C.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Castration; Doxorubicin; Estro | 1984 |
Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Doxorubicin; D | 1984 |
Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, Adriamycin (doxorubicin), and mitomycin C (modified FAM).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Fl | 1984 |
Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma.
Topics: Adenocarcinoma; Aged; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin | 1984 |
Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, doxorubicin, and mitomycin for residual localized gastric adenocarcinoma: a Southwest Oncology Group pilot study.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Therapy, Co | 1983 |
Combined modality treatment of gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Doxorubicin; Drug Therap | 1983 |
[A case of advanced gastric cancer which disappeared histopathologically after short-time chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyt | 1984 |
[Effect of 7-N-(P-hydroxyphenyl)-mitomycin C (KW-2083) against pleuritis carcinomatosa].
Topics: Adenocarcinoma; Adult; Aged; Anorexia; Antineoplastic Agents; Colonic Neoplasms; Female; Fever; Huma | 1984 |
Efficacy of dacarbazine imidazole carboxamide and mitomycin C combination therapy in patients with adenocarcinoma of the colon refractory to 5-fluorouracil therapy.
Topics: Adenocarcinoma; Colonic Neoplasms; Dacarbazine; Drug Resistance; Drug Therapy, Combination; Female; | 1981 |
Renal disease after mitomycin C therapy.
Topics: Acute Kidney Injury; Adenocarcinoma; Adult; Aged; Blood Pressure; Blood Urea Nitrogen; Creatinine; F | 1981 |
[Chemotherapy associating mitomycin C, thiotepa and vindesine in advanced breast cancers. Study of 100 cases (author's transl)].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Therapy, Combination; Dru | 1981 |
Chemotherapy of pancreatic adenocarcinoma: initial report on two transplantable models in the Syrian hamster.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cricetinae; Cyclophosphamide; Disease Models, Animal | 1982 |
Effects of selected compounds on the McCall rat colon adenocarcinoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Azaserine; Colonic Neoplasms; Drug Therapy, Combinat | 1982 |
[Chemotherapy of renal cell carcinoma. 1. MFC therapy].
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Cytarabine; Drug Therapy, Combination; Eva | 1982 |
[Mytomycin C nephrotoxicity. 3 new cases and review of the literature].
Topics: Adenocarcinoma; Carcinoid Tumor; Creatinine; Female; Gastrointestinal Neoplasms; Humans; Kidney Dise | 1982 |
[Chemotherapy of stomach cancer].
Topics: Adenocarcinoma; Antineoplastic Agents; Carmustine; Cisplatin; Doxorubicin; Drug Administration Sched | 1982 |
[Indication and effect of intra-arterial injection of mitomycin microcapsules in the treatment of kidney cancer].
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Capsules; Delayed-Action Preparations; Dogs; E | 1982 |
[Renal cell carcinoma].
Topics: Adenocarcinoma; Cytarabine; Drug Therapy, Combination; Fluorouracil; Humans; Kidney Neoplasms; Lung | 1982 |
[Phase II study of KW2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with carcinoma of the lung and metastatic pulmonary tumor].
Topics: Adenocarcinoma; Adult; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Drug Evaluation; Femal | 1983 |
[A case of gastric cancer responding well to MTX/5-FU (methotrexate/5-fluorouracil) and PMUE (CDDP, MMC, UFT, etoposide) therapies upon lymphnode recurrence].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched | 1995 |
[A case of pancreatic cancer surviving for 7 years 11 months following intra-arterial and portal infusion chemotherapy].
Topics: Adenocarcinoma; Aged; Disease-Free Survival; Female; Humans; Infusions, Intra-Arterial; Infusions, I | 1995 |
Combination chemotherapy with mitomycin C and cisplatin for advanced gastric cancer with multiple liver metastases.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy | 1994 |
[Experimental and clinical study on chemotherapy for cervical adenocarcinoma].
Topics: Aclarubicin; Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squ | 1995 |
Curative treatments of murine Colon26 solid tumors by immunochemotherapy with G-CSF and OK-432.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Col | 1995 |
Cancer recurrence following laparoscopic colectomy. Report of two patients treated with heated intraperitoneal chemotherapy.
Topics: Adenocarcinoma; Colectomy; Colonic Neoplasms; Fluorouracil; Humans; Infusions, Parenteral; Laparosco | 1995 |
[Intra-arterial infusion chemotherapy for advanced liver metastases from lung cancer via implantable vascular access: report of six cases].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplat | 1995 |
[A case of intrahepatic infusion chemotherapy with angiotensin II human for liver metastasis from early gastric cancer].
Topics: Adenocarcinoma; Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure | 1995 |
A 10-year survivor with unresectable hepatic metastases from sigmoid colon carcinoma treated with regional chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Hepatic Artery; Humans | 1995 |
Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcino | 1993 |
Anti-tumour activity of photodynamic therapy in combination with mitomycin C in nude mice with human colon adenocarcinoma.
Topics: Adenocarcinoma; Animals; Cell Cycle; Cell Death; Colonic Neoplasms; Combined Modality Therapy; Drug | 1995 |
Effects of single and combined application of anti-cancer drugs on cervical adenocarcinoma. I. Antitumor activity in vitro.
Topics: Adenocarcinoma; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Combined | 1995 |
[Home therapy approach in cancer patients-chemotherapy (case 2-1)].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorourac | 1994 |
[Home therapy approach in cancer patients-chemotherapy (case 2-3)--intra-arterial infusion cancer chemotherapy for hepatic metastasis of colorectal cancer--case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic | 1994 |
In vitro effect of lonidamine on the cytotoxicity of mitomycin C and BCNU in human colon adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Carmustine; Cell Cycle; Cell Survival; Colonic Neoplasms; Dos | 1994 |
[A case of gastric cancer with multiple liver metastasis responding to combined therapy with UFT and mitomycin C].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined | 1995 |
A single institutional experience with preoperative chemoradiotherapy for stage I-III pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Angiography; Antineoplastic Combined Chemotherapy Protocols; Blood Loss, Surgi | 1993 |
[A long-survival case of unresectable liver metastasis of colon cancer by hepatic arterial intermittent multidrug infusion chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxoru | 1994 |
[A case of gastric cancer with Borrmann type 4 responding to 5-FU-MMC combined chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Fluoro | 1994 |
5-Fluorouracil, adriamycin, and mitomycin C in adenocarcinoma of the esophagus or gastroesophageal junction tumors.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Esophageal | 1994 |
[A case of cutaneous and brain metastasis of gastric carcinoma, treated effectively by chemotherapy with CDDP, MMC, etoposide and 5'-DFUR].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Ne | 1994 |
Management of advanced colorectal cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal N | 1994 |
Effect of mitomycin C, verapamil, and hyperthermia on human gastric adenocarcinoma.
Topics: Adenocarcinoma; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Hyperthermia, | 1994 |
[Effect of targeting treatment of mitomycin C immunoconjugate on stomach neoplasm].
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Humans; Immunotoxins; Interferon Type I; Mice; Mice | 1993 |
Gastric carcinoma: curative resection and adjuvant chemotherapy.
Topics: Adenocarcinoma; Aged; Anastomosis, Roux-en-Y; Antineoplastic Combined Chemotherapy Protocols; Chemot | 1994 |
[A case of advanced gastric cancer with multiple liver metastases showing marked response to new combination chemotherapy using 5-FU, THP and MMC (FTM)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administrati | 1994 |
[In vitro drug sensitivity testing and chemotherapy of lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic | 1993 |
Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis.
Topics: Adenocarcinoma; Adult; Aged; Analysis of Variance; Chemotherapy, Cancer, Regional Perfusion; Combine | 1994 |
Synergistic antitumor activity of combination chemotherapy with mitomycin C and cisplatin against human gastric cancer xenografts in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Synergism; | 1994 |
[Hypervascular liver metastases of gastric cancer completely responding to transcatheter oily chemoembolization using epirubicin hydrochloride, mitomycin C and lipiodol].
Topics: Adenocarcinoma; Aged; Chemoembolization, Therapeutic; Epirubicin; Female; Humans; Iodized Oil; Liver | 1994 |
[Complete response in a case of unresectable gastric cancer treated by combined chemoimmunotherapy of MMC, 5-FU and OK-432].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; | 1994 |
Encapsulation of mitomycin C in albumin microspheres markedly alters pharmacokinetics, drug quinone reduction in tumour tissue and antitumour activity. Implications for the drugs' in vivo mechanism of action.
Topics: Adenocarcinoma; Albumins; Animals; Antineoplastic Agents; Biotransformation; Colonic Neoplasms; Drug | 1994 |
Morphologic analysis of three-dimensional tumors developed in fibrin matrix and agar culture system.
Topics: Adenocarcinoma; Agar; Animals; Cell Division; Cell Hypoxia; Colonic Neoplasms; Culture Techniques; E | 1993 |
Semiautomated 14C-thymidine incorporation assay for in vitro screening of anticancer drug.
Topics: Adenocarcinoma; Antineoplastic Agents; Carbon Radioisotopes; Carcinoma, Signet Ring Cell; Cell Divis | 1993 |
[Efficacy of 48-hour infusion of 5-fluorouracil for gall bladder cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chem | 1993 |
Potentiation of cytotoxicity of mitomycin C by a polyacetylenic alcohol, panaxytriol.
Topics: Adenocarcinoma; Alkynes; Animals; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Dru | 1994 |
Tumor necrosis factor induces doxorubicin resistance to lung cancer cells in vitro.
Topics: Adenocarcinoma; Cell Cycle; Cisplatin; Cytokines; Doxorubicin; Drug Resistance; G1 Phase; Humans; Lu | 1994 |
Isolation of a mitomycin-resistant human lung adenocarcinoma cell subline to investigate the modulation by sodium butyrate of cell growth and drug resistance.
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Cell Division; Cell Survival; Cisplatin; DNA, Neoplasm; Dru | 1993 |
Concomitant preoperative radiochemotherapy in operable locally advanced rectal cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluoroura | 1994 |
[A case of advanced gastric cancer with liver and lung metastasis effectively treated by combined chemo-immunotherapy of MMC, 5'-DFUR, OK-432].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dru | 1993 |
[Intraperitoneal repeated chemotherapy using CDDP combined with MMC for carcinomatous peritonitis].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administratio | 1993 |
[Four long-surviving cases of gastric cancer with peritoneal dissemination treated by intraperitoneal administration of mitomycin C adsorbed on activated carbon particles].
Topics: Adenocarcinoma; Adult; Aged; Carbon; Chemotherapy, Adjuvant; Delayed-Action Preparations; Female; Ga | 1993 |
[Advanced breast cancer with onset of multi-organ metastases successfully treated with combined loco-regional therapies: a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Ch | 1993 |
Synergistic antitumor activity of mitomycin C and cisplatin against gastric cancer cells in vitro.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Synergism; Humans; M | 1993 |
[A case of bilateral pulmonary metastasis from rectal cancer successfully treated with resection after high-dose 5'-DFUR plus MMC combination chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Flox | 1993 |
Histopathological findings in oesophageal carcinoma with and without preoperative chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1993 |
[Alternative combination chemotherapy with mitomycin C, vincristine, methotrexate, 5-fluorouracil, cis-platinum and adriamycin for adenocarcinoma of the lung].
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Do | 1993 |
Potentiation of photodynamic therapy by mitomycin C in cultured human colon adenocarcinoma cells.
Topics: Adenocarcinoma; Cell Survival; Colonic Neoplasms; Dihematoporphyrin Ether; Dose-Response Relationshi | 1993 |
Reduced bone marrow toxicity of KW-2149, a mitomycin C derivative, in mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Blood Cell Count; Bone Marrow Diseases; Colony-Formi | 1993 |
Differential chemosensitivity of local and metastatic human gastric cancer after orthotopic transplantation of histologically intact tumor tissue in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Combined Modali | 1993 |
Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Tr | 1995 |
[FAM as a palliative chemotherapy for gastric cancer with bone metastasis].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disseminated Intrava | 1996 |
An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Combined Modality Therapy; Duod | 1996 |
Quinone-induced apoptosis in human colon adenocarcinoma cells via DT-diaphorase mediated bioactivation.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Aziridines; Benzoquinones; Colonic Neoplasms; Elec | 1996 |
[A case of effective chemotherapy by combination of 5'-DFUR and MMC for recurrent colon cancer with multiple liver metastasis].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonic Neoplasms; Drug A | 1996 |
Enzymology of mitomycin C metabolic activation in tumour tissue. Characterization of a novel mitochondrial reductase.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Mice; Mice, Inbred Strains; Mitochondria; Mitomycin; Mol | 1996 |
Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brac | 1995 |
A study of induced genotoxicity in MCF-7 cells.
Topics: Adenocarcinoma; Breast Neoplasms; Chromosome Aberrations; DNA Damage; DNA, Neoplasm; Dose-Response R | 1995 |
Sensitivity of cell lines to mitomycin C.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Dose-Response Relationship, Drug; Humans; Hydr | 1996 |
[Liver resection in a case of multiple liver metastases of gastric cancer following hepatic arterial infusion chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy | 1996 |
A case of advanced gastric cancer complicated by severe toxicity induced by a combination of tegafur, uracil and mitomycin C, and associated with abnormal pharmacokinetics.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bone Marrow Diseas | 1996 |
"Sandwich" preoperative and postoperative combined chemotherapy and radiation in tethered and fixed rectal cancer: impact of treatment intensity on local control and survival.
Topics: Adenocarcinoma; Adult; Aged; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Combined Mod | 1997 |
Influence of chemotherapy on FDG uptake by human cancer xenografts in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cisplatin; Deoxyglucose; Doxorubicin; Fluorine Radio | 1997 |
[A case of inoperable advanced gastric cancer remarkably responding to combined chemotherapy with UFT-E, MMC and PSK].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug C | 1997 |
[Secondary hepatic resections in a case of sigmoid colon cancer with multiple liver metastasis (H3) after successful continuous hepatic artery infusion chemotherapy oriented by in vitro chemosensitivity test].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug | 1997 |
Differential effects of EGF and amphiregulin on adhesion molecule expression and migration of colon carcinoma cells.
Topics: Adenocarcinoma; Amphiregulin; Androstadienes; Antigens, CD; Cadherins; Cell Adhesion; Cell Adhesion | 1997 |
Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplas | 1997 |
[Combination therapy with 5'-DFUR, MMC and CDDP in patient with far advanced gastric cancer: report of a case].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; F | 1997 |
[Complete tumor regression obtained by chemoendocrine therapy including toremifene in two cases of pulmonary metastasis of breast cancer with a history of tamoxifen treatment].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; | 1997 |
Retrospective comparison of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (modified FAM) combination chemotherapy versus palliative therapy in treatment of advanced gastric cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplasti | 1997 |
[Evaluation of a new anti-cancer drug regimen against uterine cervical cancer in nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Camptothecin; Ca | 1997 |
5-Fluorouracil + cisplatin + mitomycin C is a relatively most effective combination against xenograft lines of human colorectal cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisp | 1997 |
Suppository administration of chemotherapeutic drugs with concomitant radiation for rectal cancer.
Topics: Adenocarcinoma; Administration, Rectal; Animals; Antibiotics, Antineoplastic; Chromatography, High P | 1997 |
Preliminary results of the use of intraperitoneal carbon-adsorbed mitomycin C in intra-abdominal malignancy.
Topics: Adenocarcinoma; Adsorption; Aged; Antibiotics, Antineoplastic; Carbon; Female; Humans; Male; Middle | 1997 |
Cutaneous metastasis as a complication of hepatic intra-arterial chemotherapy.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorourac | 1997 |
[Locoregional therapy with hypoxic liver perfusion in malignant neoplasms of the gallbladder. Preliminary experience].
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Carcinoid Tumor; Chemotherapy, Cancer, Regional P | 1997 |
Inhibition of lung colonisation of a mouse mammary carcinoma by therapeutic vaccination with interferon-alpha gene-transduced tumor cells.
Topics: Adenocarcinoma; Animals; Cancer Vaccines; Female; Injections, Intraperitoneal; Injections, Intraveno | 1998 |
[A CR case of amylase-producing tumor treated by hyperthermochemotherapy].
Topics: Adenocarcinoma; Amylases; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Floxu | 1998 |
[A case of multiple liver metastasis of gastric cancer responding to hepatic arterial infusion chronotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Circadian Rhythm; Cisplatin; Drug Ad | 1998 |
Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anal Canal; Antineoplastic Combined Chemotherapy Pro | 1998 |
[A case of gastric cancer with peritonitis carcinomatosa and malignant biliary stenosis treated by intraperitoneal CDDP and MMC with UFT therapy].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract | 1998 |
Mitomycin C-related hemolytic uremic syndrome in cancer patients.
Topics: Adenocarcinoma; Adult; Antibiotics, Antineoplastic; Breast Neoplasms; Female; Hemolytic-Uremic Syndr | 1998 |
[Intra-arterial infusion chemotherapy for advanced endometrial cancer before surgical treatment].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel | 1998 |
Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamou | 1998 |
Pharmacological determinants of the antitumour activity of mitomycin C.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Biotransformation; Colonic Neoplasms; Metaboli | 1998 |
[Isolated hypoxic perfusion with mitomycin C confers no benefit for patients with advanced pancreatic carcinoma].
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Cell Hypoxia; Disease Progression; Female; Humans | 1998 |
[Neoadjuvant chemotherapy for advanced cervical cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamou | 1999 |
Investigation of longitudinal vascular changes in control and chemotherapy-treated tumors to serve as therapeutic efficacy predictors.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Capillary Permeability; Contrast Media; Female | 1999 |
Anti-cachectic effect of FK317, a novel anti-cancer agent, in colon26 and LX-1 models in mice.
Topics: Adenocarcinoma; Adipose Tissue; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Blood G | 1998 |
FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biotransformation; Body Weight; Carcinoma, Large Cel | 1998 |
[A case report: modified PMUE therapy might be effective for advanced gastric carcinoma with pulmonary carcinomatous lymphangitis].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched | 1999 |
Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines.
Topics: Acetylcysteine; Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma; C | 1999 |
Clinical significance of serum p53 antibody detection on chemosensitivity assay in human colorectal cancer.
Topics: Adenocarcinoma; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cispla | 1999 |
[Combination of 5'-DFUR and MMC for recurrent rectal cancer with pulmonary metastasis].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; | 1999 |
Peritonectomy and intraperitoneal chemotherapy in appendiceal and colorectal cancer.
Topics: Abscess; Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; | 1999 |
[Intraarterial chemotherapy for uterine cervical adenocarcinoma: evaluation of its efficacy as neoadjuvant therapy].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel | 1999 |
Sensitization of resting T cells to autologous natural-killer-cell-mediated lysis by phytohemagglutinin.
Topics: Adenocarcinoma; Colonic Neoplasms; Concanavalin A; Cycloheximide; Cytotoxicity, Immunologic; Dactino | 1999 |
In vitro augmentation of antitumor effect in combination with CPT-11 and CDDP for human colorectal cancer.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogeni | 2000 |
[A case of recurrent pancreatic cancer brought into a complete response by a multimodal treatment with intraarterial chemotherapy and radiotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy | 2000 |
[A case of stage IVb (H2P0N4T4) gastric cancer successfully treated with neoadjuvant chemotherapy (PMFE therapy)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Fluorour | 2000 |
[Complete remission in a case of sigmoid colon cancer with multiple liver metastases-treatment with arterial chemotherapy and percutaneous microwave coagulation therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Admi | 2000 |
Growth suppression of human ovarian carcinoma OV-MZ-2a and OV-MZ-32 cells mediated by gene transfer of wild-type p53 enhanced by chemotherapy in vitro.
Topics: Adenocarcinoma; Adenoviridae; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cis | 2000 |
[Histoculture drug response assay on non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Camptothecin; Carcinoma, Non- | 2000 |
A case of stage-IVb cervical adenocarcinoma successfully treated by combination chemotherapy: case report.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Adminis | 2000 |
Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas.
Topics: Adenocarcinoma; Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; | 2000 |
Multidrug resistance increment in a human colon carcinoma cell line by colchicine.
Topics: Adenocarcinoma; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Colc | 2000 |
Combination therapy with vascular endothelial growth factor neutralizing antibody and mitomycin C on human gastric cancer xenograft.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Body Weight; Cell Divi | 2000 |
Long-term survival after multimodality treatment for resectable pancreatic cancer.
Topics: Adenocarcinoma; Aged; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Mitomycin; Pancr | 2000 |
Tumor biology: use of tiled images in conjunction with measurements of cellular proliferation and death in response to drug treatments.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycl | 2000 |
Mitomycin C induces apoptosis in a caspases-dependent and Fas/CD95-independent manner in human gastric adenocarcinoma cells.
Topics: Adenocarcinoma; Amino Acid Chloromethyl Ketones; Antibiotics, Antineoplastic; Apoptosis; Caspase 3; | 2000 |
[Lymph node and peritoneum metastases of bile duct cancer responding to chronochemotherapy--a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Cisplatin | 2000 |
[A case of advanced rectal cancer with unresectable liver metastasis for which chemotherapy was markedly effective].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Combined Modal | 2000 |
[A case of colonic cancer with multiple liver metastases effectively treated by intra-arterial chemotherapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Femal | 2000 |
Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis.
Topics: Adenocarcinoma; Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; bcl-X Protein; BH | 2000 |
Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 2000 |
[Induced hypertensive chemotherapy with angiotensin II found effective for mediastinal lymph node metastases of unknown origin].
Topics: Adenocarcinoma; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Doxo | 2000 |
[Long survival in a case of unresectable hepatic metastasis from rectal carcinoma treated with second-look hepatectomy plus pharmacokinetic modulating chemotherapy (PMC)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dru | 2001 |
Options for investigative postsurgical therapy for gastric cancer, and case report of using the option for combined immunotherapy and chemotherapy.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Combin | 2001 |
Advanced adenocarcinoma of the urinary bladder successfully treated by the combination of cisplatinum, mitomycin-C, etoposide and tegafur-uracil chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans | 2001 |
[Long-term survival of a patient with postoperative liver metastasis of stage IVa gallbladder cancer responding to hepatic arterial infusion chemotherapy].
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; C | 2001 |
Undifferentiated leukemia following treatment of gastric cancer with 5 fluorouracil, doxorubicin, mitomycin C chemotherapy.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Marrow; | 2000 |
P-glycoprotein, glutathione and glutathione S-transferase increase in a colon carcinoma cell line by colchicine.
Topics: Adenocarcinoma; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Colc | 2000 |
Apoptosis and epithelial phagocytosis in mitomycin C-treated human pulmonary adenocarcinoma A549 cells.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Apoptosis; Cell Nucleus; Cytosol; Endoplasmic Reticulum | 2001 |
Antitumor activity of expanded human tumor-infiltrating gammadelta T lymphocytes.
Topics: Adenocarcinoma; Adult; Aged; Animals; Cytokines; Cytotoxicity Tests, Immunologic; Female; Humans; Im | 2001 |
Expression of metallothionein in colorectal cancers and synchronous liver metastases.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cispla | 2001 |
Prophylaxis of peritoneal carcinomatosis in experimental investigations.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cisplatin; Fluorouracil; Infusions, Parenteral; Male | 2001 |
Cardiac tamponade as the first manifestation of gastric cancer and remission after chemotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cardiac Tamponade; Cisplatin; | 2001 |
[Adenocarcinomas of the distal esophagus and gastric cardia: what chemotherapy or chemoradiotherapy for recurrent or metastatic disease?].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cardia; Cisplatin; Combined Modality | 2001 |
Implications of peritoneal washing cytology in patients with potentially resectable pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chem | 2002 |
Evaluation of intraoperative intraperitoneal cytology for advanced gastric carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Car | 2002 |
Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transport | 2002 |
Metastatic bronchioloalveolar carcinoma and metastatic adenocarcinoma of the lung: comparison of clinical manifestations, chemotherapeutic responses, and prognosis.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Age Factors; Aged; Antineoplastic Combin | 1992 |
[A case of multiple pulmonary metastases from duodenal cancer showing partial response using 5'-DFUR and a small dose of MMC].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Duodenal Neoplasms; Female; Fl | 1992 |
[Successful treatment of adenocarcinoma of the lung with bone metastases by combined chemotherapy with epirubicin, mitomycin C and carboplatin].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Epirubi | 1992 |
Advantages of the Papillon protocol in the preoperative treatment of rectal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Protocols; Com | 1992 |
Cytotoxicity and cytokinetic effects of mitomycin C and/or photochemotherapy in a human colon adenocarcinoma cell line.
Topics: Adenocarcinoma; Cell Cycle; Cell Survival; Colonic Neoplasms; Flow Cytometry; Humans; Mitomycin; Pho | 1992 |
Effects of chemotherapy on ultrastructure of oesophageal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Nucleolus; Cisplat | 1992 |
[A new method of in vitro chemosensitivity test using multicellular spheroids of cholangiocarcinoma cell line cocultured with fibroblasts].
Topics: Adenocarcinoma; Bile Duct Neoplasms; Drug Screening Assays, Antitumor; Fibroblasts; Humans; Mitomyci | 1992 |
Myeloprotective activity of deoxyspergualin: influence on splenic colony-forming cell injury and antitumor activity of mitomycin C in mice.
Topics: Adenocarcinoma; Animals; Blood Cells; Bone Marrow; Bone Marrow Cells; Colonic Neoplasms; Dose-Respon | 1992 |
Complete disappearance of metastatic abdominal tumors from gastric cancer after treatment with irsogladine maleate.
Topics: Abdominal Neoplasms; Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Pro | 1992 |
[Chemotherapy-associated hemolytic uremic syndrome--a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; | 1992 |
Effect of mitomycin C on the uptake of photofrin II in a human colon adenocarcinoma cell line.
Topics: Adenocarcinoma; Cell Cycle; Cell Division; Cell Membrane Permeability; Cell Survival; Colonic Neopla | 1992 |
Mitomycin C, 5-fluorouracil and radiation in advanced, locally recurrent rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 1992 |
[Histological evaluation of intra-arterial infusion and systemic chemotherapy of pancreatic carcinomas].
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy | 1992 |
[Estimating doses of anti-cancer agents in sensitivity tests in vitro].
Topics: Adenocarcinoma; Antineoplastic Agents; Carboplatin; Cisplatin; Doxorubicin; Drug Screening Assays, A | 1992 |
[A case of advanced gastric cancer with liver metastasis completely responding to a combined immunochemotherapy with UFT, mitomycin C and lentinan].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Humans; Lentinan; Liver Neopla | 1992 |
[A case report of complete remission of liver metastasis from rectal carcinoma treated with intra-arterial infusion chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Infusion | 1992 |
[Intra-arterial infusion chemotherapy using implantable reservoir for liver metastasis of the lung cancer--an effective case].
Topics: Adenocarcinoma; Aged; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial | 1992 |
Long-term results of combined modality treatment with I-125 implantation for carcinoma of the pancreas.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Combined | 1992 |
The use of ATP bioluminescence assays in selecting a drug screen panel for chemosensitivity testing of uterine cancer cell lines.
Topics: Adenocarcinoma; Adenosine Triphosphate; Alkaloids; Antineoplastic Agents; Cisplatin; Cyclophosphamid | 1992 |
[Characterization of two novel cell lines established from a single human uterine cervical adenocarcinoma, and their chemosensitivities and hormonal effects on their proliferation].
Topics: Adenocarcinoma; Animals; Carbazilquinone; Cell Division; Drug Screening Assays, Antitumor; Estradiol | 1992 |
Relationship between tumor histopathology and in vitro sensitivity to antitumor drugs in gastric cancer.
Topics: Aclarubicin; Adenocarcinoma; Antineoplastic Agents; Carbazilquinone; Cisplatin; Doxorubicin; Drug Sc | 1992 |
Doxorubicin and cyclophosphamide, alternated with bleomycin and mitomycin C as a second-line regimen in advanced ovarian carcinoma resistant to cisplatin-based chemotherapy.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 1990 |
Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; | 1991 |
Increased drug resistance of cultured human cancer cell lines in three-dimensional cellular growth assay using collagen gel matrix.
Topics: Adenocarcinoma; Antineoplastic Agents; Cisplatin; Collagen; Colonic Neoplasms; Culture Media; Doxoru | 1992 |
A phase II study of 5-fluorouracil, adriamycin and mitomycin-C in adenocarcinoma of the oesophagus.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dox | 1991 |
[Complete response in a case of rectal carcinoma with multiple liver metastasis treated by infuse-a-port].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hepatic Artery; Humans | 1991 |
5-Fluorouracil (FU) and mitomycin C (MMC) in the management of colorectal carcinoma. Part II. In vitro activity of the two drugs in short-term tumor cultures.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; DNA, Neoplasm; | 1991 |
[5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Etoposide; Female; | 1991 |
[A case of pulmonary metastasis from colon cancer responding completely to high-dose 5'-DFUR plus MMC combination chemotherapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic | 1991 |
Combination effect of recombinant human interleukin 1 alpha with antitumor drugs on syngeneic tumors in mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Col | 1991 |
[Studies on chemotherapy in adenocarcinoma of the uterine cervix using xenografts transplanted in nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cyclophospha | 1991 |
[A case of inoperable advanced gastric cancer with effective treatment by local administration of OK-432, intra-abdominal administration of CDDP, and long-term high-dose mitomycin C, and UFT].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Com | 1991 |
Subrenal capsule assay using nude mice as a predictor of the response of the gastric cancer to chemotherapy.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Fluorouracil; Huma | 1991 |
[A long-term survival case of advanced gastric cancer undergoing radical gastrectomy by second-look operation after successful chemotherapy (CDDP, MMC, 5-FU)].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy | 1991 |
[A study on hepatic arterial infusion for metastatic liver tumor].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; | 1991 |
[Long-term arterial infusion chemotherapy combined with external irradiation therapy for unresectable pancreatic cancer--a case report].
Topics: Adenocarcinoma; Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Combined Modal | 1991 |
Combined radiation therapy, mitomycin C, and 5-fluorouracil for locally recurrent rectal carcinoma: results of a pilot study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 1991 |
Extrahepatic biliary system cancer: an update of a combined modality approach.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Brach | 1991 |
5-fluorouracil, ifosfamide and mitomycin (FIM) combination for pancreatic-biliary tumors.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bili | 1991 |
[Chemotherapy in cancers of the gallbladder and bile ducts].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cytarabine; | 1991 |
[An advanced gastric carcinoma which responded to combined administration of mitomycin C, FT-207, and lentinan immunochemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Gastrecto | 1990 |
Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Hu | 1990 |
Open phase II with 5-fluorouracil, 4-epi-doxorubicin and mitomycin C (FEM) in advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Evalu | 1990 |
[Intratumoral injection of mitomycin for adenocarcinoma of the duodenum].
Topics: Adenocarcinoma; Aged; Duodenal Neoplasms; Humans; Injections, Intralesional; Male; Mitomycin; Mitomy | 1990 |
Experimental study on multidisciplinary treatment of pancreatic cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Combined Modality Therapy; Cricetinae; Disease Model | 1990 |
Acute non-lymphocytic leukemia following FAM combination adjuvant chemotherapy for gastric and lung adenocarcinoma.
Topics: Adenocarcinoma; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherap | 1990 |
[Successful treatment of advanced gastric cancer with multiple liver metastasis by combination chemotherapy using mitomycin C, 5-fluorouracil, and high-dose leucovorin: a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; | 1990 |
Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Body Weight; Colonic Neoplasms; Drug Screening Assay | 1990 |
Silent renal microangiography after mitomycin C therapy.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Human | 1990 |
[Effects of immuno-drug conjugates on growth of human gastric cancer xenograft in subrenal capsule of nude mice].
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Daunorubicin; Immunoto | 1990 |
Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. The Gastrointestinal Tumor Study Group experience.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 1990 |
[A markedly effective combination therapy of 5'-DFUR and MMC in advanced gastric cancer--a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Floxuridine; Humans; M | 1990 |
Reappraisal of bronchial arterial infusion therapy for advanced lung cancer.
Topics: Adenocarcinoma; Adjuvants, Pharmaceutic; Aged; Carbazilquinone; Carcinoma, Small Cell; Carcinoma, Sq | 1990 |
[A case of recurrent liver tumor from gastric cancer responding remarkably to intra-hepato-arterial infusion of CDDP, MMC and Lipiodol].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Hepatic Art | 1990 |
[Bronchial arterial infusion chemotherapy with or without radiotherapy for advanced lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Car | 1990 |
[Combination chemotherapy with peplomycin, cis-platinum and mitomycin C in gynecologic cancer].
Topics: Adenocarcinoma; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; | 1985 |
[Alternating combination chemotherapy (VIP-DMF) in patients with advanced adenocarcinoma of the prostate].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Drug A | 1987 |
[Combination therapy with lentinan, mitomycin c, 5-fluorouracil and radiation--a case of long-term survival of pancreas cancer after palliative surgery].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Flu | 1987 |
Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 1987 |
[Combination chemotherapy including cisplatin in lung cancer by bronchial artery infusion].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, S | 1988 |
[The inhibitory effect of mitomycin C on experimental liver metastasis of alpha-fetoprotein producing human gastric carcinoma induced by intra-splenic transplantation in nude mice].
Topics: Adenocarcinoma; alpha-Fetoproteins; Animals; Humans; Liver Neoplasms; Male; Mice; Mice, Nude; Mitomy | 1988 |
Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleo | 1989 |
[The drug sensitivity of human gastric cancer implanted into the subcutis and stomach wall of nude mice].
Topics: Adenocarcinoma; Animals; Bleomycin; Drug Screening Assays, Antitumor; Humans; Male; Mice; Mice, Inbr | 1989 |
Alternating 5-FU-mitomycin C/5-FU-dacarbazine in advanced colorectal adenocarcinoma: a phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; D | 1989 |
[Acute dyspnea following intravenous administration of vinblastine/mitomycin C].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dyspnea; Female; H | 1989 |
Postoperative adjuvant chemotherapy and radiotherapy for cancer of the large bowel and rectum.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cecal Neoplasms; Colonic Neop | 1989 |
Cisplatin, 5-fluorouracil, mitomycin C, and concurrent radiation therapy with and without esophogectomy for esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel | 1989 |
Mitomycin C adjuvant chemotherapy after Wertheim's hysterectomy for stage IB cervical cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Follow-Up Studies; Huma | 1989 |
Concurrent radiation and chemotherapy in vulvar carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone | 1989 |
[Comparative study of tegafur (p.o.) and mitomycin C (MMC) plus tegafur in cases of unresectable gastric cancer].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Female; Humans | 1989 |
Cis-platinum and mitomycin-C in treatment of recurrent, metastatic, or residual uterine cervical cancer post radiation.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cis | 1989 |
[A case report of retrovesical tumor effectively responsive to chemotherapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Mal | 1989 |
[An unresectable gastric cancer radically resectable following UFT, ADM, MMC therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubic | 1989 |
[A case of advanced gastric cancer with Virchow's node metastasis, responding to concomitant plasma exchange and immunochemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Combined Modali | 1989 |
[A case of multiple pulmonary metastases from rectal cancer which responded completely to combination chemotherapy using 5'-DFUR and MMC].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Tolerance; Floxuridine; H | 1989 |
[Metastatic liver cancer from the stomach successfully treated by combined immunochemotherapy and transarterial embolization].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabin | 1989 |
Antitumor activity of 7-N-(2-((2-(gamma-L-glutamylamino) ethyl) dithio) ethyl) mitomycin C (KW2149) against human tumor xenografts serially transplanted into nude mice.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Animals; Antineoplastic Agents; Carcinoma; Carcinoma, Int | 1989 |
[Two cases of digestive cancer demonstrated remarkable regression by hyperthermia with systemic chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Colonic N | 1989 |
[Current status in the treatment of inoperable non-small cell lung cancer (NSCLC)].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Ca | 1985 |
[Effects of bronchial artery infusion (B-AI) with single use of MMC after intravenous peplomycin (PEP) administration in lung cancer].
Topics: Adenocarcinoma; Bleomycin; Bronchial Arteries; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Huma | 1985 |
Bleomycin, vincristine, mitomycin-C, and cisplatin in the management of gynecological squamous cell carcinomas.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, S | 1985 |
Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas. A non-randomized pilot study.
Topics: Activities of Daily Living; Adenocarcinoma; Aged; Ampulla of Vater; Antineoplastic Combined Chemothe | 1989 |
Phase II trial of methotrexate-FAM (m-FAM) in adenocarcinoma of unknown primary.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Evalu | 1989 |
Mitomycin C in advanced cervical cancer.
Topics: Adenocarcinoma; Adult; Carcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Humans; M | 1987 |
Biological features and chemosensitivity of human colorectal cancer xenografted in nude mice.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Animals; Antineoplastic Agents; Carcinoembryonic Antigen; | 1987 |
Mitomycin C, vinblastine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce | 1987 |
Enhancement of differentiated type 2 cell function in the A549 cell line using mitomycin C1.
Topics: Adenocarcinoma; Cell Differentiation; Cell Division; Cell Line; Choline; Choline-Phosphate Cytidylyl | 1987 |
Enhancement of cis-diamminedichloroplatinum and mitomycin C-induced sister chromatid exchanges by dibutyryl cyclic AMP in a human salivary gland adenocarcinoma cell line in culture.
Topics: Adenocarcinoma; Bucladesine; Cisplatin; Drug Synergism; Humans; Mitomycin; Mitomycins; Salivary Glan | 1988 |
Radiation therapy for advanced gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; | 1988 |
[Experimental chemotherapy of human gastric cancer cell lines in vitro and in nude mice].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Allyl Compounds; Animals; Antibiotics, Antineoplastic; Cel | 1988 |
Simultaneous chemotherapy-radiotherapy with prophylactic cranial irradiation for inoperable adeno and large cell lung carcinoma: a Southwest Oncology Group Study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcin | 1988 |
[Missile therapy using monoclonal antibody drug conjugates in colorectal carcinoma].
Topics: Adenocarcinoma; Aged; Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Colonic Neoplasm | 1987 |
Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. II. Generation of specific and non-specific killer T cells capable of lysing autologous tumor.
Topics: Adenocarcinoma; Antigens, Differentiation, T-Lymphocyte; Carcinoma, Squamous Cell; Cell Separation; | 1988 |
[Experience with induced hypertension chemotherapy for lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood P | 1985 |
[Effect of adriamycin, mitomycin-C, and tegafur (AMF) chemotherapy on advanced lung cancer].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Doxorub | 1985 |
[A case of adenoid cystic carcinoma in the paranasal sinuses with 8-year survival after pulmonary metastasis-- clinicopathological reference to 6 non-squamous cell carcinoma cases in the paranasal sinuses].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Cyt | 1985 |
[Low-dose intermittent intra-arterial infusion chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Dox | 1985 |
Evaluation of a new drug 7-N-(p-hydroxyphenyl)-mitomycin C [KW 2083] against carcinoma of the lung by the human tumor clonogenic assay.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; C | 1985 |
[Chemotherapy with mitomycin C, vindesine and ifosfamide in the treatment of inoperable non-small cell bronchial carcinoma].
Topics: Adenocarcinoma; Aged; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug | 1985 |
[Combination chemotherapy with cis-platinum, adriamycin and mitomycin C (PAM) in the treatment of non-small cell carcinoma of the lung].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcino | 1986 |
[Combination chemotherapy with etoposide, mitomycin C, and cyclophosphamide in advanced non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; | 1986 |
[Growth rate of human colorectal cancer xenografted in nude mice].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Animals; Carcinoembryonic Antigen; Cell Division; Cell Lin | 1987 |
Poorly differentiated human gastric carcinoma is more sensitive to antitumor drugs than is well differentiated carcinoma.
Topics: Aclarubicin; Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Age | 1987 |
5-Fluorouracil, doxorubicin, and mitomycin-C in the treatment of adenocarcinoma and large cell carcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; | 1987 |
[Transcatheter arterial embolization therapy of recurrent pelvic cancer].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Catheterization | 1986 |
Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome.
Topics: Adenocarcinoma; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Colonic N | 1986 |
[Combination cancer chemotherapy of human gastric and colon carcinomas in nude mice--sequential cancer chemotherapy involving mitomycin C and tegafur].
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; DNA, Neo | 1986 |
[Changes in cancer associated cellular proteins after administration of antitumor agent using 2-dimensional PAGE--index of efficacy of antitumor agents].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Electrophoresis, Polyacrylamide Gel; Female; Humans; | 1986 |
Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycin.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Arginine; Argininosuccinic Ac | 1986 |
Combined preoperative neoadjuvant radiotherapy and chemotherapy for anal and rectal cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squ | 1986 |
[In vitro sensitivity testing of human kidney tumors to cytostatic drugs with a rapid in vitro test].
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Survival | 1986 |
[A case of multiple liver metastases from sigmoid carcinoma treated successfully with arterial infusion chemotherapy].
Topics: Adenocarcinoma; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Catheterization; Dru | 1986 |
A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Colonic Neoplasms; Female; Hemolytic-Uremic Syndrome; Humans; Hypoxia; | 1986 |
[Microangiopathic hemolytic anemia associated with gastric cancer].
Topics: Adenocarcinoma; Aged; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Benzodiazep | 1986 |
[A case of an aged woman with advanced gastric cancer which dramatically responded to combined chemotherapy with UFT and mitomycin C].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Mitomycin; Mit | 1986 |
Microangiopathic hemolytic anemia, noncardiac pulmonary edema, and renal failure after treatment of metastatic adenocarcinoma of the colon with 5-fluorouracil and mitomycin-C: report of a case.
Topics: Adenocarcinoma; Anemia, Hemolytic; Colonic Neoplasms; Female; Fluorouracil; Humans; Kidney Failure, | 1986 |
Prognostic factors in metastatic carcinoma of unknown primary.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; | 1986 |
[Combined effect of PT-050 (recombinant human TNF) and antitumor drugs on syngeneic murine tumors].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Doxo | 1986 |
[Effect of intratumor mitomycin-C injection on growth of homologously implanted pancreatic cancer in Syrian golden hamster].
Topics: Adenocarcinoma; Animals; Cricetinae; Instillation, Drug; Mesocricetus; Mitomycin; Mitomycins; Neopla | 1986 |
[Huge Virchow's metastasis in gastric cancer made resectable by hyperthermochemoradiotherapy].
Topics: Adenocarcinoma; Aged; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Hypertherm | 1986 |
[Combination chemotherapy with mitomycin C, adriamycin and cisplatin (MAP) in advanced adenocarcinoma of the lung: clinical effect and renal toxicity].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; | 1987 |
Phase II clinical trial of triazinate in combination with mitomycin C for patients with advanced gastric cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Human | 1987 |
[A model for the sensitivity determination of anticancer agents against human cancer using nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Cell Line; Cisplatin; Colonic Neoplas | 1987 |
[Successful treatment of advanced gastric cancer by combined cisplatinum, mitomycin C and 5-FU administration. A case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Gas | 1987 |
Chronic glomerular microangiopathy complicating metastatic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Anemia, Hemolytic; Blood Coagulation; Chronic Disease; Female; Hemolyti | 1987 |
[Improved quality of life in a patient with Borrmann type 4 gastric cancer treated with combination chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Methot | 1987 |
[Advanced gastric cancer with DIC and multiple bone metastasis treated with surgical resection and chemotherapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Co | 1987 |
[Complete response of unresectable gastric cancer (Borrmann's type III) treated with combination chemotherapy of UFT and mitomycin--a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Humans; Male; Mitomycin; Mitom | 1987 |
Production and biological activity of rebeccamycin, a novel antitumor agent.
Topics: Actinomycetales; Adenocarcinoma; Aminoglycosides; Animals; Anti-Bacterial Agents; Antibiotics, Antin | 1987 |
[Microangiopathic hemolytic anemia (MAHA) observed after administration of mitomycin C (MMC)].
Topics: Adenocarcinoma; Anemia, Hemolytic; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Postoperative C | 1987 |
[A case of gastric cancer with peritonitis carcinomatosa which improved upon oral administration of UFT, mitomycin C and lentinan].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; | 1987 |
Liver metastasis of colon 26 cells implanted into the superior mesenteric vein in mice.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Disease Models, Animal; Injections, Intravenous; Liver N | 1987 |
[Flow cytometry DNA analysis of a gastric cancer before and after intra-arterial anticancer chemotherapy--report of a case].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; DNA, Neoplasm; Doxorubicin; Fe | 1988 |
Cure of advanced gastric cancer by combined chemotherapy with cisplatinum, mitomycin C, and 5-fluorouracil.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorourac | 1988 |
Effect of endocrine treatment on prostatic blood flow in patients with prostatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Castration; Combined Modality Therap | 1988 |
[A case of intrahepatic bile duct cancer responding to 5-fluorouracil, adriamycin and mitomycin C chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Int | 1988 |
5-Fluorouracil, high-dose folinic acid, and mitomycin C combination chemotherapy in advanced gastrointestinal adenocarcinomas. A pilot study.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; | 1988 |
Intraperitoneal mitomycin C in the treatment of peritoneal carcinomatosis following second-look surgery.
Topics: Adenocarcinoma; Aged; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Carcinoma; Combi | 1988 |
[Changes in two-dimensional gel electrophoretic patterns of cellular protein spots in tumors after administration of mitomycin C].
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Electrophoresis, Polyacrylamide Gel; Female; Mice; Mice, | 1988 |
[Two cases of obstructive jaundice due to advanced gastric cancer with marked response to the intravenous administration of cisplatinum].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cholestasis; Cisplatin; Female | 1988 |
[Intra-arterial chemotherapy combined with mitomycin C and degradable starch microspheres in unresectable metastatic liver carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Papillary; Combined Modality Therapy; Embolization, Therapeu | 1988 |
[Complete response in a case of unresectable gastric cancer with a combination of tegafur, 5-fluorouracil and mitomycin C].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Infusion | 1988 |
[An experimental attempt to potentiate therapeutic effects of combined use of pulsing magnetic fields and antitumor agents].
Topics: Adenocarcinoma; Animals; Cell Division; Combined Modality Therapy; Cricetinae; DNA, Neoplasm; Electr | 1988 |
Combined modality preoperative therapy in poor prognostic rectal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Comb | 1988 |
[Hemolytic-uremic syndrome caused by mitomycin C].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Hemolytic-Uremic Syndr | 1988 |
[Anticancer activities of a new mitomycin derivative KW 2149, against human tumors xenografted into nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Colonic Neoplasms; Infusions, Parenteral; Lethal Dos | 1988 |
[Three cases of renal failure associated with microangiopathic hemolytic anemia after mitomycin C therapy].
Topics: Adenocarcinoma; Aged; Anemia, Hemolytic; Breast Neoplasms; Female; Fluorouracil; Glomerulonephritis, | 1988 |
Hepatobiliary scintigraphy in patients receiving hepatic artery infusion chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cholecystitis; Colonic Neoplasms; Do | 1985 |
5-Fluorouracil, doxorubicin and mitomycin C (FAM) combination chemotherapy for metastatic adenocarcinoma of unknown primary.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Evalu | 1988 |
[Clinical evaluation of implantable drug delivery system (Port-A-Cath) in cancer chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 1988 |
Phase II trial of sequential chemotherapy and low-dose radiotherapy in advanced gastric adenocarcinoma. A Southwest Oncology Group Pilot Study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carm | 1987 |
Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.
Topics: Adenocarcinoma; Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Body Wei | 1986 |
5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Evalu | 1986 |
Cardiac tamponade as the only initial feature of malignancy: a case report and review of the literature.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiac Tamponade; Common Col | 1986 |
Chemotherapy improves pulmonary function in a patient with gastric cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Hum | 1986 |
5-Fluorouracil, adriamycin, and mitomycin-C (FAM) in the treatment of inoperable adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Admin | 1986 |
Gastric cancer: complete chemotherapy response in an elderly woman: current status of treatment.
Topics: Adenocarcinoma; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fema | 1985 |
Mitomycin and methotrexate: negative experience in untreated colorectal carcinoma.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Hem | 1985 |
[Fluctuations of cancer tissue cell proteins determined by two-dimensional electrophoresis before and after antineoplastic agent administration--indices of the efficacy of antineoplastic agents].
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; DNA Replication; Electrophoresis; Female; Humans; Mice; | 1985 |
Characteristics of T cells involved in the expression of delayed hypersensitivity and tumor rejection immunity to 13762A rat mammary adenocarcinoma.
Topics: Adenocarcinoma; Animals; Antigens, Neoplasm; Antigens, Surface; Cyclophosphamide; Female; Hydroxyure | 1985 |
Cyclic combination chemotherapy in advanced adenocarcinoma of the lung: comparison of two FAM schedules.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Fl | 1985 |
Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
Topics: Acute Kidney Injury; Adenocarcinoma; Adult; Anemia, Hemolytic; Antibiotics, Antineoplastic; Antigen- | 1985 |
Erosive gastroduodenitis with marked epithelial atypia after hepatic arterial infusion chemotherapy.
Topics: Adenocarcinoma; Aluminum; Cimetidine; Colonic Neoplasms; Fluorouracil; Gastric Mucosa; Humans; Infus | 1985 |
Enhancement of antitumor effect of cytotoxic agents by bestatin.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Cisplatin; Colonic Neop | 1985 |
[A case of gastric cancer successfully treated with hyperthermo-chemo-radiotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; H | 1985 |
Mitomycin-C plus metronidazole in advanced carcinoma of the breast.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Breas | 1985 |
Gastric epithelial atypia associated with hepatic arterial infusion chemotherapy. Its distinction from early gastric carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Biopsy; Diagnosis, Differential; Endoscopy; Epithelium; Female; Gastrec | 1985 |
[A long survival case of carcinoma of the colon with hepatic metastasis following intra-arterial infusion chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Calcinosis; Colonic Neoplasms; Fluor | 1985 |
[A combined chemotherapy with UFT and mitomycin C in advanced gastric cancer; report of 2 cases].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Drug Administr | 1985 |
Chemoradiation therapy and resection for carcinoma of the esophagus: short-term results.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Proto | 1985 |
[Coexisting malignant lymphoma and advanced adenocarcinoma of the colon--a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Cyclophosphamide; | 1985 |
Chemotherapy for adenocarcinomas of bladder and urachal origin: 5-fluorouracil, doxorubicin, and mitomycin-C.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antige | 1985 |
Combination chemotherapy with mitomycin-C, cisplatin, and vinblastine in the treatment of non-small-cell lung cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Bronchog | 1985 |
[Administration of mitomycin-C with an inactivator].
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Drug Therapy, Combination; Humans; Lactates; L | 1985 |
In vitro chemosensitivity tests on human tumor xenografts by clonogenic assay: the combined use of mitomycin C with alpha-interferon or gamma-interferon.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Colonic Neoplasms; Colony-Forming Units Assay; | 1985 |
[Clinical application of local hyperthermia combined with antineoplastic agents].
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Adult; Aged; Antineoplastic Agents; Body Temperature; Cis | 1985 |
[Effective postoperative chemotherapy of gastric cancer associated with disseminated carcinomatosis of the bone marrow].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Marrow; | 1985 |
[Effect of KW-2083 in Stage D adenocarcinoma of the prostate].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Drug Administration Schedule; Humans; Male; Mitomycin; | 1985 |
[A combination chemotherapy using mitomycin C, vincristine and cisplatin (MVP) for advanced cervical cancer].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug | 1985 |
Immunochemosurgery for gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Combined Modali | 1985 |